<SEC-DOCUMENT>0000950103-25-011965.txt : 20250922
<SEC-HEADER>0000950103-25-011965.hdr.sgml : 20250922
<ACCEPTANCE-DATETIME>20250922173012
ACCESSION NUMBER:		0000950103-25-011965
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20250922
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250922
DATE AS OF CHANGE:		20250922

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Strive, Inc.
		CENTRAL INDEX KEY:			0001920406
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		ORGANIZATION NAME:           	09 Crypto Assets
		EIN:				881293236
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41612
		FILM NUMBER:		251331019

	BUSINESS ADDRESS:	
		STREET 1:		100 CRESCENT CT
		STREET 2:		7TH FLOOR
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201
		BUSINESS PHONE:		214-459-3117

	MAIL ADDRESS:	
		STREET 1:		100 CRESCENT CT
		STREET 2:		7TH FLOOR
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Asset Entities Inc.
		DATE OF NAME CHANGE:	20220330
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>dp234662_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:ASST="http://assetentities.com/20250922">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_ASST_assetentities.com_20250922 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20250922_20250922 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0001920406 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-09-22" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-22" id="Fact000004" name="dei:EntityCentralIndexKey">0001920406</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="asst-20250922.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-09-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001920406</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-22</xbrli:startDate>
        <xbrli:endDate>2025-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 14pt"><b>FORM <span id="xdx_90C_edei--DocumentType_c20250922__20250922_z9mviBdZI0Aa"><ix:nonNumeric contextRef="AsOf2025-09-22" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 OR 15(d) of The Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span id="xdx_905_edei--DocumentPeriodEndDate_c20250922__20250922_z2HnD9huy7y5"><ix:nonNumeric contextRef="AsOf2025-09-22" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">September 22, 2025</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 100%; font-size: 12pt; text-align: center"><span style="font-size: 14pt"><b><span id="xdx_90C_edei--EntityRegistrantName_c20250922__20250922_zvdQbIyBB6X8"><ix:nonNumeric contextRef="AsOf2025-09-22" id="Fact000011" name="dei:EntityRegistrantName">STRIVE, INC.</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 12pt; text-align: center"><span style="font-size: 10pt">(Exact name of Company as specified in its charter)</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20250922__20250922_zSDeLij1PYsh"><ix:nonNumeric contextRef="AsOf2025-09-22" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_900_edei--EntityFileNumber_c20250922__20250922_zXlG1cz3F5Cb"><ix:nonNumeric contextRef="AsOf2025-09-22" id="Fact000013" name="dei:EntityFileNumber">001-41612</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20250922__20250922_z4o7VfFsDlL5"><ix:nonNumeric contextRef="AsOf2025-09-22" id="Fact000014" name="dei:EntityTaxIdentificationNumber">88-1293236</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of incorporation)&#160;</p></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)&#160;</p></td></tr>
  </table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 49%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressAddressLine1_c20250922__20250922_zjIcIgMuniPb"><ix:nonNumeric contextRef="AsOf2025-09-22" id="Fact000015" name="dei:EntityAddressAddressLine1">200 Crescent Ct</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressAddressLine2_c20250922__20250922_zzdnrpLkJFCg"><ix:nonNumeric contextRef="AsOf2025-09-22" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 1400</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressCityOrTown_c20250922__20250922_zp3yYeAudhu9"><ix:nonNumeric contextRef="AsOf2025-09-22" id="Fact000017" name="dei:EntityAddressCityOrTown">Dallas</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressStateOrProvince_c20250922__20250922_zAhJNHU9pyg1"><ix:nonNumeric contextRef="AsOf2025-09-22" id="Fact000018" name="dei:EntityAddressStateOrProvince">TX</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 49%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressPostalZipCode_c20250922__20250922_zgzm6xiI4BWe"><ix:nonNumeric contextRef="AsOf2025-09-22" id="Fact000019" name="dei:EntityAddressPostalZipCode">75201</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(Address of principal executive offices)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 100%; text-align: center"><span style="font-size: 10pt"><b>(<span id="xdx_90A_edei--CityAreaCode_c20250922__20250922_znNdCPM2fayg"><ix:nonNumeric contextRef="AsOf2025-09-22" id="Fact000020" name="dei:CityAreaCode">855</ix:nonNumeric></span>) <span id="xdx_908_edei--LocalPhoneNumber_c20250922__20250922_zWuaIbf4ZtYk"><ix:nonNumeric contextRef="AsOf2025-09-22" id="Fact000021" name="dei:LocalPhoneNumber">427-7360</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(Company&#8217;s telephone number, including area code)</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 100%; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt">(Former name or former address, if changed since last report)</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><span id="xdx_903_edei--WrittenCommunications_c20250922__20250922_z7Cn67973B8a"><ix:nonNumeric contextRef="AsOf2025-09-22" format="ixt:booleantrue" id="Fact000022" name="dei:WrittenCommunications">&#9746;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><span id="xdx_90F_edei--SolicitingMaterial_c20250922__20250922_z3pOttGlu5A3"><ix:nonNumeric contextRef="AsOf2025-09-22" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><span id="xdx_90D_edei--PreCommencementTenderOffer_c20250922__20250922_zQR01iIa2i3k"><ix:nonNumeric contextRef="AsOf2025-09-22" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><span id="xdx_905_edei--PreCommencementIssuerTenderOffer_c20250922__20250922_z63A2scDDX83"><ix:nonNumeric contextRef="AsOf2025-09-22" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_903_edei--Security12bTitle_c20250922__20250922_z1t0dFnfvg3b"><ix:nonNumeric contextRef="AsOf2025-09-22" id="Fact000026" name="dei:Security12bTitle">Class A Common Stock, $0.001 par value per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_906_edei--TradingSymbol_c20250922__20250922_z5UwQHmM9scb"><ix:nonNumeric contextRef="AsOf2025-09-22" id="Fact000027" name="dei:TradingSymbol">ASST</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><span id="xdx_90F_edei--SecurityExchangeName_c20250922__20250922_z5lmtmtoF2vf"><ix:nonNumeric contextRef="AsOf2025-09-22" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">Indicate by check
mark whether the Company is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities
Exchange Act of 1934. </span>	</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging Growth Company <span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20250922__20250922_zQjQ7RNiVGve"><ix:nonNumeric contextRef="AsOf2025-09-22" format="ixt:booleantrue" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the Company has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_90E_edei--EntityExTransitionPeriod_c20250922__20250922_zZoGYCsI69c1"><ix:nonNumeric contextRef="AsOf2025-09-22" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0in"/><td style="width: 8%; text-align: left"><b>Item 1.01</b></td><td style="width: 92%"><b>Entry into a Material Definitive Agreement.</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Agreement and Plan of Merger </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Overview </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 22, 2025, Strive, Inc., or Strive, entered into an Agreement
and Plan of Merger, or the Merger Agreement, with Semler Scientific, Inc., or Semler Sci. Upon the terms and subject to the conditions
of the Merger Agreement, a to be formed subsidiary of Strive, who will join as a party to the Merger Agreement via a joinder after its
formation, or Merger Sub, will merge with and into Semler Sci, or the Merger, with Semler Sci surviving as a wholly owned subsidiary of
Strive, or the Surviving Corporation. The parties also intend, and Strive has agreed to take such actions as are necessary to cause, immediately
following the effective time of the Merger, or the Effective Time, and as part of an integrated transaction with the Merger, the Surviving
Corporation to merge with and into a Delaware limited liability company which is a direct, wholly owned subsidiary of Strive, or Second
Merger Sub, with Second Merger Sub surviving as a direct, wholly owned subsidiary of Strive, or the Second Merger. For U.S. federal income
tax purposes, each of the parties to the Merger Agreement intends that the Merger and Second Merger, taken together, will constitute an
integrated transaction that qualifies as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the U.S. Internal Revenue
Code of 1986, as amended. Entry into the Merger Agreement was unanimously approved by the Board of Directors of each of Strive and Semler
Sci.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the Merger Agreement, at the Effective Time, each share
of common stock, par value $0.001 per share, of Semler Sci, or Company Common Stock, issued and outstanding immediately before the Effective
Time (other than treasury shares held by Semler Sci and certain shares held by Strive) will be converted into the right to receive 21.05
shares, or the Exchange Ratio, of Class A common stock, par value $0.001 per share, of Strive, or Strive Class A Common Stock, and such
consideration, the Common Merger Consideration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Treatment of Semler Sci Equity Awards </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At the Effective Time, each outstanding option to purchase shares of
Company Common Stock, or Company Option, whether vested or unvested, will be converted into an option to purchase a number of shares of
Strive Class A Common Stock based on the Exchange Ratio, or a Converted Option, on same terms and conditions as applied to such Company
Option prior to the Effective Time, including with respect to vesting and exercisability, except that (i) if the holder is a non-employee
director whose service continues through the date of the closing of the Merger, or (ii) if the holder&#8217;s employment or service is
terminated without cause at or during the six months immediately following the Effective Time, the vesting of the unvested portion of
the Converted Option will immediately accelerate as of the Effective Time or the date of such termination of employment, as applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Closing Conditions </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The obligation of the parties to consummate the Merger is subject to
customary conditions, including, among others, (i) the approval and adoption of the Merger Agreement by the holders of a majority of the
outstanding shares of Company Common Stock, (ii) the approval and adoption of the issuance of shares of Strive Class A Common Stock in
connection with the Merger, as contemplated by the Merger Agreement, by holders of a majority of the outstanding voting power of the outstanding
shares of Strive Class A Common Stock and Strive Class B Common Stock, (iii) the absence of any applicable law, regulation, injunction,
judgment, order or decree preventing or making illegal the consummation of the Merger or any of the other transactions contemplated by
the Merger Agreement (or in the case of Strive&#8217;s obligation to close, imposing a Burdensome Condition (as defined below)), (iv)
the absence of pending litigation or similar legal action by any governmental authority (in any jurisdiction in which Strive, Semler Sci
or any of their respective subsidiaries conducts material operations) seeking to prohibit or restrain the Merger (or in the case of Strive&#8217;s
obligation to close, seeking to impose a Burdensome Condition); (v) the early termination or expiration of any applicable waiting period
or periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, or the HSR Act (or in the case of Strive&#8217;s
obligations to close, without the imposition of a Burdensome Condition); (vi) compliance by Strive and Semler Sci in all material respects
with their respective obligations under the Merger Agreement and (vii) subject in most cases to exceptions that do not rise to the level
of a &#8220;Parent Material Adverse Effect&#8221; or a &#8220;Company Material Adverse Effect&#8221; (each as defined in the Merger Agreement),
as applicable, the accuracy of representations and warranties made by Semler Sci and Strive, respectively. The obligation of Semler Sci
and Strive to consummate the Merger is also subject to there not having occurred an event that has had or would reasonably be expected
to have, individually or in the aggregate, a &#8220;Parent Material Adverse Effect&#8221; or &#8220;Company Material Adverse Effect&#8221;,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Representations and Warranties; Covenants </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Merger Agreement contains customary representations and warranties
from both Semler Sci and Strive with respect to each party and its businesses. The Merger Agreement also contains customary covenants,
including covenants by Semler Sci to, subject to certain exceptions, conduct its business in the ordinary course, and not take certain
actions, during the interim period between the execution of the Merger Agreement and the consummation of the Merger.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the Merger Agreement, each of Semler Sci and Strive has agreed
to use its reasonable best efforts to take all actions and to do all things reasonably necessary, proper or advisable to consummate the
Merger, including in connection with obtaining all consents under the HSR Act required to be obtained from any governmental authority
to consummate the Merger. Strive has also agreed to use reasonable best efforts to resolve, avoid or eliminate impediments or objections,
if any, that may be asserted by any governmental authority with respect to the Merger, so as to enable the Merger to occur prior to the
End Date (as defined below), but in no event is Strive required to (and without Strive&#8217;s prior written consent, Semler Sci and its
subsidiaries may not) divest assets or businesses, enter into consent decrees or take certain other actions (any of the actions described
in this sentence, a Burdensome Condition).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Merger Agreement provides that Strive will take all necessary action
permitted by applicable law and the rules of any applicable stock exchange to cause one of Semler Sci&#8217;s directors (Eric Semler)
to be appointed to the Board of Directors of Strive as of the Effective Time, provided that Mr. Semler is able to meet Nasdaq&#8217;s
independence criteria.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Stockholder Meetings; Non-Solicitation; Intervening Events </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Merger Agreement requires Semler Sci to convene a stockholder meeting
for purposes of obtaining the necessary Semler Sci stockholder approval, or the Semler Sci Stockholder Meeting. In addition, subject to
certain exceptions, Semler Sci has agreed (i) not to solicit alternative transactions or enter into discussions concerning, or provide
information in connection with, any alternative transaction and (ii) that its Board of Directors will recommend that Semler Sci&#8217;s
stockholders approve and adopt the Merger Agreement, as applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prior to the adoption of the Merger Agreement by Semler Sci&#8217;s
stockholders, the Board of Directors of Semler Sci may, in connection with (i) the receipt of a &#8220;Company Superior Proposal&#8221;
(as defined in the Merger Agreement), or (ii) a &#8220;Company Intervening Event&#8221; (as defined in the Merger Agreement), respectively,
change its recommendation to Semler Sci&#8217;s stockholders to approve and adopt the Merger Agreement, subject to complying with notice
requirements and other specified conditions (including giving Strive the opportunity to propose changes to the Merger Agreement in response
to such Company Superior Proposal or Company Intervening Event, as applicable), if the failure to make such change in recommendation would
reasonably be expected to be inconsistent with its fiduciary duties. In such case, Semler Sci will remain obligated to hold the Semler
Sci Stockholder Meeting unless the Merger Agreement is terminated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Termination; Termination Fees </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Merger Agreement may be terminated by Semler Sci and Strive by
mutual agreement. Furthermore, either party may terminate the Merger Agreement if (i) the Merger has not been consummated on or before
March 22, 2026, or the End Date, (ii) an applicable law, regulation, injunction, judgment, order or decree permanently prohibits the consummation
of the Merger and, in the case of an injunction, judgment, order or decree, has become final and non-appealable (provided that the foregoing
right to terminate the Merger Agreement will not be available to any party which has not complied with its obligations under the Merger
Agreement in respect of any such applicable law, regulation, injunction, judgment, order or decree) or (iii) the required vote of Semler
Sci&#8217;s stockholders is not obtained at the Semler Sci Stockholder Meeting (including any adjournment or postponement thereof).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Strive may terminate the Merger Agreement if (i) the Board of Directors
of Semler Sci changes its recommendation to Semler Sci&#8217;s stockholders to approve and adopt the Merger Agreement prior to the Semler
Sci Stockholder Meeting, (ii) Semler Sci is in breach of the Merger Agreement in a manner that would result in a failure of an applicable
closing condition and such breach cannot be cured prior to the End Date or has not been cured within 45 days following notice to Strive
from Semler Sci of such breach or (iii) Semler Sci has willfully breached its obligations to hold the Semler Sci Stockholder Meeting or
to refrain from soliciting alternate transaction proposals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Semler Sci may terminate the Merger Agreement if (i) Strive or Merger
Sub is in breach of the Merger Agreement in a manner that would result in a failure of an applicable closing condition and such breach
cannot be cured prior to the End Date or has not been cured within 45 days following notice to Semler Sci by Strive of such breach or
(ii) Strive does not deliver the duly executed approval by September 24, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Merger Agreement further provides that, upon termination of the
Merger Agreement under specified circumstances, including termination by Strive as a result of (i) a change of recommendation by Semler
Sci&#8217;s Board of Directors that Semler Sci&#8217;s stockholders approve and adopt the Merger Agreement or (ii) Semler Sci&#8217;s
willful breach its obligations to hold the Semler Sci Stockholder Meeting or to refrain from soliciting alternate transaction proposals,
Strive will receive a termination fee from Semler Sci equal to $49 million in cash or Bitcoin at Strive&#8217;s election, on the terms
and conditions further set forth in the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the event that the Merger Agreement is terminated for certain reasons,
including termination by Semler Sci or Strive if the Merger has not been consummated on or prior to the End Date (without the Semler Sci
stockholder approval having been obtained), by Semler Sci or Strive due to the failure to obtain the required vote of Semler Sci&#8217;s
stockholders at the Semler Sci Stockholder Meeting (including any adjournment or postponement thereof) or by Strive if Semler Sci is in
breach of the Merger Agreement in a manner that would result in a failure of an applicable closing condition and such breach cannot be
cured prior to the End Date or has not been cured within 45 days following notice to Strive from Semler Sci of such breach (without the
Semler Sci stockholder approval having been obtained or, if such termination is after the Semler Sci stockholder approval has been obtained,
as a result of a willful breach by Semler Sci) and (i) at or prior to the time of termination of the Merger Agreement, a Semler Sci acquisition
proposal has been publicly disclosed or announced (in each case, and not publicly withdrawn) or made known to the management or board
of directors of Semler Sci (in each case, and not publicly withdrawn), or any person shall have publicly announced (in each case, and
not publicly withdrawn) an intention (whether or not conditional) to make a Semler Sci acquisition proposal; and (ii) on or prior to the
first anniversary of such termination of the Merger Agreement: (1) a transaction relating to a Semler Sci acquisition proposal is consummated;
or (2) a definitive agreement relating to any Semler Sci acquisition proposal is entered into by Semler Sci, Strive will receive a termination fee from Semler Sci equal to $49 million in cash or Bitcoin at Strive's election, on the terms and
conditions further set forth in the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Important Statement Regarding the Merger Agreement </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing description of the Merger Agreement does not purport
to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement, a copy of which is attached hereto
as Exhibit 2.1 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A copy of the Merger Agreement has been included to provide Semler
Sci stockholders, Strive stockholders and other security holders with information regarding its terms and is not intended to provide any
factual information about Semler Sci or Strive. The representations, warranties and covenants contained in the Merger Agreement have been
made solely for the purposes of the Merger Agreement and as of specific dates; were made solely for the benefit of the parties to the
Merger Agreement; are not intended as statements of fact to be relied upon by Semler Sci stockholders, Strive stockholders or other security
holders, but rather as a way of allocating the risk between the parties in the event the statements therein prove to be inaccurate; have
been modified or qualified by certain confidential disclosures that were made between the parties in connection with the negotiation of
the Merger Agreement, which disclosures are not reflected in the Merger Agreement itself; may no longer be true as of a given date; and
may apply standards of materiality in a way that is different from what may be viewed as material by Semler Sci stockholders, Strive stockholders
or other security holders. Semler Sci stockholders, Strive stockholders and other security holders are not third-party beneficiaries under
the Merger Agreement (except, following the Effective Time, with respect to Semler Sci stockholders&#8217; right to receive the merger
consideration provided for in the Merger Agreement and the right of holders of Semler Sci equity awards to receive the consideration provided
for such equity awards pursuant to the Merger Agreement) and should not rely on the representations, warranties and covenants or any descriptions
thereof as characterizations of the actual state of facts or condition of Semler Sci, Strive or Merger Sub. Moreover, information concerning
the subject matter of the representations and warranties may change after the date of the Merger Agreement, which subsequent information
may or may not be fully reflected in Semler Sci&#8217;s or Strive&#8217;s public disclosures. Semler Sci acknowledges that, notwithstanding
the inclusion of the foregoing cautionary statements, it is responsible for considering whether additional specific disclosures of material
information regarding material contractual provisions are required to make the statements in this Form 8-K not misleading. The Merger
Agreement should not be read alone but should instead be read in conjunction with the other information regarding the Merger Agreement,
the Merger, Strive, Semler Sci, their respective affiliates and their respective businesses, that will be contained in, or incorporated
by reference into, the Registration Statement on Form S-4 that will include a proxy statement of Semler Sci and a prospectus of Strive,
as well as in the Forms 10-K, Forms 10-Q, Forms 8-K and other filings that each of Strive and Semler Sci make with the Securities and
Exchange Commission, or the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Additional Information and Where to Find It </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the proposed transaction, Strive intends to file
with the SEC a Registration Statement on Form S-4, or the Registration Statement, to register the Class A common stock to be issued by
Strive in connection with the proposed transaction and that will include an information statement of Strive, proxy statement of Semler
Sci and a prospectus of Strive, or the Information Statement/Proxy Statement/Prospectus, and each of Strive and Semler Sci may file with
the SEC other relevant documents concerning the proposed transaction. A definitive Information Statement/Proxy Statement/Prospectus will
be sent to the stockholders of Semler Sci to seek their approval of the proposed transaction. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION,
INVESTORS AND STOCKHOLDERS OF SEMLER SCI ARE URGED TO READ THE REGISTRATION STATEMENT AND INFORMATION STATEMENT/PROXY STATEMENT/PROSPECTUS
REGARDING THE PROPOSED TRANSACTION WHEN THEY BECOME AVAILABLE AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS
OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT STRIVE, SEMLER SCI AND THE PROPOSED TRANSACTION
AND RELATED MATTERS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A copy of the Registration Statement, Information Statement/Proxy
Statement/Prospectus, as well as other filings containing information about Strive and Semler Sci, may be obtained, free of charge, at
the SEC's website (<span style="color: Blue"><b><span style="text-decoration: underline">http://www.sec.gov</span></b></span>).&#160;&#160;You will also be able to obtain these
documents, when they are filed, free of charge, from Strive by accessing Strive's website at&#160;<span style="color: Blue"><span style="text-decoration: underline">https://investors.strive.com/</span></span>.
Copies of the Registration Statement, the Information Statement/Proxy Statement/Prospectus and the filings with the SEC that will be
incorporated by reference therein can also be obtained, without charge, by directing a request to Strive's Investor Relations department
at 200 Crescent Court, Suite 1400, Dallas, Texas 75201 or by calling (855) 427-7360 or by submitting an inquiry at <span style="color: Blue"><span style="text-decoration: underline">https://investors.strive.com/ir-resources/contact-ir</span></span>.&#160;Copies
of the documents filed with the SEC by Semler Sci will be available free of charge on Semler Sci&#8217;s website at <span style="color: Blue"><span style="text-decoration: underline">https://ir.semlerscientific.com</span></span>.
The information on Strive&#8217;s or Semler Sci's respective websites is not, and shall not be deemed to be, a part of this communication
or incorporated into other filings either company makes with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Participants in the Solicitation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Strive, Semler Sci and certain of their respective directors, executive
officers and employees may be deemed to be participants in the solicitation of proxies from the stockholders of Semler Sci in connection
with the proposed transaction.&#160;&#160;Information about the interests of the directors and executive officers of Strive and Semler
Sci and other persons who may be deemed to be participants in the solicitation of stockholders of Semler Sci in connection with the proposed
transaction and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the Information
Statement/Proxy Statement/Prospectus related to the proposed transaction, which will be filed with the SEC.&#160;&#160;Information about
the directors and executive officers of Semler Sci, their ownership of Semler Sci common stock, and Semler Sci's transactions with related
persons is set forth in the section entitled "INFORMATION REGARDING OUR BOARD OF DIRECTORS AND CORPORATE GOVERNANCE," "EXECUTIVE
OFFICERS," "SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT," &#8220;DIRECTOR COMPENSATION,&#8221; and
"TRANSACTIONS WITH RELATED PERSONS" included in Semler Sci's&#160;<span style="color: Blue"><span style="text-decoration: underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001554859/000110465925068553/tm2517662-3_def14a.htm">definitive proxy statement</a></span></span>&#160;in
connection with its 2025 Annual Meeting of Stockholders, as filed with the SEC on&#160;July 17, 2025. Additional information regarding
ownership of Semler Scientific&#8217;s securities by its directors and executive officers is included in such persons&#8217; SEC filings
on Forms 3 or 4, which are available at https://www.sec.gov/cgi-bin/own-disp?action=getissuer&amp;CIK=0001554859. Information about the
directors and executive officers of Strive is contained in Strive&#8217;s Current Report on <span style="color: Blue"><span style="text-decoration: underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001920406/000121390025087387/ea0257312-8k_strive.htm">Form 8-K</a></span></span>
filed with the SEC on September 15, 2025, Strive's Current Report on <span style="color: Blue"><span style="text-decoration: underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001920406/000121390025087387/ea0257312-8k_strive.htm">Form 8-K</a></span></span> filed with the
SEC on September 12, 2025 and under &#8220;Meet the Leadership Team&#8221; accessed through the &#8220;About Us&#8221; link on Strive&#8217;s
website at https://strive.com/team. Additional information regarding ownership of Strive&#8217;s securities by its directors and executive
officers is included in such persons&#8217; SEC filings on Forms 3 or 4, which are available at https://www.sec.gov/cgi-bin/own-disp?action=getissuer&amp;CIK=1920406.
These documents and the other SEC filings described in this paragraph may be obtained free of charge as described above under the heading
&#8220;Additional Information and Where to Find It.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>No Offer or Solicitation </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This communication is not intended to and shall not constitute an offer
to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities or the solicitation of any vote
of approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except
by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or the Securities Act, or pursuant
to an exemption from, or in a transaction not subject to, such registration requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cautionary Statement Regarding Forward-Looking Statements </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain statements herein and the documents incorporated herein by
reference may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of
1995, Section 27A of the Securities Act and Rule 175 promulgated thereunder, and Section 21E of the Securities Exchange Act of 1934, as
amended, or the Exchange Act, and Rule 3b-6 promulgated thereunder, which statements involve inherent risks and uncertainties. Examples
of forward-looking statements include, but are not limited to, statements regarding the outlook and expectations of Strive and Semler
Sci, respectively, with respect to the proposed transaction, the strategic benefits and financial benefits of the proposed transaction,
including the expected impact of the proposed transaction on the combined company's future financial performance, the timing of the closing
of the proposed transaction, and the ability to successfully integrate the combined businesses. Such statements are often characterized
by the use of qualified words (and their derivatives) such as "may," "will," "anticipate," "could,"
"should," "would," "believe," "contemplate," "expect," "estimate," "continue,"
"plan," "project," "predict," "potential," "assume," "forecast," "target,"
"budget," "outlook," "trend," "guidance," "objective," "goal," "strategy,"
"opportunity," and "intend," as well as words of similar meaning or other statements concerning opinions or judgment
of Strive, Semler Sci or their respective management about future events. Forward-looking statements are based on assumptions as of the
time they are made and are subject to risks, uncertainties and other factors that are difficult to predict with regard to timing, extent,
likelihood and degree of occurrence, which could cause actual results to differ materially from anticipated results expressed or implied
by such forward-looking statements. Such risks, uncertainties and assumptions, include, among others, the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the occurrence of any event, change or other circumstances that could give rise to the right of one or both of Strive and Semler Sci
to terminate the merger agreement between Strive and Semler Sci;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received
or satisfied on a timely basis or at all;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the outcome of any legal proceedings that may be instituted against Strive or Semler Sci or the combined company;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains,
are not realized when expected or at all, including as a result of changes in, or problems arising from, implementation of Bitcoin treasury
strategies and risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates,
monetary policy, laws and regulations and their enforcement;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the possibility that the integration of the two companies may be more difficult, time-consuming or costly than expected;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result
of unexpected factors or events;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the diversion of management's attention from ongoing business operations and opportunities;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>potential adverse reactions of Strive&#8217;s or Semler Sci&#8217;s customers or changes to business or employee relationships, including
those resulting from the announcement or completion of the proposed transaction;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>changes in Strive&#8217;s or Semler Sci&#8217;s share price before closing; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>other factors that may affect future results of Strive, Semler Sci or the combined company.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These factors are not necessarily all of the factors that could cause
Strive&#8217;s, Semler Sci&#8217;s or the combined company's actual results, performance or achievements to differ materially from those
expressed in or implied by any of the forward-looking statements. Other factors, including unknown or unpredictable factors, also could
harm Strive, Semler Sci's or the combined company's results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Although each of Strive and Semler Sci believes that its expectations
with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business
and operations, there can be no assurance that actual results of Strive or Semler Sci will not differ materially from any projected future
results expressed or implied by such forward-looking statements.&#160;&#160;Additional factors that could cause results to differ materially
from those described above can be found in Strive&#8217;s current report on Form 8-K filed with the SEC on September 12, 2025 (including
the documents incorporated by reference therein), Semler Sci's most recent annual report on&#160;<span style="color: Blue"><span style="text-decoration: underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001554859/000155485925000011/smlr-20241231x10k.htm">Form 10-K for the fiscal year ended&#160;December 31, 2024</a></span></span> and quarterly reports on Form 10-Q, and other documents subsequently filed
by Strive and Semler Sci with the SEC.&#160;&#160;The actual results anticipated may not be realized or, even if substantially realized,
they may not have the expected consequences to or effects on Strive, Semler Sci or their respective businesses or operations.&#160;&#160;Investors
are cautioned not to rely too heavily on any such forward-looking statements.&#160;&#160;Forward-looking statements speak only as of
the date they are made and Strive and Semler Sci undertake no obligation to update or clarify these forward-looking statements, whether
as a result of new information, future events or otherwise, except to the extent required by applicable law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 8%"><span style="font-size: 10pt"><b>Item 9.01</b></span></td>
    <td style="width: 92%"><span style="font-size: 10pt"><b>Financial Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 8%; text-align: left"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Exhibit No.</span></b></span></td>
    <td style="width: 92%"><span style="font-size: 10pt"><b><span style="text-decoration: underline">Description</span></b></span></td></tr>
  <tr>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td><a href="dp234662_ex0201.htm"><span style="font-size: 10pt">2.1</span></a></td>
    <td><a href="dp234662_ex0201.htm"><span style="font-size: 10pt">Agreement and Plan of Merger, dated as of September 22, 2025, by and between Strive, Inc. and Semler Scientific, Inc.*</span></a></td></tr>
  <tr>
    <td><span style="font-size: 10pt">104</span></td>
    <td><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: top; width: 2%"><span style="font-size: 10pt">* </span></td>
    <td><span style="font-size: 10pt">The schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Semler Sci agrees to furnish supplementally a copy of such schedules and exhibits, or any section thereof, to the SEC upon request.</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Date: September 22, 2025</span></td>
    <td colspan="2"><span style="font-size: 10pt">STRIVE, INC.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 45%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><span style="font-size: 10pt">/s/ Matthew Cole</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Name:</span></td>
    <td><span style="font-size: 10pt">Matthew Cole</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Title:</span></td>
    <td><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LLoVFdyjY4o4RYaIr9VlUtyakdbpPsm/tG6IIRCSe8+NECOxppWukOG8zDM4Yt1UyiHkWCKjuaJ3JJttDH7meNPWsTKuX39gQp5Bz8zH8uLvvbPVFosYwsVEyomcQTiNIwmHnQi+ekKm1AUap1UFyhRwYGpYo1PcDQlH9SJDddd/OiFbTSaGaBwO8htk6PP21Kon8d1CliUiGPUViDXTo/Gu9OXQfElIK6z9OzvQ/w4+zDtKXQ== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>dp234662_ex0201.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 2.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AGREEMENT AND PLAN OF MERGER<BR>
<BR>
dated as of<BR>
<BR>
September 22, 2025<BR>
<BR>
by and among<BR>
<BR>
<FONT STYLE="text-transform: uppercase">Strive, inc.</FONT>,</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">and</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SEMLER SCIENTIFIC, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TABLE OF CONTENTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><U>Page</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;1</FONT><BR>
Definitions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-indent: 0in">Section&nbsp;1.01.</TD>
    <TD STYLE="width: 81%; text-indent: 0in">Definitions</TD>
    <TD STYLE="text-align: right; width: 5%; text-indent: 0in">6</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;1.02.</TD>
    <TD STYLE="text-indent: 0in">Other Definitional and Interpretative Provisions</TD>
    <TD STYLE="text-align: right; text-indent: 0in">19</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;2</FONT><BR>
Closing; Merger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-indent: 0in">Section&nbsp;2.01.</TD>
    <TD STYLE="width: 81%; text-indent: 0in">Closing</TD>
    <TD STYLE="text-align: right; width: 5%; text-indent: 0in">20</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;2.02.</TD>
    <TD STYLE="text-indent: 0in">The Merger</TD>
    <TD STYLE="text-align: right; text-indent: 0in">20</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;2.03.</TD>
    <TD STYLE="text-indent: 0in">Conversion of Shares.</TD>
    <TD STYLE="text-align: right; text-indent: 0in">21</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;2.04.</TD>
    <TD STYLE="text-indent: 0in">Surrender and Payment</TD>
    <TD STYLE="text-align: right; text-indent: 0in">21</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;2.05.</TD>
    <TD STYLE="text-indent: 0in">Company Equity Awards</TD>
    <TD STYLE="text-align: right; text-indent: 0in">24</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;2.06.</TD>
    <TD STYLE="text-indent: 0in">Adjustments</TD>
    <TD STYLE="text-align: right; text-indent: 0in">25</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;2.07.</TD>
    <TD STYLE="text-indent: 0in">Fractional Shares</TD>
    <TD STYLE="text-align: right; text-indent: 0in">25</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;2.08.</TD>
    <TD STYLE="text-indent: 0in">Withholding Rights</TD>
    <TD STYLE="text-align: right; text-indent: 0in">25</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;2.09.</TD>
    <TD STYLE="text-indent: 0in">Lost Certificates</TD>
    <TD STYLE="text-align: right; text-indent: 0in">25</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;2.10.</TD>
    <TD STYLE="text-indent: 0in">Further Assurances</TD>
    <TD STYLE="text-align: right; text-indent: 0in">26</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;3</FONT><BR>
Organizational Documents; Directors and Officers</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-indent: 0in">Section&nbsp;3.01.</TD>
    <TD STYLE="width: 81%; text-indent: 0in">Certificate of Incorporation and Bylaws of the Surviving Corporation</TD>
    <TD STYLE="text-align: right; width: 5%; text-indent: 0in">26</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;3.02.</TD>
    <TD STYLE="text-indent: 0in">Directors and Officers of the Surviving Corporation</TD>
    <TD STYLE="text-align: right; text-indent: 0in">26</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;3.03.</TD>
    <TD STYLE="text-indent: 0in">Board of Parent</TD>
    <TD STYLE="text-align: right; text-indent: 0in">26</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;4</FONT><BR>
Representations and Warranties of the Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-indent: 0in">Section&nbsp;4.01.</TD>
    <TD STYLE="width: 81%; text-indent: 0in">Corporate Existence and Power</TD>
    <TD STYLE="text-align: right; width: 5%; text-indent: 0in">27</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.02.</TD>
    <TD STYLE="text-indent: 0in">Corporate Authorization</TD>
    <TD STYLE="text-align: right; text-indent: 0in">27</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.03.</TD>
    <TD STYLE="text-indent: 0in">Governmental Authorization</TD>
    <TD STYLE="text-align: right; text-indent: 0in">27</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.04.</TD>
    <TD STYLE="text-indent: 0in">Non-contravention</TD>
    <TD STYLE="text-align: right; text-indent: 0in">28</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.05.</TD>
    <TD STYLE="text-indent: 0in">Capitalization</TD>
    <TD STYLE="text-align: right; text-indent: 0in">28</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.06.</TD>
    <TD STYLE="text-indent: 0in">Subsidiaries</TD>
    <TD STYLE="text-align: right; text-indent: 0in">29</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.07.</TD>
    <TD STYLE="text-indent: 0in">Regulatory Reports, SEC Filings and the Sarbanes-Oxley Act</TD>
    <TD STYLE="text-align: right; text-indent: 0in">30</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.08.</TD>
    <TD STYLE="text-indent: 0in">Financial Statements and Financial Matters</TD>
    <TD STYLE="text-align: right; text-indent: 0in">32</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.09.</TD>
    <TD STYLE="text-indent: 0in">Disclosure Documents</TD>
    <TD STYLE="text-align: right; text-indent: 0in">32</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.10.</TD>
    <TD STYLE="text-indent: 0in">Absence of Certain Changes</TD>
    <TD STYLE="text-align: right; text-indent: 0in">32</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.11.</TD>
    <TD STYLE="text-indent: 0in">No Undisclosed Material Liabilities</TD>
    <TD STYLE="text-align: right; text-indent: 0in">33</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.12.</TD>
    <TD STYLE="text-indent: 0in">Litigation</TD>
    <TD STYLE="text-align: right; text-indent: 0in">33</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.13.</TD>
    <TD STYLE="text-indent: 0in">Permits</TD>
    <TD STYLE="text-align: right; text-indent: 0in">33</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-indent: 0in">Section&nbsp;4.14.</TD>
    <TD STYLE="width: 81%; text-indent: 0in">Compliance with Applicable Laws</TD>
    <TD STYLE="text-align: right; width: 5%; text-indent: 0in">34</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.15.</TD>
    <TD STYLE="text-indent: 0in">Digital Asset.</TD>
    <TD STYLE="text-align: right; text-indent: 0in">35</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.16.</TD>
    <TD STYLE="text-indent: 0in">FDA Matters; Medical Device Matters; Compliance</TD>
    <TD STYLE="text-align: right; text-indent: 0in">35</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.17.</TD>
    <TD STYLE="text-indent: 0in">Material Contracts</TD>
    <TD STYLE="text-align: right; text-indent: 0in">38</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.18.</TD>
    <TD STYLE="text-indent: 0in">Taxes</TD>
    <TD STYLE="text-align: right; text-indent: 0in">40</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.19.</TD>
    <TD STYLE="text-indent: 0in">Employees and Employee Benefit Plans</TD>
    <TD STYLE="text-align: right; text-indent: 0in">41</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.20.</TD>
    <TD STYLE="text-indent: 0in">Labor Matters</TD>
    <TD STYLE="text-align: right; text-indent: 0in">43</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.21.</TD>
    <TD STYLE="text-indent: 0in">Intellectual Property</TD>
    <TD STYLE="text-align: right; text-indent: 0in">43</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.22.</TD>
    <TD STYLE="text-indent: 0in">Properties</TD>
    <TD STYLE="text-align: right; text-indent: 0in">45</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.23.</TD>
    <TD STYLE="text-indent: 0in">Environmental Matters</TD>
    <TD STYLE="text-align: right; text-indent: 0in">46</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.24.</TD>
    <TD STYLE="text-indent: 0in">Antitakeover Statutes</TD>
    <TD STYLE="text-align: right; text-indent: 0in">46</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.25.</TD>
    <TD STYLE="text-indent: 0in">Opinion of Financial Advisor</TD>
    <TD STYLE="text-align: right; text-indent: 0in">46</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.26.</TD>
    <TD STYLE="text-indent: 0in">Finders&rsquo; Fees</TD>
    <TD STYLE="text-align: right; text-indent: 0in">47</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.27.</TD>
    <TD STYLE="text-indent: 0in">No Ownership of Parent Common Stock</TD>
    <TD STYLE="text-align: right; text-indent: 0in">47</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.28.</TD>
    <TD STYLE="text-indent: 0in">No Ownership of Company Stock</TD>
    <TD STYLE="text-align: right; text-indent: 0in">47</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;4.29.</TD>
    <TD STYLE="text-indent: 0in">No Other Company Representations and Warranties</TD>
    <TD STYLE="text-align: right; text-indent: 0in">47</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;5</FONT><BR>
Representations and Warranties of Parent</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-indent: 0in">Section&nbsp;5.01.</TD>
    <TD STYLE="width: 81%; text-indent: 0in">Corporate Existence and Power</TD>
    <TD STYLE="text-align: right; width: 5%; text-indent: 0in">48</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.02.</TD>
    <TD STYLE="text-indent: 0in">Corporate Authorization</TD>
    <TD STYLE="text-align: right; text-indent: 0in">48</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.03.</TD>
    <TD STYLE="text-indent: 0in">Governmental Authorization</TD>
    <TD STYLE="text-align: right; text-indent: 0in">49</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.04.</TD>
    <TD STYLE="text-indent: 0in">Non-contravention</TD>
    <TD STYLE="text-align: right; text-indent: 0in">49</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.05.</TD>
    <TD STYLE="text-indent: 0in">Capitalization</TD>
    <TD STYLE="text-align: right; text-indent: 0in">49</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.06.</TD>
    <TD STYLE="text-indent: 0in">Subsidiaries</TD>
    <TD STYLE="text-align: right; text-indent: 0in">50</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.07.</TD>
    <TD STYLE="text-indent: 0in">Regulatory Reports, SEC Filings and the Sarbanes-Oxley Act</TD>
    <TD STYLE="text-align: right; text-indent: 0in">51</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.08.</TD>
    <TD STYLE="text-indent: 0in">Financial Statements and Financial Matters</TD>
    <TD STYLE="text-align: right; text-indent: 0in">52</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.09.</TD>
    <TD STYLE="text-indent: 0in">Disclosure Documents</TD>
    <TD STYLE="text-align: right; text-indent: 0in">53</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.10.</TD>
    <TD STYLE="text-indent: 0in">Absence of Certain Changes</TD>
    <TD STYLE="text-align: right; text-indent: 0in">53</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.11.</TD>
    <TD STYLE="text-indent: 0in">No Undisclosed Material Liabilities</TD>
    <TD STYLE="text-align: right; text-indent: 0in">53</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.12.</TD>
    <TD STYLE="text-indent: 0in">Litigation</TD>
    <TD STYLE="text-align: right; text-indent: 0in">53</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.13.</TD>
    <TD STYLE="text-indent: 0in">Permits</TD>
    <TD STYLE="text-align: right; text-indent: 0in">54</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.14.</TD>
    <TD STYLE="text-indent: 0in">Compliance with Applicable Laws</TD>
    <TD STYLE="text-align: right; text-indent: 0in">54</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.15.</TD>
    <TD STYLE="text-indent: 0in">Material Contracts.</TD>
    <TD STYLE="text-align: right; text-indent: 0in">55</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.16.</TD>
    <TD STYLE="text-indent: 0in">Taxes</TD>
    <TD STYLE="text-align: right; text-indent: 0in">56</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.17.</TD>
    <TD STYLE="text-indent: 0in">Employees and Employee Benefit Plans</TD>
    <TD STYLE="text-align: right; text-indent: 0in">57</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.18.</TD>
    <TD STYLE="text-indent: 0in">Labor Matters</TD>
    <TD STYLE="text-align: right; text-indent: 0in">58</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.19.</TD>
    <TD STYLE="text-indent: 0in">Intellectual Property</TD>
    <TD STYLE="text-align: right; text-indent: 0in">58</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.20.</TD>
    <TD STYLE="text-indent: 0in">Properties</TD>
    <TD STYLE="text-align: right; text-indent: 0in">60</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.21.</TD>
    <TD STYLE="text-indent: 0in">Environmental Matters</TD>
    <TD STYLE="text-align: right; text-indent: 0in">61</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.22.</TD>
    <TD STYLE="text-indent: 0in">Antitakeover Statutes</TD>
    <TD STYLE="text-align: right; text-indent: 0in">61</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.23.</TD>
    <TD STYLE="text-indent: 0in">Finders&rsquo; Fees</TD>
    <TD STYLE="text-align: right; text-indent: 0in">61</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.24.</TD>
    <TD STYLE="text-indent: 0in">No Ownership of Company Stock</TD>
    <TD STYLE="text-align: right; text-indent: 0in">61</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;5.25.</TD>
    <TD STYLE="text-indent: 0in">No Other Parent Representations and Warranties</TD>
    <TD STYLE="text-align: right; text-indent: 0in">61</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;6</FONT><BR>
Covenants of the Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-indent: 0in">Section&nbsp;6.01.</TD>
    <TD STYLE="width: 81%; text-indent: 0in">Conduct of the Company</TD>
    <TD STYLE="text-align: right; width: 5%; text-indent: 0in">62</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;6.02.</TD>
    <TD STYLE="text-indent: 0in">Access to Information; Confidentiality</TD>
    <TD STYLE="text-align: right; text-indent: 0in">65</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;6.03.</TD>
    <TD STYLE="text-indent: 0in">No Solicitation by the Company</TD>
    <TD STYLE="text-align: right; text-indent: 0in">66</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;6.04.</TD>
    <TD STYLE="text-indent: 0in">Indenture</TD>
    <TD STYLE="text-align: right; text-indent: 0in">70</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;6.05.</TD>
    <TD STYLE="text-indent: 0in">Financing Cooperation.</TD>
    <TD STYLE="text-align: right; text-indent: 0in">71</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;7<BR>
Covenants of Parent</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-indent: 0in">Section&nbsp;7.01.</TD>
    <TD STYLE="width: 81%; text-indent: 0in">Conduct of Parent</TD>
    <TD STYLE="text-align: right; width: 5%; text-indent: 0in">72</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;7.02.</TD>
    <TD STYLE="text-indent: 0in">Obligations of Merger Sub</TD>
    <TD STYLE="text-align: right; text-indent: 0in">72</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;7.03.</TD>
    <TD STYLE="text-indent: 0in">Director and Officer Liability</TD>
    <TD STYLE="text-align: right; text-indent: 0in">73</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;7.04.</TD>
    <TD STYLE="text-indent: 0in">Employee Matters</TD>
    <TD STYLE="text-align: right; text-indent: 0in">74</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;7.05.</TD>
    <TD STYLE="text-indent: 0in">Parent Stockholder Approval</TD>
    <TD STYLE="text-align: right; text-indent: 0in">75</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;7.06.</TD>
    <TD STYLE="text-indent: 0in">Merger Sub.</TD>
    <TD STYLE="text-align: right; text-indent: 0in">75</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;8</FONT><BR>
Covenants of Parent and the Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-indent: 0in">Section&nbsp;8.01.</TD>
    <TD STYLE="width: 81%; text-indent: 0in">Reasonable Best Efforts</TD>
    <TD STYLE="text-align: right; width: 5%; text-indent: 0in">75</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;8.02.</TD>
    <TD STYLE="text-indent: 0in">Certain Filings; SEC Matters</TD>
    <TD STYLE="text-align: right; text-indent: 0in">77</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;8.03.</TD>
    <TD STYLE="text-indent: 0in">Company Stockholder Meeting</TD>
    <TD STYLE="text-align: right; text-indent: 0in">79</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;8.04.</TD>
    <TD STYLE="text-indent: 0in">Public Announcements</TD>
    <TD STYLE="text-align: right; text-indent: 0in">80</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;8.05.</TD>
    <TD STYLE="text-indent: 0in">Notices of Certain Events</TD>
    <TD STYLE="text-align: right; text-indent: 0in">80</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;8.06.</TD>
    <TD STYLE="text-indent: 0in">Section&nbsp;16 Matters</TD>
    <TD STYLE="text-align: right; text-indent: 0in">81</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;8.07.</TD>
    <TD STYLE="text-indent: 0in">Transaction Litigation</TD>
    <TD STYLE="text-align: right; text-indent: 0in">81</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;8.08.</TD>
    <TD STYLE="text-indent: 0in">Stock Exchange Delisting</TD>
    <TD STYLE="text-align: right; text-indent: 0in">81</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;8.09.</TD>
    <TD STYLE="text-indent: 0in">State Takeover Statutes</TD>
    <TD STYLE="text-align: right; text-indent: 0in">81</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;8.10.</TD>
    <TD STYLE="text-indent: 0in">Tax Matters</TD>
    <TD STYLE="text-align: right; text-indent: 0in">81</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;8.11.</TD>
    <TD STYLE="text-indent: 0in">Second Merger</TD>
    <TD STYLE="text-align: right; text-indent: 0in">82</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;8.12.</TD>
    <TD STYLE="text-indent: 0in">At-the-Market Offering Facilities</TD>
    <TD STYLE="text-align: right; text-indent: 0in">83</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;9</FONT><BR>
Conditions to the Merger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-indent: 0in">Section&nbsp;9.01.</TD>
    <TD STYLE="width: 81%; text-indent: 0in">Conditions to the Obligations of Each Party</TD>
    <TD STYLE="text-align: right; width: 5%; text-indent: 0in">83</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;9.02.</TD>
    <TD STYLE="text-indent: 0in">Conditions to the Obligations of Parent and Merger Sub</TD>
    <TD STYLE="text-align: right; text-indent: 0in">84</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;9.03.</TD>
    <TD STYLE="text-indent: 0in">Conditions to the Obligations of the Company</TD>
    <TD STYLE="text-align: right; text-indent: 0in">85</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;10</FONT><BR>
Termination</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-indent: 0in">Section&nbsp;10.01.</TD>
    <TD STYLE="width: 81%; text-indent: 0in">Termination</TD>
    <TD STYLE="text-align: right; width: 5%; text-indent: 0in">86</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;10.02.</TD>
    <TD STYLE="text-indent: 0in">Effect of Termination</TD>
    <TD STYLE="text-align: right; text-indent: 0in">87</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;10.03.</TD>
    <TD STYLE="text-indent: 0in">Termination Fees</TD>
    <TD STYLE="text-align: right; text-indent: 0in">88</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&nbsp;11</FONT><BR>
Miscellaneous</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 14%; text-indent: 0in">Section&nbsp;11.01.</TD>
    <TD STYLE="width: 81%; text-indent: 0in">Notices</TD>
    <TD STYLE="text-align: right; width: 5%; text-indent: 0in">89</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;11.02.</TD>
    <TD STYLE="text-indent: 0in">Survival</TD>
    <TD STYLE="text-align: right; text-indent: 0in">90</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;11.03.</TD>
    <TD STYLE="text-indent: 0in">Amendments and Waivers</TD>
    <TD STYLE="text-align: right; text-indent: 0in">90</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;11.04.</TD>
    <TD STYLE="text-indent: 0in">Expenses</TD>
    <TD STYLE="text-align: right; text-indent: 0in">90</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;11.05.</TD>
    <TD STYLE="text-indent: 0in">Disclosure Schedule References and SEC Document References</TD>
    <TD STYLE="text-align: right; text-indent: 0in">91</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;11.06.</TD>
    <TD STYLE="text-indent: 0in">Binding Effect; Benefit; Assignment</TD>
    <TD STYLE="text-align: right; text-indent: 0in">91</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;11.07.</TD>
    <TD STYLE="text-indent: 0in">Governing Law</TD>
    <TD STYLE="text-align: right; text-indent: 0in">92</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;11.08.</TD>
    <TD STYLE="text-indent: 0in">Jurisdiction/Venue</TD>
    <TD STYLE="text-align: right; text-indent: 0in">92</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;11.09.</TD>
    <TD STYLE="text-indent: 0in">WAIVER OF JURY TRIAL</TD>
    <TD STYLE="text-align: right; text-indent: 0in">92</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;11.10.</TD>
    <TD STYLE="text-indent: 0in">Counterparts; Effectiveness</TD>
    <TD STYLE="text-align: right; text-indent: 0in">93</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;11.11.</TD>
    <TD STYLE="text-indent: 0in">Entire Agreement</TD>
    <TD STYLE="text-align: right; text-indent: 0in">93</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;11.12.</TD>
    <TD STYLE="text-indent: 0in">Severability</TD>
    <TD STYLE="text-align: right; text-indent: 0in">93</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Section&nbsp;11.13.</TD>
    <TD STYLE="text-indent: 0in">Specific Performance</TD>
    <TD STYLE="text-align: right; text-indent: 0in">93</TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EXHIBITS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exhibit&nbsp;A&#9;-&#9;Amended and Restated Certificate
of Incorporation of Surviving Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AGREEMENT AND PLAN OF MERGER</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This AGREEMENT AND PLAN OF
MERGER (this &ldquo;<B>Agreement</B>&rdquo;), dated as of September 22, 2025, is entered into by and among (i) Strive, Inc., a Nevada
corporation (&ldquo;<B>Parent</B>&rdquo;), (ii) after giving effect to the joinder contemplated by Section 7.06, Merger Sub (as defined
herein) and (iii) Semler Scientific, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, upon the terms and
subject to the conditions of this Agreement and in accordance with Delaware Law and other Applicable Law, the parties intend that Merger
Sub merge with and into the Company (the &ldquo;<B>Merger</B>&rdquo;), with the Company as the surviving corporation&nbsp;&nbsp;(the &ldquo;<B>Surviving
Corporation</B>&rdquo;) and a wholly owned subsidiary of Parent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Board of Directors
of the Company has unanimously (i) determined that this Agreement and the transactions contemplated hereby (including the Merger) are
advisable, fair to and in the best interests of the Company&rsquo;s stockholders, (ii) approved, adopted and declared advisable this Agreement
and the transactions contemplated hereby (including the Merger), (iii) directed that the approval and adoption of this Agreement (including
the Merger) be submitted to a vote at a meeting of the Company&rsquo;s stockholders, and (iv)&nbsp;recommended the approval and adoption
of this Agreement (including the Merger) by the Company&rsquo;s stockholders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, (A) the Board of
Directors of Parent has unanimously (i) determined that this Agreement and the transactions contemplated hereby (including the Parent
Share Issuance) are advisable, fair to and in the best interests of Parent and its stockholders and (ii) approved and adopted this Agreement
and the transactions contemplated hereby (including the Parent Share Issuance) and (B) promptly following the execution of this Agreement,
holders of a majority of the outstanding voting power of the outstanding shares of Parent Common Stock shall have approved and adopted
the Parent Share Issuance (the &ldquo;<B>Parent Stockholder Approval</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, (A) as of the time
it executes and delivers the joinder contemplated by Section 7.06, the Board of Directors of Merger Sub will unanimously (i)&nbsp;determine
that this Agreement and the transactions contemplated hereby (including the Merger) are advisable, fair to and in the best interests of
Merger Sub and the sole stockholder of Merger Sub, (ii) approve, adopt and declare advisable this Agreement and the transactions contemplated
hereby (including the Merger), (iii)&nbsp;direct that this Agreement (including the Merger) be submitted for approval and adoption by
the sole stockholder of Merger Sub and (iv) recommend the approval and adoption of this Agreement (including the Merger) by the sole stockholder
of Merger Sub, and (B) Parent, promptly following the execution of this Agreement, as the sole stockholder of Merger Sub, shall approve
and adopt this Agreement (including the Merger);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, upon the terms and
subject to the conditions of this Agreement and in accordance with Delaware Law and other Applicable Law, the parties intend that (a)&nbsp;promptly
following the date of this Agreement, Parent will form a Delaware limited liability company as a direct, wholly owned Subsidiary of Parent
(&ldquo;<B>Second Merger Sub</B>&rdquo;), (b) immediately following the Merger, and as part of an integrated transaction with the Merger,
the Surviving Corporation will merge with and into Second Merger Sub (the &ldquo;<B>Second Merger</B>&rdquo;, together with the Merger,
the &ldquo;<B>Mergers</B>&rdquo;), with Second Merger Sub being the surviving entity of the Second Merger (Second</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Merger Sub, in its capacity as the surviving entity
of the Second Merger, is sometimes referred to as the &ldquo;<B>Surviving Entity</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, for U.S. federal
income tax purposes, each of the parties intends that the Mergers, taken together, will constitute an integrated transaction, described
in Rev. Rul. 2001-46, 2001-2 C.B. 321, that qualifies as a &ldquo;reorganization&rdquo; within the meaning of Section&nbsp;368(a)&nbsp;of
the Code and the Treasury Regulations, and that this Agreement be, and hereby is, adopted as a &ldquo;plan of reorganization&rdquo; for
the purposes of Section&nbsp;368 of the Code and Treasury Regulations Section&nbsp;1.368-2(g); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company, Parent
and Merger Sub desire to make certain representations, warranties, covenants and agreements specified in this Agreement in connection
with the Merger and to prescribe certain conditions to the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the foregoing and the representations, warranties, covenants and agreements contained in this Agreement, the parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article&nbsp;1</FONT><U><BR>
Definitions</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;1.01.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Definitions</I>. (a) As used in this Agreement, the following terms have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Affiliate</B>&rdquo;
means, (i) with respect to any Person (other than Parent or Merger Sub), any other Person, whether now or in the future, directly or indirectly
controlling, controlled by, or under common control with such Person and (ii) with respect to Parent or Merger Sub, any other Person,
whether now or in the future, directly or indirectly controlled by Parent or Merger Sub.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Antitrust Laws</B>&rdquo;
shall mean the Sherman Act of 1890, the Clayton Act of 1914, the Federal Trade Commission Act of 1914, the HSR Act and all other Applicable
Laws in effect from time to time that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect
of monopolization or restraint of trade or lessening of competition, including through merger or acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Applicable Law(s)</B>&rdquo;
means, with respect to any Person, any U.S., non-U.S. or transnational federal, state or local law (statutory, common or otherwise), constitution,
treaty, convention, ordinance, code, rule, regulation, executive order, Order, directive or other similar legislation or requirement enacted,
adopted, promulgated or applied by a Governmental Authority that is binding upon or applicable to such Person, as the same may be amended
from time to time unless expressly specified otherwise in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Business Day</B>&rdquo;
means a day, other than Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or required by Applicable
Law to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Code</B>&rdquo;
means the U.S. Internal Revenue Code of 1986, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Acquisition
Proposal</B>&rdquo; means (other than the Transactions) any indication of interest, proposal or offer from any Person or Group, other
than Parent and its Subsidiaries, relating</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">to any (i) direct or indirect acquisition (whether
in a single transaction or a series of related transactions) of assets of the Company or its Subsidiaries (including securities of the
Company&rsquo;s Subsidiaries) equal to 20% or more of the consolidated assets of the Company, or to which 20% or more of the revenues
or earnings of the Company on a consolidated basis are attributable, (ii) direct or indirect acquisition or issuance (whether in a single
transaction or a series of related transactions) of (1) 20% or more of any class of equity or voting securities of the Company or (2)
any equity or voting securities of the Company or any of the Company&rsquo;s Subsidiaries representing, directly or indirectly, 20% or
more of the consolidated assets of the Company or 20% or more of the revenues or earnings of the Company and its Subsidiaries on a consolidated
basis, (iii) tender offer or exchange offer that, if consummated, would result in such Person or Group beneficially owning (1) 20% or
more of any class of equity or voting securities of the Company or (2) any equity or voting securities of the Company or any of the Company&rsquo;s
Subsidiaries representing, directly or indirectly, 20% or more of the consolidated assets of the Company and its Subsidiaries or 20% or
more of the revenues or earnings of the Company and its Subsidiaries on a consolidated basis, or (iv) merger, consolidation, share exchange,
business combination, joint venture, reorganization, recapitalization, liquidation, dissolution or similar transaction involving the Company
or any of its Subsidiaries, under which such Person or Group would acquire, directly or indirectly, (A) assets (including securities of
the Company&rsquo;s Subsidiaries) equal to 20% or more of the consolidated assets of the Company and its Subsidiaries, or to which 20%
or more of the revenues or earnings of the Company and its Subsidiaries on a consolidated basis are attributable, or (B) beneficial ownership
of (1) 20% or more of any class of equity or voting securities of the Company or (2) any equity or voting securities of the Company or
any of the Company&rsquo;s Subsidiaries representing, directly or indirectly, 20% or more of the consolidated assets of the Company and
its Subsidiaries or 20% or more of the revenues or earnings of the Company and its Subsidiaries on a consolidated basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company ATM Agreement</B>&rdquo;
means the Controlled Equity Offering<SUP>SM</SUP> Sales Agreement, dated April 15, 2025, by and among the Company and Barclays Capital
Inc., Cantor Fitzgerald &amp; Co., Canaccord Genuity LLC, Needham &amp; Company, LLC, Craig-Hallum Capital Group LLC and Lake Street Capital
Markets, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Balance
Sheet</B>&rdquo; means the consolidated balance sheet of the Company and its Subsidiaries as of the Company Balance Sheet Date, and the
footnotes to such consolidated balance sheet, in each case set forth in the Company&rsquo;s quarterly report on Form 10-Q for the fiscal
quarter ended June 30, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Balance
Sheet Date</B>&rdquo; means June 30, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Convertible
Notes</B>&rdquo; means the $100.0 million aggregate principal amount of 4.25% convertible senior notes due 2030 issued by the Company
in January 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Disclosure
Schedule</B>&rdquo; means the Company Disclosure Schedule delivered to Parent on the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Employee
Plan</B>&rdquo; means any Employee Plan (i) that is sponsored, maintained, administered, contributed to or entered into by the Company
or any of its Subsidiaries for the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">current or future benefit of any Company Service
Provider, or (ii) for which the Company or any of its Subsidiaries has any direct or indirect liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Equity Awards</B>&rdquo;
means Company Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Material
Adverse Effect</B>&rdquo; means any event, circumstance, development, change, occurrence or effect that, individually or in the aggregate,
is or is reasonably likely to result in, a material adverse effect on (x) the condition (financial or otherwise), assets, liabilities,
business or results of operations of the Company and its Subsidiaries, taken as a whole, or (y) the ability of the Company and its Subsidiaries
to timely consummate the Closing (including the Merger) on the terms set forth herein or to perform their agreements or covenants hereunder;
<I>provided</I> that, in the case of clause&nbsp;(x) only, no event, circumstance, development, change, occurrence or effect to the extent
resulting from, arising out of, or relating to any of the following shall be deemed to constitute, or shall be taken into account in determining
whether there has been, a Company Material Adverse Effect, or whether a Company Material Adverse Effect would reasonably be expected to
occur: (i) any changes after the date hereof in general United States or global economic conditions, including changes in United States
or global securities, credit, financial, debt or other capital markets, (ii) any changes after the date hereof in conditions generally
affecting the industries in which the Company or any of its Subsidiaries materially engages, (iii) any decline, in and of itself, in the
market price or trading volume of the Company Stock and any changes in credit ratings and any changes in any analysts&rsquo; recommendations
or ratings with respect to the Company or any of its Subsidiaries (it being understood and agreed that this clause&nbsp;(iii) shall not
preclude Parent from asserting that any facts or occurrences giving rise to or contributing to such decline that are not otherwise excluded
from the definition of Company Material Adverse Effect should be deemed to constitute, or be taken into account in determining whether
there has been, or would reasonably be expected to be, a Company Material Adverse Effect), (iv) any changes in the price or trading volume
of Bitcoin (it being understood and agreed that this clause&nbsp;(iv) shall not preclude Parent from asserting that any facts or occurrences
giving rise to or contributing to such changes that are not otherwise excluded from the definition of Company Material Adverse Effect
should be deemed to constitute, or be taken into account in determining whether there has been, or would reasonably be expected to be,
a Company Material Adverse Effect), (v) any failure, in and of itself, by the Company or any of its Subsidiaries to meet any internal
or published projections, forecasts, estimates or predictions in respect of revenues, earnings or other financial or operating metrics
for any period (it being understood and agreed that this clause&nbsp;(v) shall not preclude Parent from asserting that any facts or occurrences
giving rise to or contributing to such failure that are not otherwise excluded from the definition of Company Material Adverse Effect
should be deemed to constitute, or be taken into account in determining whether there has been, or would reasonably be expected to be,
a Company Material Adverse Effect), (vi) the execution and delivery of this Agreement, the public announcement or the pendency of this
Agreement (it being understood and agreed that this clause&nbsp;(vi) shall not apply with respect to any representation or warranty that
is intended to address the consequences of the execution and delivery of this Agreement or the public announcement or the pendency of
this Agreement), (vii) any changes after the date hereof in any Applicable Law or GAAP (or authoritative interpretations thereof), (viii)
any action or omission taken by the Company pursuant to the written request of Parent or Merger Sub, (ix) any acts of God, natural disasters,
terrorism, armed hostilities, sabotage, war or any escalation or worsening of acts of war, epidemic, pandemic or disease outbreak (including
the COVID-19 virus), or (x) regulatory or clinical, competitive,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">pricing, reimbursement, supply or manufacturing Effects
relating to or affecting any Company Product or any product competitive with or related to any Company Product (it being understood and
agreed that this clause (x) shall not apply with respect to any representation or warranty that is intended to address the subject matter
of this clause (x)), except in the case of each of clauses&nbsp;(i), (ii), (iv), (vii), (ix) or (x), to the extent that any such event,
circumstance, development, change, occurrence or effect has a disproportionate adverse effect on the Company and its Subsidiaries relative
to other companies operating in the industries in which the Company or any of its subsidiaries materially engages, in which case only
the incremental disproportionate impact or impacts may be taken into account in determining whether or not there has been a Company Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Product</B>&rdquo;
means QuantaFlo.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Service
Provider</B>&rdquo; means any director, officer, employee or individual independent contractor of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Stock</B>&rdquo;
means the common stock, $0.001 par value, of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Stock Plans</B>&rdquo;
means the Company&rsquo;s 2014 Stock Option and Incentive Plan and the Company&rsquo;s 2024 Stock Option and Incentive Plan, in each case,
as amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Consent</B>&rdquo;
means any consent, approval, waiver, license, permit, variance, exemption, franchise, clearance, authorization, acknowledgment, Order
or other confirmation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Contract</B>&rdquo;
means, with respect to a Person, any written or oral contract, agreement, obligation, commitment, arrangement, understanding, instrument,
lease, sublease or license to which such Person is a party or by which such Person is otherwise bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Digital Asset</B>&rdquo;
means a digital unit that generally may be recorded or transferred by means of a distributed ledger technology system, including digital
units that (a) have a centralized repository or administrator, (b) are decentralized and have no centralized repository or administrator
or (c) may be created or obtained by computing or manufacturing effort, including in each case, (i) any cryptographic tokens, cryptographic
coins, cryptographic currencies, or other cryptographic assets, or other, virtual or blockchain-based assets that may function as a medium
of exchange, a form of digitally stored value, or otherwise purport to provide the holder with access to a distributed ledger technology-related
system or service, and (ii) options, or warrants to purchase any of the items described in the foregoing clause (i) or that are, or may
become, convertible or exchangeable into or exercisable for (directly or indirectly) any of the items described in the foregoing clause
(i). For the avoidance of doubt, Digital Asset includes but is not limited to any asset that would constitute &ldquo;Virtual Currency&rdquo;
as defined by 23 NYCRR 200.2(p)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Employee Plan</B>&rdquo;
means any (i) &ldquo;employee benefit plan&rdquo; as defined in Section 3(3) of ERISA (whether or not subject to ERISA), (ii)&nbsp;compensation,
employment, consulting, severance, termination protection, change in control, transaction bonus, retention or similar plan, agreement,
arrangement, program or policy, or (iii) other plan, agreement, arrangement, program or policy providing for compensation, bonuses, profit-sharing,
equity or equity-based compensation or other forms of incentive or deferred compensation, vacation benefits, insurance (including any
self-</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">insured arrangement), medical, dental, vision, prescription
or fringe benefits, life insurance, relocation or expatriate benefits, perquisites, disability or sick leave benefits, employee assistance
program, workers&rsquo; compensation, supplemental unemployment benefits or post-employment or retirement benefits, excluding, in each
case, any such arrangement required to be maintained, sponsored or contributed to by a Governmental Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Environmental Law</B>&rdquo;
means any Applicable Law relating to (i) human health and safety, (ii) the protection, preservation or restoration of the environment
(including air, surface water, groundwater, drinking water supply, surface land, subsurface land, plant and animal life or any other natural
resource), or (iii) the exposure to, or the use, storage, recycling, treatment, generation, transportation, processing, handling, labeling,
production, release or disposal of Hazardous Substances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Environmental Permits</B>&rdquo;
means all Consents (including consents required by Contract) of Governmental Authorities required by Environmental Law and affecting,
or relating to, the business of the Company or any of its Subsidiaries, or the business of Parent or any of its Subsidiaries, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>ERISA</B>&rdquo;
means the Employee Retirement Income Security Act of 1974.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>ERISA Affiliate</B>&rdquo;
means, with respect to any entity, any other entity that, together with such entity, would (at any relevant time) be treated as a single
employer under Section 414 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>ERISA Client</B>&rdquo;
means each Client that is (i) an &ldquo;employee benefit plan&rdquo; (as defined in Section 3(3) of ERISA) that is subject to Title I
of ERISA, (ii) a plan, individual retirement account or other arrangement that is subject to Section 4975 of the Code, (iii) an employee
benefit plan, plan, account or arrangement that is subject to any Similar Law, or (iv) any entity whose underlying assets are considered
to include &ldquo;plan assets&rdquo; (as defined by the regulations of the Department of Labor, as amended by Section 3(42) of ERISA)
of any such employee benefit plan, plan, account or arrangement, or a Person acting on behalf of such a Client.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Filing</B>&rdquo;
means any registration, petition, statement, application, schedule, form, declaration, notice, notification, report, submission or other
filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>GAAP</B>&rdquo;
means United States generally accepted accounting principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Governmental Authority</B>&rdquo;
means any transnational, domestic or foreign federal, state or local governmental, regulatory or administrative authority, department,
court, agency, bureau, office, board, instrumentality, commission or official, including any political subdivision thereof, or any non-governmental
self-regulatory agency, commission or authority, and any individual, body or entity exercising or having the authority to exercise under
the Applicable Laws thereof any executive, legislative, judicial, regulatory or administrative functions of or pertaining to government,
including any Taxing Authority, board of trade, federal revenue offices, securities exchanges commission, stock exchange, and any court,
arbitrator or arbitration panel with proper authority and jurisdiction under such Applicable Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Group</B>&rdquo;
means a &ldquo;group&rdquo; as defined in Section 13(d) of the Securities Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Hazardous Substance</B>&rdquo;
means any substance, material or waste that is listed, defined, designated or classified as hazardous, toxic, radioactive, dangerous or
a &ldquo;pollutant&rdquo; or &ldquo;contaminant&rdquo; or words of similar meaning under any Applicable Law relating to the environment
or natural resources or that is otherwise regulated, or for which liability may be imposed, by any Governmental Authority with jurisdiction
over Environmental Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Health Care Laws</B>&rdquo;
means all Applicable Laws, if and to the extent applicable to the Company and its Subsidiaries, relating in any way to: (a) the study,
design, development, testing, manufacture, processing, labeling, supply, sale, advertising, labeling, packaging, marketing, promoting,
commercializing, distribution, import, export, storage, service, record keeping, traceability, training, reporting (including medical
device reporting, adverse event and incident reporting, field alert reporting, and any other reporting required by Applicable Laws), handling,
provision, or payment for, health care services, equipment, supplies, materials, Medical Devices, biologics, combination products, or
precursors, ingredients, or components of Medical Devices, biologics, combination products, Products, goods, or services related to the
Company or its Subsidiaries; (b) required Health Care Permits; (c) quality, safety certification, and accreditation standards and requirements
related to the study, design, development, testing, manufacture, processing, labeling, supply, sale, advertising, promoting, labeling,
packaging, marketing, commercializing, distribution, import, export, storage, service, handling, provision, or payment for health care
services, equipment, supplies, materials, Medical Devices, biologics, precursors, ingredients, or components of Medical Devices, biologics,
combination products, Products, goods, or services related to the Company or its Subsidiaries; (d) the Food, Drug, and Cosmetic Act (21
U.S.C. &sect; 301 et seq.) and its implementing regulations, including those relating to the study, design, development, testing, manufacture,
processing, labeling, supply, sale, advertising, labeling, packaging, marketing, promotion, commercializing, distribution, import, export,
storage, service, handling, provision, or payment for health care services, equipment, supplies, Medical Devices, biologics, precursors,
ingredients, materials, or components of Medical Devices, biologics, combination products, Products, goods, or services related to the
Company or its Subsidiaries including all applicable rules and requirements of the FDA and the Federal Trade Commission; (e) the Quality
System Regulation as set forth in 21 C.F.R. Part 820; (f) the standards for the manufacture, processing, packaging, testing, transportation,
handling and holding of Medical Devices and biologics as set forth in the U.S. Federal Food, Drug, and Cosmetic Act (21 U.S.C. &sect;&sect;
301 et seq.), as amended (the &ldquo;<B>FDC Act</B>&rdquo;) and applicable regulations promulgated by the FDA (including, for example,
21 C.F.R. Parts 11) and such standards of good manufacturing practices as are required by applicable Governmental Authorities; (g) all
Applicable Laws pertaining to the standards for clinical studies and trials for the design, conduct, performance, monitoring, auditing,
recording, analysis, and reporting (including all applicable requirements relating to protection of human subjects), as set forth in the
FDC Act and applicable regulations promulgated by the FDA (including, for example, 21 C.F.R. Parts 11, 50, 54, 56, and 812) and such standards
of good clinical practice (including all applicable requirements relating to protection of human subjects) as are required by any other
applicable Governmental Authority; (h) the standards for conducting non-clinical laboratory studies, as set forth in the FDC Act and applicable
regulations promulgated by the FDA (including, for example, 21 C.F.R. Parts 11 and 58) and such standards of good laboratory practices
as are required by applicable Governmental Authorities in any other jurisdiction; (i) the standards and practices of creating and maintaining
records that are accurate, attributable, verified as genuine, legible, contemporaneous and complete, and are created and stored using
security measures that protect the confidential nature (if applicable) and integrity of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">the records, and prevent unauthorized access to,
and alteration, corruption or loss of such records in a manner sufficient to satisfy the requirements contained in 21 C.F.R. Parts 58,
and all comparable standards of any other applicable Governmental Authority; (j) any and all other Applicable Laws including applicable
federal, state or local health care laws, rules, codes, regulations, manuals, orders, ordinances, professional or ethical rules, administrative
guidance and requirements (including those pursuant to which Health Care Permits are issued), as the same may be amended, modified or
supplemented from time to time; (k) the Anti-Kickback Statute (42 U.S.C. &sect; 1320a-7b) and all similar Applicable Laws in any jurisdiction;
(l) the Civil Monetary Penalty Statute (42 U.S.C. &sect; 1320a-7a) and all similar Applicable Laws in any jurisdiction; (m) the False
Claims Act (31 U.S.C. &sect;&sect; 3729 et seq.) and all similar Applicable Laws in any jurisdiction; (n) the Federal Sunshine Act (42
U.S.C. &sect; 1320a-7h) along with its reporting requirements and all similar Laws in any jurisdiction; and (o) HIPAA and all similar
Applicable Laws in any jurisdiction. Health Care Laws shall include all similar Applicable Laws of any Governmental Authority addressing
the subject matter of clauses (a) through (o).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Health Care Permits</B>&rdquo;
means all licenses, approvals, authorizations, permissions, certificates, registrations, or clearances required by any Governmental Authority
or issued pursuant to any Applicable Laws that are required to carry on the Company and its Subsidiaries&rsquo; business in order to study,
design, develop, test, manufacture, process, label, supply, sell, advertise, promote, label, package, market, commercialize, distribute,
import, export, store, service, handle, provide or pay for any of the Company or its Subsidiaries&rsquo; Medical Devices, biologics, combination
products, or Products involving the Company or its Subsidiaries, or any products or services in which the Company or its Subsidiaries&rsquo;
Products are components, parts, or materials including manufacturing materials. Health Care Permits shall include premarket approvals,
premarket notifications, De Novos, Investigational Device Exemptions, IRB Approvals, Humanitarian Device Exemptions, Biologics License
Applications, establishment registration and listing with FDA, U.S. state manufacturing, distribution, or wholesale licenses, permits,
or registrations, and any supplements or amendments to any Health Care Permits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>HIPAA</B>&rdquo;
means the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and
Clinical Health (HITECH) Act, together with all implementing regulations thereof, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>HSR Act</B>&rdquo;
means the Hart-Scott-Rodino Antitrust Improvements Act of 1976.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Intellectual Property</B>&rdquo;
means any and all of the following, whether or not registered, and all rights therein, arising in the United States or any other jurisdiction
throughout the world: (i)&nbsp;trademarks, service marks, trade names, certification marks, logos, trade dress, brand names, corporate
names, Internet domain names and other indicia of origin, together with all goodwill associated therewith or symbolized thereby, and all
registrations and applications relating to the foregoing; (ii) patents and pending patent applications and all divisions, continuations,
continuations-in-part, reissues, reexaminations, and any extensions thereof; (iii) registered and unregistered copyrights (including those
in Software), all registrations and applications to register the same, and all renewals, extensions, reversions and restorations thereof;
(iv) trade secrets and rights in confidential technology and information, know-how, inventions, improvements, processes, formulae, algorithms,
models, methodologies, customer and supplier lists, pricing and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">cost information and business and marketing plans
and proposals; (v) rights in Software; and (vi) other similar types of proprietary or intellectual property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investment Advisers
Act</B>&rdquo; means the Investment Advisers Act of 1940.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>IRS</B>&rdquo; means
the U.S. Internal Revenue Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>IT Assets</B>&rdquo;
means any and all computers, Software, firmware, middleware, servers, workstations, routers, hubs, switches, data communications lines
and all other information technology equipment, and all associated documentation, owned by or purported to be owned by an applicable Person
or any of its Subsidiaries, or licensed or leased, or purported to the licensed or leased, to an applicable Person or any of its Subsidiaries
(excluding any public networks).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Key Employee</B>&rdquo;
means an employee of the Company or any of its Subsidiaries with the title of vice president or above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>knowledge</B>&rdquo;
of the Company or Parent means the knowledge, after reasonable inquiry, of those individuals set forth in Section&nbsp;&lrm;1.01 of the
Company Disclosure Schedule or Section&nbsp;&lrm;1.01 of the Parent Disclosure Schedule, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Licensed Intellectual
Property</B>&rdquo; means any and all Intellectual Property owned by a Third Party and licensed or sublicensed to or purported to be licensed
or sublicensed to the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Lien</B>&rdquo;
means, with respect to any property or asset, any mortgage, lien, license, pledge, charge, security interest, real property covenant,
encumbrance or other adverse claim of any kind in respect of such property or asset. For purposes of this Agreement, a Person shall be
deemed to own subject to a Lien any property or asset that it has acquired or holds subject to the interest of a vendor or lessor under
any conditional sale agreement, capital lease or other title retention agreement relating to such property or asset.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Medical Device</B>&rdquo;
has the same meaning as the term &ldquo;device&rdquo; is defined in 21 U.S.C. &sect; 321(h)(1) of the Federal Food, Drug, and Cosmetic
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Nasdaq</B>&rdquo;
means The Nasdaq Stock Market LLC, or any successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Order</B>&rdquo;
means any order, writ, decree, judgment, award, decision, injunction, ruling, settlement, subpoena, verdict, consent decree, compliance
order, civil or administrative order, or stipulation issued, promulgated, made, rendered or entered into by or with any Governmental Authority
or arbitrator (in each case, whether temporary, preliminary or permanent).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Owned Intellectual
Property</B>&rdquo; means, with respect to any Person, any and all Intellectual Property owned or purported to be owned by such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Parent Balance Sheet</B>&rdquo;
means the unaudited pro forma combined consolidated financial information of Parent and its Subsidiaries as of the Parent Balance Sheet
Date, and the footnotes to such consolidated financial information, in each case set forth in Parent&rsquo;s registration statement on
Form S-4 deemed filed with the SEC on August 6, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Parent Balance Sheet
Date</B>&rdquo; means June 30, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Parent Class A Common
Stock</B>&rdquo; means the Class A Common Stock, $0.001 par value per share, of Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Parent Class B Common
Stock</B>&rdquo; means the Class B Common Stock, $0.001 par value per share, of Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Parent Common Stock</B>&rdquo;
means the Parent Class A Common Stock and the Parent Class B Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Parent Disclosure
Schedule</B>&rdquo; means the Parent Disclosure Schedule delivered to the Company on the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Parent Employee
Plan</B>&rdquo; means any Employee Plan (i) that is sponsored, maintained, administered, contributed to or entered into by the Parent
or any of its Subsidiaries for the current or future benefit of any Parent Service Provider, or (ii) for which the Parent or any of its
Subsidiaries has any direct or indirect liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Parent Material
Adverse Effect</B>&rdquo; means any event, circumstance, development, change, occurrence or effect that, individually or in the aggregate,
is or is reasonably likely to result in, a material adverse effect on (x) the condition (financial or otherwise), assets, liabilities,
business or results of operations of Parent and its Subsidiaries, taken as a whole, or (y) the ability of Parent and its Subsidiaries
to timely consummate the Closing (including the Merger) on the terms set forth herein, or to perform their agreements or covenants hereunder;
<I>provided</I> that, in the case of clause&nbsp;(x) only, no event, circumstance, development, change, occurrence or effect to the extent
resulting from, arising out of, or relating to any of the following shall be deemed to constitute, or shall be taken into account in determining
whether there has been, a Parent Material Adverse Effect, or whether a Parent Material Adverse Effect would reasonably be expected to
occur: (i) any changes after the date hereof in general United States or global economic conditions, including changes in United States
or global securities, credit, financial, debt or other capital markets, (ii) any changes after the date hereof in conditions generally
affecting the industries in which the Parent or any of its Subsidiaries materially engages, (iii) any decline, in and of itself, in the
market price or trading volume of Parent Class A Common Stock, any changes in credit ratings and any changes in any analysts&rsquo; recommendations
or ratings with respect to Parent or any of its Subsidiaries (it being understood and agreed that this clause&nbsp;(iii) shall not preclude
the Company from asserting that any facts or occurrences giving rise to or contributing to such decline that are not otherwise excluded
from the definition of Parent Material Adverse Effect should be deemed to constitute, or be taken into account in determining whether
there has been, or would reasonably be expected to be, a Parent Material Adverse Effect), (iv) any changes in the price or trading volume
of Bitcoin (it being understood and agreed that this clause&nbsp;(iv) shall not preclude the Company from asserting that any facts or
occurrences giving rise to or contributing to such changes that are not otherwise excluded from the definition of Parent Material Adverse
Effect should be deemed to constitute, or be taken into account in determining whether there has been, or would reasonably be expected
to be, a Parent Material Adverse Effect), (v) any failure, in and of itself, by Parent or any of its Subsidiaries to meet any internal
or published projections, forecasts, estimates or predictions in respect of revenues, earnings or other financial or operating metrics
for</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">any period (it being understood and agreed that this
clause&nbsp;(v) shall not preclude the Company from asserting that any facts or occurrences giving rise to or contributing to such failure
that are not otherwise excluded from the definition of Parent Material Adverse Effect should be deemed to constitute, or be taken into
account in determining whether there has been, or would reasonably be expected to be, a Parent Material Adverse Effect), (vi) the execution
and delivery of this Agreement, the public announcement or the pendency of this Agreement (it being understood and agreed that this clause&nbsp;(vi)
shall not apply with respect to any representation or warranty that is intended to address the consequences of the execution and delivery
of this Agreement or the public announcement or the pendency of this Agreement), (vii) any changes after the date hereof in any Applicable
Law or GAAP (or authoritative interpretations thereof), (viii) any action or omission taken by Parent or Merger Sub pursuant to the written
request of the Company or (ix) any acts of God, natural disasters, terrorism, armed hostilities, sabotage, war or any escalation or worsening
of acts of war, epidemic, pandemic or disease outbreak (including the COVID-19 virus), except in the case of each of clauses&nbsp;(i),
(ii), (iv), (vii) or (ix), to the extent that any such event, circumstance, development, change, occurrence or effect has a disproportionate
adverse effect on Parent and its Subsidiaries relative to other companies operating in the industries in which Parent or any of its subsidiaries
materially engages, in which case only the incremental disproportionate impact or impacts may be taken into account in determining whether
or not there has been a Parent Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Parent Preferred
Stock</B>&rdquo; means the Series A Convertible Preferred Stock, $0.001 par value per share, of Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Parent Service Provider</B>&rdquo;
means any director, officer, employee or individual independent contractor of the Parent or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Parent Share Issuance</B>&rdquo;
means the issuance of shares of Parent Class A Common Stock in connection with the Merger, as contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Parent Warrants</B>&rdquo;
means the warrants exercisable to purchase Parent Class B Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Permitted Lien</B>&rdquo;
means (i) Liens for Taxes not yet due and payable or which are being contested in good faith by appropriate proceedings and, in each case,
with respect to which adequate reserves have been established in accordance with GAAP and set forth in the audited consolidated financial
statements and unaudited consolidated interim financial statements of the Company included or incorporated by reference in the Company&rsquo;s
quarterly report on Form 10-Q for the fiscal quarter ended June 30, 2025, (ii) carriers&rsquo;, warehousemen&rsquo;s, mechanics&rsquo;,
materialmen&rsquo;s, repairmen&rsquo;s or other similar liens, in each case, arising in the ordinary course of business, in each case,
with respect to which adequate reserves have been established in accordance with GAAP and set forth in the audited consolidated financial
statements and unaudited consolidated interim financial statements of the Company included or incorporated by reference in the Company&rsquo;s
quarterly report on Form 10-Q for the fiscal quarter ended June 30, 2025, (iii) pledges or deposits in connection with workers&rsquo;
compensation, unemployment insurance and other social security legislation, in each case, arising in the ordinary course of business,
(iv) easements, rights-of-way, covenants, restrictions and other encumbrances incurred in the ordinary course of business that do not,
in any case, materially detract from the value or the use of the property subject</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">thereto, (v) statutory landlords&rsquo; liens and
liens granted to landlords under any lease, (vi) non-exclusive licenses to Intellectual Property granted in the ordinary course of business
or (vii) any Liens which are disclosed on the Company Balance Sheet (in the case of Liens applicable to the Company or any of its Subsidiaries)
or the Parent Balance Sheet (in the case of Liens applicable to Parent or any of its Subsidiaries) or the notes thereto or (viii) any
Liens that are not material to the Company and its Subsidiaries or Parent and its Subsidiaries, as applicable, taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Person</B>&rdquo;
means any individual, corporation, partnership, limited liability company, association, trust or other entity or organization, including
a government or political subdivision or an agency or instrumentality of such government or political subdivision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Proceeding</B>&rdquo;
means any legal, administrative, arbitral or other proceeding (including disciplinary proceeding), claim, suit, action or governmental
or regulatory investigation or inquiry of any nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Product</B>&rdquo;
means any and all products, product candidates, parts, materials, components, Medical Devices, biologics, goods, and services of the Company
or any of its Subsidiaries, including Software of or related to the Company and its Subsidiaries, including those that are or have been
studied, designed, developed, manufactured, propagated, supplied, prepared, processed, tested, assembled, packaged, labelled, processed,
sold, serviced, marketed, advertised, commercialized, distributed, imported, exported, transported, stored, handled, provided, or paid
for by, on behalf of, with, or at the direction of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Sarbanes-Oxley Act</B>&rdquo;
means the Sarbanes-Oxley Act of 2002.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>SEC</B>&rdquo; means
the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Securities Act</B>&rdquo;
means the Securities Act of 1933.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Securities Exchange
Act</B>&rdquo; means the Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Securities Laws</B>&rdquo;
means the Securities Act, the Securities Exchange Act, the Investment Company Act of 1940, the Investment Advisers Act, state &ldquo;blue
sky,&rdquo; securities and investment advisory laws, all applicable foreign securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Similar Law</B>&rdquo;
means any law similar to Title I of ERISA or Section 4975 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Software</B>&rdquo;
means all (i) computer programs and other software including any and all software implementations of algorithms, models and, methodologies,
assemblers, applets, compilers, development tools, design tools and user interfaces, whether in source code or object code form, (ii)
databases and compilations, including all data and collections of data, whether machine readable or otherwise, and (iii) updates, upgrades,
modifications, improvements, enhancements, derivative works, new versions, new releases and corrections to or based on any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subsidiary</B>&rdquo;
means, when used with reference to a Person, (A) any other Person of which securities or other ownership interests having ordinary voting
power to elect a majority of the board of directors or other governing body or Persons performing similar functions, or more than</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">50% of the outstanding voting securities of which,
are owned, directly or indirectly, by such first Person or (B) any other Person with respect to which such first Person controls the management.
For purposes of this Agreement, a Subsidiary shall be considered a &ldquo;wholly owned Subsidiary&rdquo; of a Person as long as such Person
directly or indirectly owns all of the securities or other ownership interests (excluding any securities or other ownership interests
held by an individual director or officer required to hold such securities or other ownership interests pursuant to Applicable Law) of
such Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Tax</B>&rdquo; means
any income, gross receipts, franchise, sales, use, ad valorem, property, payroll, withholding, excise, severance, transfer, employment,
estimated, alternative or add-on minimum, value added, stamp, occupation, premium, environmental or windfall profits taxes, and any other
taxes, charges, fees, levies, imposts, duties, licenses or other assessments, together with any interest, penalties, additions to tax
or other additional amounts with respect to any of the foregoing (including penalties for failure to file or late filing of any tax return,
report or other filing, and any interest in respect of such penalties, additions to tax or other additional amounts) imposed by any federal,
state, local, non-U.S. or other Governmental Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Tax Return</B>&rdquo;
means any report, return, document, statement, declaration or other information or filing filed or required to be filed with any Taxing
Authority with respect to Taxes, including information returns, claims for refunds, any documents with respect to or accompanying payments
of estimated Taxes or any documents with respect to or accompanying requests for the extension of time in which to file any such report,
return, document, declaration or other information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Tax Sharing Agreement</B>&rdquo;
means any existing agreement binding any Person that provides for the allocation, apportionment, sharing or assignment of any Tax liability
or benefit, or the transfer or assignment of income, losses, revenues, receipts, or gains for the purpose of determining any Person&rsquo;s
Tax liability, other than agreements entered into in the ordinary course of business that do not have as a principal purpose addressing
Tax matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Taxing Authority</B>&rdquo;
means any Governmental Authority responsible for the imposition or collection of any Tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Third Party</B>&rdquo;
means any Person or Group, other than the Company, Parent, any of their respective Affiliates or the Representatives of any such Persons
acting in such capacity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Transactions</B>&rdquo;
means the transactions contemplated by this Agreement (including the Merger).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Treasury Regulations</B>&rdquo;
means the Treasury regulations promulgated under the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>U.S. Plan</B>&rdquo;
means any Employee Plan that covers Company Service Providers or Parent Service Providers located primarily within the U.S.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>WARN</B>&rdquo;
means the Worker Adjustment and Retraining Notification Act and any comparable foreign, state or local law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each of the following terms is defined in the Section set forth opposite such term:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 87%; text-align: justify"><B><U>Term</U></B></TD>
    <TD STYLE="width: 13%; text-align: right"><B><U>Section</U></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Agreement</TD>
    <TD STYLE="text-align: right">Preamble</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Alternate Company Acquisition Agreement</TD>
    <TD STYLE="text-align: right">&lrm;6.03(i)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Anti-Money Laundering Laws</TD>
    <TD STYLE="text-align: right">&lrm;4.14(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Bankruptcy and Equity Exceptions</TD>
    <TD STYLE="text-align: right">&lrm;4.02(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Burdensome Condition</TD>
    <TD STYLE="text-align: right">&lrm;8.01(c)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Certificate of Merger</TD>
    <TD STYLE="text-align: right">&lrm;2.02(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Closing</TD>
    <TD STYLE="text-align: right">&lrm;2.01</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Closing Date</TD>
    <TD STYLE="text-align: right">&lrm;2.01</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Collection Expenses</TD>
    <TD STYLE="text-align: right">&lrm;10.03(c)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Common Merger Consideration</TD>
    <TD STYLE="text-align: right">&lrm;2.03</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Common Stock Certificates</TD>
    <TD STYLE="text-align: right">&lrm;2.04(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company</TD>
    <TD STYLE="text-align: right">Preamble</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Acquisition Proposal</TD>
    <TD STYLE="text-align: right">&lrm;10.03(a)(ii)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Adverse Recommendation Change</TD>
    <TD STYLE="text-align: right">&lrm;6.03(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Approval Time</TD>
    <TD STYLE="text-align: right">&lrm;6.03(b)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Board Recommendation</TD>
    <TD STYLE="text-align: right">&lrm;4.02(b)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Indemnified Parties</TD>
    <TD STYLE="text-align: right">&lrm;7.03(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Intervening Event</TD>
    <TD STYLE="text-align: right">&lrm;6.03(g)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Material Contract</TD>
    <TD STYLE="text-align: right">&lrm;4.17(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Notes</TD>
    <TD STYLE="text-align: right">&lrm;6.04</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Option</TD>
    <TD STYLE="text-align: right">2.05(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Organizational Documents</TD>
    <TD STYLE="text-align: right">&lrm;4.01</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Permits</TD>
    <TD STYLE="text-align: right">&lrm;4.13(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Registered IP</TD>
    <TD STYLE="text-align: right">&lrm;4.21(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Regulatory Agreement</TD>
    <TD STYLE="text-align: right">&lrm;4.14(g)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company SEC Documents</TD>
    <TD STYLE="text-align: right">&lrm;4.07(b)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Securities</TD>
    <TD STYLE="text-align: right">&lrm;4.05(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Stockholder Approval</TD>
    <TD STYLE="text-align: right">&lrm;4.02(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Stockholder Meeting</TD>
    <TD STYLE="text-align: right">&lrm;8.03(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Subsidiary Securities</TD>
    <TD STYLE="text-align: right">&lrm;4.06(b)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Superior Proposal</TD>
    <TD STYLE="text-align: right">&lrm;6.03(f)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Company Termination Fee</TD>
    <TD STYLE="text-align: right">&lrm;10.03(a)(ii)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Confidentiality Agreement</TD>
    <TD STYLE="text-align: right">6.02(a) </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Converted Option</TD>
    <TD STYLE="text-align: right">2.05(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Delaware Law</TD>
    <TD STYLE="text-align: right">&lrm;2.02(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Effective Time</TD>
    <TD STYLE="text-align: right">&lrm;2.02(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">e-mail</TD>
    <TD STYLE="text-align: right">&lrm;11.01</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">End Date</TD>
    <TD STYLE="text-align: right">&lrm;10.01(b)(i)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Exchange Agent</TD>
    <TD STYLE="text-align: right">&lrm;2.04(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Exchange Fund</TD>
    <TD STYLE="text-align: right">&lrm;2.04(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Exchange Ratio</TD>
    <TD STYLE="text-align: right">&lrm;2.03</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Excluded Shares</TD>
    <TD STYLE="text-align: right">&lrm;2.03</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Field Action</TD>
    <TD STYLE="text-align: right">4.16(g)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Indenture</TD>
    <TD STYLE="text-align: right">&lrm;6.04</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 19; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 87%">Information Statement/Proxy Statement/Prospectus</TD>
    <TD STYLE="text-align: right; width: 13%">&lrm;8.02(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">internal controls</TD>
    <TD STYLE="text-align: right">&lrm;4.07(g)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Lease</TD>
    <TD STYLE="text-align: right">&lrm;4.22</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Merger</TD>
    <TD STYLE="text-align: right">2.02(b)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Merger Sub</TD>
    <TD STYLE="text-align: right">7.06</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Mergers</TD>
    <TD STYLE="text-align: right">Recitals</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Parent</TD>
    <TD STYLE="text-align: right">Preamble</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Parent&nbsp;&nbsp;Securities</TD>
    <TD STYLE="text-align: right">5.05(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Parent Material Contract</TD>
    <TD STYLE="text-align: right">&lrm;5.15</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Parent Organizational Documents</TD>
    <TD STYLE="text-align: right">&lrm;5.01</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Parent Permits</TD>
    <TD STYLE="text-align: right">&lrm;5.13(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Parent Qualified Plan</TD>
    <TD STYLE="text-align: right">&lrm;7.04(d)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Parent Registered IP</TD>
    <TD STYLE="text-align: right">&lrm;5.19(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Parent Regulatory Agreement</TD>
    <TD STYLE="text-align: right">&lrm;5.14(f)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Parent RSU Awards</TD>
    <TD STYLE="text-align: right">5.05(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Parent SEC Documents</TD>
    <TD STYLE="text-align: right">&lrm;5.07(b)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Parent Stockholder Approval</TD>
    <TD STYLE="text-align: right">Recitals</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Parent Stockholder Approval Deadline</TD>
    <TD STYLE="text-align: right">7.05</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Parent Subsidiary Securities</TD>
    <TD STYLE="text-align: right">&lrm;5.06(b)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Premium Cap</TD>
    <TD STYLE="text-align: right">&lrm;7.03(b)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">principal executive officer</TD>
    <TD STYLE="text-align: right">&lrm;4.07(f)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">principal financial officer</TD>
    <TD STYLE="text-align: right">&lrm;4.07(f)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">QPAM Exemption</TD>
    <TD STYLE="text-align: right">&lrm;4.14(e)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Registration Statement</TD>
    <TD STYLE="text-align: right">&lrm;8.02(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Regulation S-K</TD>
    <TD STYLE="text-align: right">&lrm;4.11</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Regulation S-X</TD>
    <TD STYLE="text-align: right">&lrm;6.01(m)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Regulatory Agencies</TD>
    <TD STYLE="text-align: right">&lrm;4.07(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Related Party</TD>
    <TD STYLE="text-align: right">&lrm;4.17(a)(ix)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Related Party Contract</TD>
    <TD STYLE="text-align: right">&lrm;4.17(a)(ix)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Release</TD>
    <TD STYLE="text-align: right">&lrm;8.04</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Representatives</TD>
    <TD STYLE="text-align: right">&lrm;6.03(a)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Sanctions</TD>
    <TD STYLE="text-align: right">&lrm;4.14(b)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Second Merger</TD>
    <TD STYLE="text-align: right">Recitals</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Second Merger Sub</TD>
    <TD STYLE="text-align: right">Preamble</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Second Surviving LLC</TD>
    <TD STYLE="text-align: right">Recitals</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Surviving Corporation</TD>
    <TD STYLE="text-align: right">2.02(b)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Transaction Litigation</TD>
    <TD STYLE="text-align: right">&lrm;8.07</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Uncertificated Common Shares</TD>
    <TD STYLE="text-align: right">&lrm;2.04(a)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;1.02.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Other Definitional and Interpretative Provisions</I>. The following rules of interpretation shall apply to this Agreement: (i)
the words &ldquo;hereof,&rdquo; &ldquo;hereby,&rdquo; &ldquo;herein&rdquo; and &ldquo;hereunder&rdquo; and words of like import used in
this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement; (ii) the table of contents
and captions in this Agreement are included for convenience of reference only and shall be ignored in the construction or interpretation
hereof; (iii) references to Articles, Sections and Exhibits are to Articles, Sections and Exhibits of this Agreement unless otherwise
specified; (iv) all Exhibits and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">schedules annexed to this Agreement or referred
to in this Agreement, including the Company Disclosure Schedule and the Parent Disclosure Schedule, are hereby incorporated in and made
a part of this Agreement as if set forth in full in this Agreement; (v) any capitalized term used in any Exhibit, the Company Disclosure
Schedule or the Parent Disclosure Schedule but not otherwise defined therein shall have the meaning set forth in this Agreement; (vi)
any singular term in this Agreement shall be deemed to include the plural, and any plural term shall be deemed to include the singular,
and references to any gender shall include all genders; (vii) whenever the words &ldquo;include,&rdquo; &ldquo;includes&rdquo; or &ldquo;including&rdquo;
are used in this Agreement, they shall be deemed to be followed by the words &ldquo;without limitation,&rdquo; whether or not they are
in fact followed by those words or words of like import; (viii) &ldquo;writing,&rdquo; &ldquo;written&rdquo; and comparable terms refer
to printing, typing and other means of reproducing words (including by electronic media) in a visible form; (ix) references to any Applicable
Law shall be deemed to refer to such Applicable Law as amended or supplemented from time to time and to any rules, regulations and interpretations
promulgated thereunder; (x) references to any Contract are to that Contract as amended, modified or supplemented from time to time in
accordance with the terms hereof and thereof; <I>provided</I> that with respect to any Contract listed on any schedule hereto, all such
amendments, modifications or supplements must also be listed in the appropriate schedule; (xi) references to any Person include the successors
and permitted assigns of that Person; (xii) references to &ldquo;from&rdquo; or &ldquo;through&rdquo; any date mean, unless otherwise
specified, &ldquo;from and including&rdquo; or &ldquo;through and including,&rdquo; respectively; (xiii) references to &ldquo;dollars&rdquo;
and &ldquo;$&rdquo; means U.S. dollars; (xiv) the term &ldquo;made available&rdquo; and words of similar import mean that the relevant
documents, instruments or materials were (A) posted and made available prior to the date hereof by the Company in the BOX due diligence
data site maintained by the Company, (B) provided via electronic mail or in person prior to the date hereof, or (C) filed with or furnished
to the SEC and publicly available on the SEC&rsquo;s EDGAR reporting system prior to the date hereof; (xv) the word &ldquo;extent&rdquo;
in the phrase &ldquo;to the extent&rdquo; shall mean the degree to which a subject or other theory extends and such phrase shall not mean
&ldquo;if&rdquo;; and (xvi) the parties hereto have participated jointly in the negotiation and drafting of this Agreement and, in the
event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the parties
hereto and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision
of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article&nbsp;2</FONT><U><BR>
Closing; Merger</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;2.01.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Closing</I>. The closing of the Merger (the &ldquo;<FONT STYLE="color: windowtext"><B>Closing</B></FONT>&rdquo;) shall take place
in New York City at the offices of Davis Polk &amp; Wardwell LLP, 450 Lexington Avenue, New York, New York, 10017 at 10:00 a.m., Eastern
time, on the third (3<SUP>rd</SUP>) Business Day after the date the conditions set forth in Article&nbsp;&lrm;9 (other than conditions
that by their nature are to be satisfied at the Closing, but subject to the satisfaction or, to the extent permitted by Applicable Law,
waiver of such conditions by the party or parties entitled to the benefit thereof at the Closing) have been satisfied or, to the extent
permitted by Applicable Law, waived by the party or parties entitled to the benefit thereof, or at such other place, at such other time
or on such other date as Parent and the Company may mutually agree (the date on which the Closing occurs, the &ldquo;<FONT STYLE="color: windowtext"><B>Closing
Date</B></FONT>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;2.02.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Merger</I>. (a) At the Closing, the Company shall file a certificate of merger (the &ldquo;<FONT STYLE="color: windowtext"><B>Certificate
of Merger</B></FONT>&rdquo;) with the Delaware Secretary of State and make all other</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">filings or recordings required by the General
Corporation Law of the State of Delaware (the &ldquo;<B>Delaware Law</B>&rdquo;) in connection with the Merger. The Merger shall become
effective at such time (the &ldquo;<B>Effective Time</B>&rdquo;) as the Certificate of Merger is duly filed with the Delaware Secretary
of State (or at such later time as Parent, Merger Sub and the Company shall agree and is specified in the Certificate of Merger).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At the Effective Time, Merger Sub shall be merged&nbsp;&nbsp;with and into the Company in accordance with Delaware Law, whereupon
the separate existence of Merger Sub shall cease, and the Company shall be the surviving corporation&nbsp;&nbsp;and a wholly owned subsidiary
of Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>From and after the Effective Time, the Surviving Corporation shall possess all the rights, powers, privileges and franchises and
be subject to all of the obligations, liabilities, restrictions and disabilities of the Company and Merger Sub, all as provided under
Delaware Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">Section&nbsp;2.03.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Conversion of Shares. <FONT STYLE="font-style: normal">At the Effective Time, by virtue of the Merger and without any action
on the part of Parent, Merger Sub, the Company, the holders of the Company Stock or any other Person:</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="color: windowtext">each share of Company Stock outstanding immediately prior to the Effective Time (other than shares
of Company Stock to be cancelled pursuant to <U>Section&nbsp;&lrm;2.03(ii)</U> (the &ldquo;<B>Excluded Shares</B>&rdquo;)) shall, subject
to <U>Section&nbsp;&lrm;2.07</U>, be converted into the right to receive 21.05 shares (the &ldquo;<B>Exchange Ratio</B>&rdquo;) of Parent
Class A Common Stock (the &ldquo;<B>Merger Consideration</B>&rdquo;);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>each share of Company Stock held immediately prior to the Effective Time by the Company as treasury stock or by Parent shall be
cancelled, and no consideration shall be paid with respect thereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>each share of common stock of Merger Sub outstanding immediately prior to the Effective Time shall be converted into and become
one share of common stock, par value $0.01 per share, of the Surviving Corporation with the same rights, powers and privileges as the
shares so converted and shall constitute the only outstanding shares of capital stock of the Surviving Corporation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>all outstanding shares of Company Stock shall no longer be outstanding and shall automatically be cancelled and retired and shall
cease to exist, and each share of Company Stock that was outstanding immediately prior to the Effective Time shall thereafter represent
only the right to receive the Merger Consideration, any dividends or other distributions pursuant to <U>Section&nbsp;&lrm;2.04(f)</U>
and any cash in lieu of any fractional shares of Parent Class A Common Stock pursuant to <U>Section&nbsp;&lrm;2.07</U>, in each case to
be issued or paid in accordance with <U>Section&nbsp;&lrm;2.04</U>, without interest, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;2.04.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Surrender and Payment</I>. (a) Prior to the Effective Time, Parent shall appoint an exchange agent reasonably acceptable to the
Company (the &ldquo;<FONT STYLE="color: windowtext"><B>Exchange Agent</B></FONT>&rdquo;) and enter into an exchange agent agreement with
the Exchange Agent for the purpose of exchanging (in each case, other than Excluded Shares) for the Merger Consideration (A) certificates
representing shares of Company Stock (the &ldquo;<FONT STYLE="color: windowtext"><B>Common Stock Certificates</B></FONT>&rdquo;) or (B)
uncertificated shares of Company Stock which immediately prior to the Effective Time were registered to a</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">holder on the stock transfer books of the Company
(the &ldquo;<B>Uncertificated Common Shares</B>&rdquo;). At or prior to the Effective Time, Parent shall deposit with the Exchange Agent,
for the benefit of the holders of shares of Company Stock, for exchange in accordance with this <U>Section&nbsp;&lrm;2.04</U> through
the Exchange Agent, evidence of shares in book-entry form representing the shares of Parent Class A Common Stock issuable pursuant to
&lrm;<U>Section&nbsp;2.03(i</U>) in exchange for outstanding shares of Company Stock. Parent agrees to make promptly available, directly
or indirectly, to the Exchange Agent from time to time as needed additional cash sufficient to pay any dividends or other distributions
to which holders of Company Stock are entitled pursuant to <U>Section&nbsp;&lrm;2.04(f)</U> and cash in lieu of any fractional shares
of Parent Class A Common Stock to which such holders are entitled pursuant to <U>Section &lrm;2.07</U>. Promptly after the Effective Time
and in any event within three (3) Business Days after the Closing Date, Parent shall send, or shall cause the Exchange Agent to send,
to each holder of shares of Company Stock represented by a Certificate at the Effective Time a letter of transmittal and instructions
(which shall specify that delivery shall be effected, and risk of loss and title shall pass, only upon proper delivery of the Certificates
or transfer of the Uncertificated Shares to the Exchange Agent and which shall otherwise be in customary form and shall include customary
provisions with respect to delivery of an &ldquo;agent&rsquo;s message&rdquo; regarding the book-entry transfer of Uncertificated Shares)
for use in such exchange. All evidence of shares in book-entry form and cash deposited with the Exchange Agent pursuant to this <U>Section&nbsp;&lrm;2.04</U>
shall be referred to in this Agreement as the &ldquo;<B>Exchange Fund.</B>&rdquo; Parent shall cause the Exchange Agent to deliver the
Merger Consideration contemplated to be issued or paid pursuant to this Article&nbsp;&lrm;2 out of the Exchange Fund in accordance herewith.
The Exchange Fund shall not be used for any other purpose. The Exchange Agent shall invest any cash included in the Exchange Fund as directed
by Parent; <I>provided</I> that no such investment or losses thereon shall affect the dividends or other distributions to which holders
of Company Stock are entitled pursuant to <U>Section&nbsp;&lrm;2.04(f)</U> or cash in lieu of fractional interests to which holders of
Company Stock are entitled pursuant to <U>Section&nbsp;&lrm;2.07</U>. Any interest and other income resulting from such investments shall
be the property of, and paid to, Parent upon termination of the Exchange Fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each holder of shares of Company Stock that have been converted into the right to receive the Merger Consideration shall be entitled
to receive, upon (i) surrender to the Exchange Agent of a Certificate, together with a properly completed letter of transmittal, or (ii)
receipt of an &ldquo;agent&rsquo;s message&rdquo; by the Exchange Agent (or such other evidence, if any, of transfer as the Exchange Agent
may reasonably request) in the case of a book-entry transfer of Uncertificated Shares, in respect of each share of Company Stock represented
by such Certificate or Uncertificated Share (A) the Merger Consideration and (B) any cash in lieu of any fractional shares of Parent Class
A Common Stock and any dividends and distributions with respect thereto as contemplated by <U>Section&nbsp;&lrm;2.07</U> and <U>Section&nbsp;&lrm;2.04(f)</U>,
as applicable). The shares of Parent Class A Common Stock constituting part of such Merger Consideration shall, at Parent&rsquo;s option,
be in uncertificated book-entry form, unless a physical certificate is required under Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If any portion of the Merger Consideration (or cash in lieu of any fractional shares of Parent Class A Common Stock or any dividends
and distributions with respect thereto contemplated by <U>Section&nbsp;&lrm;2.07</U> or <U>Section&nbsp;&lrm;2.04(f)</U>, as applicable)
is to be paid to a Person other than the Person in whose name the surrendered Certificate or the transferred Uncertificated Share is registered,
it shall be a condition to such payment that (i) either such Certificate shall be properly endorsed or shall otherwise be in proper form
for transfer or such Uncertificated Share shall be properly transferred and (ii) the Person requesting such payment shall pay to the Exchange
Agent</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">any transfer or similar
Taxes required as a result of such payment to a Person other than the registered holder of such Certificate or Uncertificated Share or
establish to the satisfaction of the Exchange Agent that such transfer or similar Taxes have been paid or are not payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>From and after the Effective Time, there shall be no further registration of transfers of shares of Company Stock on the records
of the Company. If, after the Effective Time, Certificates or Uncertificated Shares are presented to Parent, the Surviving Corporation
or the Exchange Agent for any reason, they shall be cancelled and exchanged for the Merger Consideration (and cash in lieu of any fractional
shares of Parent Class A Common Stock and any dividends and distributions with respect to the Merger Consideration as contemplated by
<U>Section&nbsp;&lrm;2.07</U> and <U>Section&nbsp;&lrm;2.04(f)</U>, as applicable) with respect thereto in accordance with the procedures
set forth in, or as otherwise contemplated by, this Article&nbsp;&lrm;2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any portion of the Exchange Fund that remains unclaimed by the holders of shares of Company Stock twelve (12) months following
the Closing Date shall be delivered to Parent or as otherwise instructed by Parent, upon demand, and any such holder who has not exchanged
shares of Company Stock for the Merger Consideration in accordance with this <U>Section&nbsp;&lrm;2.04</U> prior to such time shall thereafter
look only to Parent for payment of such Merger Consideration (and cash in lieu of any fractional shares of Parent Class A Common Stock
and any dividends and distributions with respect thereto as contemplated by <U>Section&nbsp;&lrm;2.07</U> and <U>Section&nbsp;&lrm;2.04(f)</U>,
as applicable), without any interest thereon. Notwithstanding the foregoing, Parent and its Subsidiaries (including, after the Closing,
the Surviving Corporation and its Subsidiaries) shall not be liable to any holder of shares of Company Stock for any amounts properly
paid to a public official in compliance with applicable abandoned property, escheat or similar laws. Any amounts remaining unclaimed by
holders of shares of Company Stock immediately prior to such time when the amounts would otherwise escheat to or become property of any
Governmental Authority shall become, to the extent permitted by Applicable Law, the property of Parent free and clear of any claims or
interest of any Person previously entitled thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Following the surrender of any Certificates or the transfer of any Uncertificated Shares as provided in this <U>Section&nbsp;&lrm;2.04</U>,
and in any event within two (2) Business Days of such surrender or transfer, the Exchange Agent shall promptly pay, or cause to be paid,
without interest, to the Person in whose name the shares of Parent Class A Common Stock constituting the Merger Consideration have been
registered, (i) in connection with the payment of the Merger Consideration, (x) the amount of any cash payable in lieu of fractional shares
to which such Person is entitled pursuant to <U>Section&nbsp;&lrm;2.07</U>, as applicable, and (y) the aggregate amount of all dividends
or other distributions payable with respect to such shares of Parent Class A Common Stock with a record date on or after the Effective
Time that were paid prior to the time of such surrender or transfer, and (ii) at the appropriate payment date after the payment of the
Merger Consideration, the amount of all dividends or other distributions payable with respect to whole shares of Parent Class A Common
Stock constituting the Merger Consideration with a record date on or after the Effective Time and prior to the time of such surrender
or transfer and with a payment date subsequent to the time of such surrender or transfer. No dividends or other distributions with respect
to shares of Parent Class A Common Stock constituting the Merger Consideration, and no cash payment in lieu of fractional shares pursuant
to <U>Section&nbsp;&lrm;2.07</U>, as applicable, shall be paid to the holder of any Certificates not surrendered or of any Uncertificated
Shares not transferred until</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">such Certificates
or Uncertificated Shares are surrendered or transferred, as the case may be, as provided in this <U>Section&nbsp;&lrm;2.04</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The payment of any transfer, documentary, sales, use, stamp, registration, value added and other Taxes and fees (including any
penalties and interest) incurred solely by a holder of Company Stock in connection with the Merger, and the filing of any related Tax
Returns and other documentation with respect to such Taxes and fees, shall be the sole responsibility of such holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;2.05.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Company Equity Awards</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Company Options</I>.&nbsp;&nbsp;Each option to purchase shares of Company Stock, whether vested or unvested (each, a &ldquo;<B>Company
Option</B>&rdquo;) that is outstanding under any Company Stock Plan immediately prior to the Effective Time, shall, as of the Effective
Time, be converted into an option (an &ldquo;<B>Converted Option</B>&rdquo;) to purchase, on the same terms and conditions (including
with respect to vesting and exercisability, except that (i) if the holder is a non-employee director whose service to the Company continues
through the Closing Date, or (ii) if the holder&rsquo;s employment or service to the Company is terminated by the Company without Cause
(as defined on Section 2.05 of the Company Disclosure Schedules) at or during the six (6) months immediately following the Effective Time,
the vesting of the unvested portion of the Converted Option will immediately accelerate as of the Effective Time (in the case of clause
(i)) or the date of such termination of employment (in the case of clause (ii))) as were applicable to such Company Option immediately
prior to the Effective Time, the number of shares of Parent Class A Common Stock, rounded down to the nearest whole share, determined
by multiplying the number of shares of Company Stock subject to such Company Option immediately prior to the Effective Time by the Exchange
Ratio, at an exercise price per share of Parent Class A Common Stock, rounded up to the nearest whole cent, equal to the per share exercise
price for the shares of Company Stock otherwise purchasable pursuant to such Company Option immediately prior to the Effective Time divided
by the Exchange Ratio; provided, however, that the adjustments provided in this Section 2.05 with respect to any Company Options, whether
or not they are &ldquo;incentive stock options&rdquo; as defined in Section 422 of the Code, are intended to be effected in a manner that
is consistent with Section 424(a) of the Code and Section 409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Board Actions</I>. Prior to the Effective Time, the Board of Directors of the Company (and/or the Compensation Committee of
the Board of Directors of the Company) and the Board of Directors of Parent (and/or the Compensation Committee of the Board of Directors
of Parent) shall adopt such resolutions as are necessary to give effect to the transactions contemplated by this <U>Section&nbsp;&lrm;2.05</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><I>Parent Actions</I>(d). Parent shall take all corporate action necessary to reserve for issuance a sufficient number of shares
of Parent Class A Common Stock for delivery upon exercise of the Converted Options in accordance with this <U>Section 2.05</U>.&nbsp;&nbsp;As
soon as reasonably practicable after the Effective Time, Parent shall file a registration statement on an appropriate form, or a post-effective
amendment to a registration statement previously filed under the Securities Act, with respect to the shares of Parent Class A Common Stock
subject to such Converted Options and shall maintain the effectiveness of such registration statement or registration statements (and
maintain</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">the current status
of the prospectus or prospectuses contained therein) for so long as such Converted Options remain outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;2.06.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Adjustments</I>. Without limiting or affecting any of the provisions of <U>Section&nbsp;&lrm;6.01</U> or <U>Section&nbsp;&lrm;7.01</U>
(or any corresponding sections of the Company Disclosure Schedule or Parent Disclosure Schedule, as applicable), if, during the period
between the date of this Agreement and the Effective Time, any change in the outstanding shares of capital stock of the Company or Parent
shall occur as a result of any reclassification, recapitalization, stock split (including reverse stock split), exchange or readjustment
of shares, subdivision or other similar transaction or event, or any stock dividend thereon with a record date during such period (but,
for the avoidance of doubt, excluding any change that results from (i) the exercise of stock options or other equity awards to purchase
shares of Parent Common Stock or Company Stock or the settlement of restricted stock or restricted stock units of Parent or the Company
or (ii) the grant of equity-based compensation to directors or employees of Parent or the Company), the Merger Consideration and any other
amounts payable pursuant to this Agreement shall be appropriately adjusted to eliminate the effect of such event on the Merger Consideration
or any such other amounts payable pursuant to this Agreement, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;2.07.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Fractional Shares</I>. Notwithstanding anything in this Agreement to the contrary, no fractional shares of Parent Class A Common
Stock shall be issued in the Merger. All fractional shares of Parent Class A Common Stock that a holder of shares of Company Stock would
otherwise be entitled to receive as a result of the Merger shall be aggregated and, if a fractional share results from such aggregation,
such holder shall be entitled to receive, in lieu thereof, an amount in cash, without interest, determined by multiplying the fraction
of the applicable share of Parent Class A Common Stock to which such holder would otherwise have been entitled by the closing price of
such applicable share of Parent Class A Common Stock on Nasdaq on the last trading day preceding the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;2.08.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Withholding Rights</I>. Notwithstanding any provision contained herein to the contrary, each of the Exchange Agent, Parent and
the Surviving Corporation shall be entitled to deduct and withhold from the consideration otherwise payable pursuant to this Agreement
such amounts as it is required to deduct and withhold with respect to the making of such payment under any provision of any Applicable
Law, including federal, state, local or non-U.S. Tax law. If the Exchange Agent, Parent or the Surviving Corporation, as the case may
be, so deducts and withholds any such amounts, such amounts shall be treated for all purposes of this Agreement as having been paid to
the Person in respect of which the Exchange Agent, Parent or the Surviving Corporation, as the case may be, made such deduction and withholding.
The Exchange Agent, Parent or the Surviving Corporation, as applicable, shall pay, or shall cause to be paid, all amounts so deducted
or withheld to the appropriate Taxing Authority within the period required under Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;2.09.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Lost Certificates</I>. If any Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact
by the Person claiming such Certificate to be lost, stolen or destroyed and, if required by the Surviving Corporation, the posting by
such Person of a customary bond issued for a lost, stolen or destroyed Certificate, in such amount as the Surviving Corporation may direct,
as indemnity against any claim that may be made against the Surviving Corporation with respect to such Certificate, the Exchange Agent
will issue, in exchange for such</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">lost, stolen or destroyed Certificate, the Merger
Consideration to be paid in respect of the shares of Company Stock represented by such Certificate, as contemplated by this Article&nbsp;&lrm;2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;2.10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Further Assurances</I>. From and after the Effective Time, the officers and directors of the Surviving Corporation shall be authorized
to execute and deliver, in the name and on behalf of the Company, any of its Subsidiaries or Merger Sub, any deeds, bills of sale, assignments
or assurances and to take and do, in the name and on behalf of the Company, any of its Subsidiaries or Merger Sub, any other actions and
things to vest, perfect or confirm of record or otherwise in the Surviving Corporation any and all right, title and interest in, to and
under any of the rights, properties or assets of the Company acquired or to be acquired by the Surviving Corporation as a result of, or
in connection with, the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article&nbsp;3</FONT><U><BR>
Organizational Documents; Directors and Officers</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;3.01.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Certificate of Incorporation and Bylaws of the Surviving Corporation</I>. At the Effective Time and by virtue of the Merger, the
certificate of incorporation of the Company shall be amended and restated so that it reads in its entirety as set forth on <U>Exhibit&nbsp;A</U>
hereto. From and after the Effective Time, the certificate of incorporation of the Company as so amended and restated shall be the certificate
of incorporation of the Surviving Corporation until thereafter amended as provided therein or by Applicable Law. The bylaws of Merger
Sub, as in effect immediately prior to the Effective Time, shall be the bylaws of the Surviving Corporation from and after the Effective
Time until thereafter amended as provided therein, in the certificate of incorporation of the Surviving Corporation or by Applicable Law,
except that the name of the corporation reflected therein shall be &ldquo;Semler Scientific, Inc.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;3.02.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Directors and Officers of the Surviving Corporation</I>. From and after the Effective Time, until their respective successors are
duly elected or appointed and qualified in accordance with Applicable Law, (i) the directors of Merger Sub immediately prior to the Effective
Time shall be the directors of the Surviving Corporation and (ii) the officers of Merger Sub immediately prior to the Effective Time shall
be the officers of the Surviving Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;3.03.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Board of Parent</I>. Parent shall take all actions permitted by Applicable Law and the rules of any applicable stock exchange so
that, effective as of the Closing, the individual specified on <U>Section 3.03</U> of the Company Disclosure Schedule (if willing and
able to serve) shall become a director on the Board of Directors of Parent (for the avoidance of doubt, until his or her successor is
duly elected or appointed and qualified in accordance with Applicable Law or until his or her earlier resignation, death or removal);
provided that such new designee shall meet Nasdaq&rsquo;s independence criteria.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article&nbsp;4</FONT><U><BR>
Representations and Warranties of the Company</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to <U>Section&nbsp;&lrm;11.05</U>,
except (i) other than with respect to the representations and warranties in <U>Section&nbsp;&lrm;4.01</U>, <U>Section&nbsp;&lrm;4.02</U>,
<U>Section&nbsp;&lrm;4.05(a)</U>, &lrm;Section&nbsp;4.06(b), <U>Section&nbsp;&lrm;4.24</U>, <U>Section&nbsp;&lrm;4.25</U>, <U>Section&nbsp;&lrm;4.26</U>
and <U>Section&nbsp;&lrm;4.27</U>, as disclosed in any publicly available Company SEC Document filed after January 1, 2025 and prior to
the date hereof or (ii) as set forth in the Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Disclosure Schedule, the Company represents and warrants
to Parent and Merger Sub as of the date hereof and as of the Closing (in each case except to the extent that any such representation and
warranty speaks as of a particular date, in which case such representation and warranty shall be true and correct as of such earlier date)
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.01.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Corporate Existence and Power</I>. The Company is a corporation duly incorporated, validly existing and in good standing under
the laws of the State of Delaware. The Company has all corporate powers required to own or lease all of its properties or assets and to
carry on its business as now conducted. The Company is duly qualified to do business and is in good standing in each jurisdiction where
such qualification is necessary, except for those jurisdictions where failure to be so qualified is not and would not reasonably be expected
to be material to the Company and its Subsidiaries, taken as a whole. Prior to the date of this Agreement, the Company has made available
to Parent true and complete copies of the certificate of incorporation and bylaws of the Company as in effect on the date of this Agreement
(the &ldquo;<FONT STYLE="color: windowtext"><B>Company Organizational Documents</B></FONT>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.02.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Corporate Authorization</I>. (a) The execution, delivery and performance by the Company of this Agreement and the consummation
by the Company of the Transactions are within the corporate powers of the Company and, except for the Company Stockholder Approval required
in connection with the consummation of the Merger, have been duly authorized by all necessary corporate action on the part of the Company.
The affirmative vote of the holders of a majority of the outstanding shares of Company Stock is the only vote of the Company&rsquo;s stockholders
required to approve and adopt this Agreement (the &ldquo;<FONT STYLE="color: windowtext"><B>Company Stockholder Approval</B></FONT>&rdquo;).
This Agreement has been duly executed and delivered by the Company and (assuming due authorization, execution and delivery by the other
parties hereto) constitutes a valid and binding agreement of the Company enforceable against the Company in accordance with its terms
(subject to applicable bankruptcy, insolvency, reorganization, moratorium and similar laws affecting creditors&rsquo; rights and remedies
generally, and subject, as to enforceability, to general principles of equity (regardless of whether enforcement is sought in a proceeding
at law or in equity) (collectively, the &ldquo;<FONT STYLE="color: windowtext"><B>Bankruptcy and Equity Exceptions</B></FONT>&rdquo;)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At a meeting duly called and held, the Board of Directors of the Company has (i) unanimously determined that this Agreement and
the Transactions are fair to and in the best interests of the Company&rsquo;s stockholders, (ii) approved, adopted and declared advisable
this Agreement and the Transactions, (iii) directed that the approval of the Merger and approval and adoption of this Agreement be submitted
to a vote at a meeting of the Company&rsquo;s stockholders, and (iv) recommended approval and adoption of this Agreement (including the
Merger) by the Company&rsquo;s stockholders (such recommendation, the &ldquo;<FONT STYLE="color: windowtext"><B>Company Board Recommendation</B></FONT>&rdquo;).
Except as permitted by <U>Section&nbsp;&lrm;6.03</U>, the Board of Directors of the Company has not subsequently rescinded, modified or
withdrawn any of the foregoing resolutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.03.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Governmental Authorization</I>. The execution, delivery and performance by the Company of this Agreement, and the consummation
of the Transactions, require no action by or in respect of, Consents of, or Filings with, any Governmental Authority other than (i) the
filing of each of the Certificate of Merger with the Delaware Secretary of State, and appropriate documents with the relevant authorities
of other states in which the Company is qualified to do business, (ii) compliance with any applicable requirements of the HSR Act, (iii)
compliance with</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">any applicable requirements of the Securities
Act, the Securities Exchange Act and any other applicable U.S. state or federal securities laws or pursuant to the listing requirements
of Nasdaq, and (iv) any other actions, Consents or Filings the absence of which has not had and would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.04.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Non-contravention</I>. The execution, delivery and performance by the Company of this Agreement and the consummation of the Transactions
do not and will not (i)&nbsp;contravene, conflict with, or result in any violation or breach of any provision of the Company Organizational
Documents, (ii) assuming compliance with the matters referred to in <U>Section&nbsp;&lrm;4.03</U> and receipt of the Company Stockholder
Approval, contravene, conflict with or result in any violation or breach of any provision of any Applicable Law, (iii) assuming compliance
with the matters referred to in <U>Section&nbsp;&lrm;4.03</U> and receipt of the Company Stockholder Approval, require any Consent or
other action by any Person under, constitute a default, or an event that, with or without notice or lapse of time or both, would constitute
a default under, give rise to a payment obligation or other liability under, or cause or permit the termination, cancellation, acceleration
or other change of any right or obligation or the loss of any benefit to which the Company or any of its Subsidiaries is entitled under,
any provision of any Contract binding upon the Company or any of its Subsidiaries, any governmental Consents (including Consents required
by Contract) affecting, or relating in any way to, the Company or any of its Subsidiaries or any of its or their respective assets or
businesses or any Company Permit or (iv) result in the creation or imposition of any Lien on any asset of the Company or any of its Subsidiaries,
with only such exceptions, in the case of each of clauses&nbsp;(ii) through (iv), as has not had and would not reasonably be expected
to have, individually or in the aggregate, a Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.05.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Capitalization</I>. (a) The authorized capital stock of the Company consists of 50,000,000 shares of Company Stock. As of September
18, 2025, there were outstanding 15,356,617 shares of Company Stock (214,422 of which is treasury stock), (ii) 1,219,407 shares of Company
Stock&nbsp;&nbsp;underlying Company Options, (iii) 1,865,880 additional shares of Company Stock were reserved for issuance pursuant to
the grant of future awards under the Company Stock Plans, and (iv) 1,635,320 additional shares of Company Stock were reserved for future
issuance upon the conversion of the Company Convertible Notes. All outstanding shares of capital stock of the Company have been, and all
shares that may be issued pursuant to any employee stock option or other compensation plan or arrangement will be, when issued in accordance
with the respective terms thereof, duly authorized and validly issued, fully paid and nonassessable and free of preemptive rights. Except
as set forth in this <U>Section&nbsp;&lrm;4.05(a)</U> and for changes since September 18, 2025 resulting from (A) the exercise of Company
Options, (B) the conversion of the Company Convertible Notes (on their terms as of the date hereof), (C) issuances of Company Stock under
the Company ATM Agreement (on their terms as of the date hereof), (D) adjustments to the number of shares of Company Stock reserved for
future issuance upon the conversion of the Company Convertible Notes and (E) the issuance of Company Equity Awards, in each case as and
to the extent permitted by <U>Section&nbsp;&lrm;6.01</U>, there are no issued, reserved for issuance or outstanding (i) shares of capital
stock or other voting securities of, or other ownership interest in, the Company, (ii) securities of the Company or any of its Subsidiaries
convertible into or exchangeable for shares of capital stock or other voting securities of, or other ownership interests in, the Company,
(iii)&nbsp;warrants, calls, options or other rights to acquire from the Company or any of its Subsidiaries, or other obligations of the
Company or any of its Subsidiaries to issue, any capital stock or other</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">voting securities of, or other ownership interests
in, or securities convertible into or exchangeable for capital stock or other voting securities of, or other ownership interests in, the
Company, or (iv)&nbsp;restricted shares, stock appreciation rights, performance shares or units, contingent value rights, &ldquo;phantom&rdquo;
stock or similar securities or rights issued by or with the approval of the Company or any of its Subsidiaries that are derivative of,
or provide economic benefits based, directly or indirectly, on the value or price of, any capital stock or other voting securities of,
or other ownership interests in, the Company (the items in clauses&nbsp;(i) through (iv) being referred to collectively as the &ldquo;<B>Company
Securities</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All outstanding shares of capital stock of the Company have been, and all shares that may be issued pursuant to any equity compensation
plan or arrangement will be, when issued in accordance with the respective terms thereof, duly authorized and validly issued, fully paid
and nonassessable and free of preemptive rights. The Company has provided to Parent a true and complete list of all outstanding Company
Equity Awards as of September 18, 2025, including with respect to each such equity award, the holder, date of grant, the vesting schedule,
whether the award is in respect of a former Company Service Provider and the date on which such former Company Service Provider terminated
their service with the Company, whether subject to performance conditions, number of shares of Company Stock subject to such award (assuming
maximum performance levels were achieved, if applicable), and the amount of any accrued but unpaid dividend equivalent rights relating
to such award.&nbsp;&nbsp;Five (5) Business Days prior to the Closing Date, the Company shall provide Parent with an updated version of
the true and complete list referenced in the foregoing sentence, updated as of such date. There are no outstanding bonds, debentures,
notes or other indebtedness of the Company having the right to vote (or convertible into, or exchangeable for, securities having the right
to vote) on any matters on which stockholders of the Company may vote. There are no outstanding obligations of the Company or any of its
Subsidiaries to repurchase, redeem or otherwise acquire any Company Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There are no shareholders agreements, voting trusts, registration rights agreements or other similar Contracts to which the Company
or any Subsidiary of the Company is a party with respect to any Company Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.06.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subsidiaries</I>. (a) Each Subsidiary of the Company is a corporation or other entity duly incorporated or organized, validly existing
and in good standing under the laws of its jurisdiction of incorporation or organization and has all corporate or other organizational
powers, as applicable, required to carry on its business as now conducted, except for those jurisdictions where failure to be so organized,
validly existing and in good standing or to have such power is not and would not reasonably be expected to be material to the Company
and its Subsidiaries, taken as a whole. Each such Subsidiary is duly qualified to do business and is in good standing in each jurisdiction
where such qualification is necessary, except for those jurisdictions where failure to be so qualified is not and would not reasonably
be expected to be material to the Company and its Subsidiaries, taken as a whole. <U>Section&nbsp;&lrm;4.06</U> of the Company Disclosure
Schedule sets forth a true and complete list of each Significant Subsidiary (as defined in Rule 1-02(a) of Regulation S-X) of the Company
as of the date of this Agreement, and its jurisdiction of incorporation or organization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All of the outstanding capital stock or other voting securities of, or ownership interests in, each Subsidiary of the Company are
owned by the Company, directly or indirectly,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">free and clear of
any Lien and other free of any other limitation or restriction (including any restriction on the right to vote, sell or otherwise dispose
of such capital stock or other voting securities or other ownership interests) (other than restrictions arising under applicable Securities
Laws). There are no issued, reserved for issuance or outstanding (i) securities of the Company or any of its Subsidiaries convertible
into or exchangeable for shares of capital stock or other voting securities of, or other ownership interests in, any Subsidiary of the
Company, (ii) warrants, calls, options or other rights to acquire from the Company or any of its Subsidiaries, or other obligations of
the Company or any of its Subsidiaries to issue, any capital stock or other voting securities of, or other ownership interests in, or
any securities convertible into or exchangeable for any capital stock or other voting securities of, or other ownership interests in,
any Subsidiary of the Company, or (iii) restricted shares, stock appreciation rights, performance shares or units, contingent value rights,
&ldquo;phantom&rdquo; stock or similar securities or rights issued by or with the approval of the Company or any of its Subsidiaries that
are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any capital stock or other voting
securities of, or other ownership interests in, any Subsidiary of the Company (the items in clauses&nbsp;(i) through (iii) being referred
to collectively as the &ldquo;<FONT STYLE="color: windowtext"><B>Company Subsidiary Securities</B></FONT>&rdquo;), other than Company
Subsidiary Securities directly or indirectly owned by the Company or any of its wholly owned Subsidiaries. There are no outstanding obligations
of the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire any Company Subsidiary Securities, or to make any
material investment in any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except for the capital stock or other voting securities of, or other ownership interests in, Subsidiaries of the Company and publicly
traded securities held for investment which do not exceed 5% of the outstanding securities of any entity, neither the Company nor any
of its Subsidiaries owns, directly or indirectly, any capital stock or other voting securities of, or other ownership interests in, any
Person (other than capital stock or other voting securities of, or other ownership interests in, any Person owned by the Company or any
Subsidiary of the Company in a fiduciary, representative or other capacity on behalf of other Persons, whether or not held in a separate
account).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.07.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Regulatory Reports, SEC Filings and the Sarbanes-Oxley Act</I>. (a) The Company and each of its Subsidiaries have timely filed
with or furnished all material Filings, together with any material amendments, required to be made with respect thereto, that they were
required to file or furnish (as applicable) since January 1, 2023 with (i) any state regulatory authority, (ii) the SEC, and (iii) any
foreign regulatory authority (clauses&nbsp;(i) &ndash; (iii), collectively &ldquo;<FONT STYLE="color: windowtext"><B>Regulatory Agencies</B></FONT>&rdquo;),
including any Filing required to be filed or furnished (as applicable) pursuant to the laws, rules or regulations of the United States,
any state, any foreign entity, or any Regulatory Agency, and have paid all fees and assessments due and payable in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As of its filing date (and as of the date of any amendment), each Filing filed with or furnished to the SEC by the Company since
January 1, 2023 (together with any exhibits and schedules thereto and other information incorporated therein, and as amended from time
to time, the &ldquo;<FONT STYLE="color: windowtext"><B>Company SEC Documents</B></FONT>&rdquo;) and filed prior to the date of this Agreement
has complied, and each Company SEC Document filed subsequent to the date of this Agreement (assuming, in the case of each of the Registration
Statement and the Information Statement/Proxy Statement/Prospectus, that the representation and warranty set forth in <U>Section&nbsp;&lrm;5.09</U>
is true and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">correct) will comply,
in all material respects with the applicable requirements of Nasdaq, the Securities Act, the Securities Exchange Act and the Sarbanes-Oxley
Act, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As of its filing date (or, if amended or superseded by a filing prior to the date of this Agreement, on the date of such amended
or superseding filing), each Company SEC Document filed prior to the date of this Agreement did not, each Company SEC Document filed subsequent
to the date of this Agreement (assuming, in the case of each of the Registration Statement and the Information Statement/Proxy Statement/Prospectus,
that the representation and warranty set forth in <U>Section&nbsp;&lrm;5.09</U> is true and correct) will not contain any untrue statement
of a material fact or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances
under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Company SEC Document that is a registration statement, as amended or supplemented, as applicable, filed pursuant to the Securities
Act, as of the date such registration statement or amendment became effective, did not contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
in which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company is, and since January 1, 2023 has been, in compliance in all material respects with (i) the applicable provisions of
the Sarbanes-Oxley Act and (ii) the applicable listing and corporate governance rules and regulations of Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company and its Subsidiaries have established and maintained since January 1, 2023, and continue and maintain, disclosure controls
and procedures (as defined in Rule 13a-15 under the Securities Exchange Act). Such disclosure controls and procedures are designed to
ensure that all material information relating to the Company, including its consolidated Subsidiaries, is made known to the Company&rsquo;s
principal executive officer and its principal financial officer by others within those entities, particularly during the periods in which
the periodic reports required under the Securities Exchange Act are being prepared. Such disclosure controls and procedures are effective
in timely alerting the Company&rsquo;s principal executive officer and principal financial officer to material information required to
be included in the Company&rsquo;s periodic and current reports required under the Securities Exchange Act. For purposes of this Agreement,
&ldquo;<FONT STYLE="color: windowtext"><B>principal executive officer</B></FONT>&rdquo; and &ldquo;<FONT STYLE="color: windowtext"><B>principal
financial officer</B></FONT>&rdquo; shall have the meanings given to such terms in the Sarbanes-Oxley Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company and its Subsidiaries have established and maintained since January 1, 2023, and continue and maintain, a system of
internal control over financial reporting (as defined in Rule 13a-15 under the Securities Exchange Act) (&ldquo;<FONT STYLE="color: windowtext"><B>internal
controls</B></FONT>&rdquo;). Such internal controls are sufficient to provide reasonable assurance regarding the reliability of the Company&rsquo;s
financial reporting and the preparation of the Company&rsquo;s consolidated financial statements for external purposes in accordance with
GAAP. The Company has disclosed, based on its most recent evaluation of such internal controls prior to the date of this Agreement, to
the Company&rsquo;s auditors and the audit committee of the Board of Directors of the Company (x) all significant deficiencies and material
weaknesses in the design or operation of internal controls that are reasonably likely to adversely affect the Company&rsquo;s ability
to record, process, summarize and report financial information and (y) any fraud, whether or not material, that involves management or
other employees who have a significant role in internal controls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January 1, 2023, each of the principal executive officer and principal financial officer of the Company (or each former principal
executive officer and principal financial officer of the Company, as applicable) has made all certifications required by Rule 13a-14 and
15d-14 under the Securities Exchange Act and Sections 302 and 906 of the Sarbanes-Oxley Act and any related rules and regulations promulgated
by the SEC and Nasdaq, and the statements contained in any such certifications are true and complete.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.08.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Financial Statements and Financial Matters</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The audited consolidated financial statements and unaudited consolidated interim financial statements of the Company included or
incorporated by reference in the Company SEC Documents present fairly in all material respects, in conformity with GAAP applied on a consistent
basis during the periods involved (except as may be indicated in the notes thereto), the consolidated financial position of the Company
and its Subsidiaries as of the dates thereof and their consolidated results of operations and cash flows for the periods then ended (subject
to normal, recurring and immaterial year-end audit adjustments in the case of any unaudited interim financial statements). Such consolidated
financial statements have been prepared from, and are in accordance with, the books and records of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>From January 1, 2023 to the date of this Agreement, the Company has not received written notice from the SEC or any other Governmental
Authority indicating that any of its accounting policies or practices are or may be the subject of any review, inquiry, investigation
or challenge by the SEC or any other Governmental Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.09.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Disclosure Documents</I>. The information relating to the Company and its Subsidiaries that is, or is to be, provided by the Company,
any of its Subsidiaries or any of their respective Representatives for inclusion or incorporation by reference in the Registration Statement
or the Information Statement/Proxy Statement/Prospectus will not (i) in the case of the Registration Statement, at the time the Registration
Statement or any amendment or supplement thereto is filed with the SEC, at the time it becomes effective under the Securities Act and
at the time of the Company Stockholder Meeting, and (ii) in the case of the Information Statement/Proxy Statement/Prospectus, at the time
the Information Statement/Proxy Statement/Prospectus or any amendment or supplement thereto is first mailed to the stockholders of the
Company and at the time of the Company Stockholder Meeting, contain any untrue statement of a material fact required to be stated therein
or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they
were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Absence of Certain Changes</I>. (a) Since the Company Balance Sheet Date through the date of this Agreement, (i) the business of
the Company and its Subsidiaries has been conducted in all material respects in the ordinary course of business consistent with past practice
and (ii)&nbsp;there has not been any event, circumstance, development, change, occurrence or effect that has had or would reasonably be
expected to have, individually or in the aggregate, a Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since the Company Balance Sheet Date through the date of this Agreement, there has not been any action taken by the Company or
any of its Subsidiaries that, if taken during the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">period from the date
of this Agreement through the Effective Time without Parent&rsquo;s consent, would constitute a breach of Section&nbsp;&lrm;6.01.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Undisclosed Material Liabilities</I>. There are no liabilities or obligations of the Company or any of its Subsidiaries of any
kind whatsoever, whether accrued, contingent, absolute, determined, determinable or otherwise, other than (i) liabilities or obligations
disclosed and provided for in the Company Balance Sheet or in the notes thereto, (ii) liabilities or obligations incurred in the ordinary
course of business consistent with past practice since the Company Balance Sheet Date, and (iii) other liabilities or obligations that
have not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. There
are no off-balance sheet arrangements of any type pursuant to any off-balance sheet arrangement required to be disclosed pursuant to Item
303(a)(4) of Regulation S-K promulgated under the Securities Act (&ldquo;<FONT STYLE="color: windowtext"><B>Regulation S-K</B></FONT>&rdquo;)
that have not been so described in the Company SEC Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Litigation</I>. There is no Proceeding pending or, to the knowledge of the Company, threatened against or affecting the Company,
any of its Subsidiaries, any present or former officers, directors or employees of the Company or any of its Subsidiaries in their respective
capacities as such, or any of the respective properties of the Company or any of its Subsidiaries, before (or, in the case of threatened
Proceedings, that would be before) any arbitrator or Governmental Authority, that has had or would reasonably be expected to have, individually
or in the aggregate, a Company Material Adverse Effect or that in any manner challenges or seeks to prevent, enjoin, alter or materially
delay any of the Transactions. There is no Order outstanding or threatened against or affecting the Company, any of its Subsidiaries,
any present or former officers, directors or employees of the Company or any of its Subsidiaries in their respective capacities as such,
or any of the respective properties of any of the Company or any of its Subsidiaries, that has had or would reasonably be expected to
have, individually or in the aggregate, a Company Material Adverse Effect or that would, or would reasonably be expected to, prevent,
enjoin, alter or materially delay any of the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Permits</I>. (a) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect, the Company and each of its Subsidiaries hold all governmental Consents, including Health Care Permits, necessary
for the operation of their respective businesses (the &ldquo;<FONT STYLE="color: windowtext"><B>Company Permits</B></FONT>&rdquo;). The
Company and each of its Subsidiaries are and since January 1, 2023, have been in compliance with the terms of the Company Permits, except
for failures to comply that have not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect. There is no Proceeding pending, or, to the knowledge of the Company, threatened in writing that seeks, or, to the knowledge
of the Company, any existing condition, situation or set of circumstances that would reasonably be expected to result in, the revocation,
cancellation, termination, non-renewal or adverse modification of any Company Permit except where such revocation, cancellation, termination,
non-renewal or adverse modification has not had and would not reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the Company nor any of its Subsidiaries has any material business, conducts any material operations or engages in any material
activities, in each case, outside of the U.S. and its territories.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Section&nbsp;4.13(c) of the Company Disclosure Schedule sets forth a complete list of all material securities exchange, commodities
exchange, boards of trade, clearing organizations and similar organizations in which the Company or any of its Subsidiaries hold memberships
or have been granted trading privileges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Compliance with Applicable Laws</I>. (a) Each of the Company and its Subsidiaries, except as would not be material to the Company
and its Subsidiaries, taken as a whole, are, and have been since January 1, 2023, in compliance in all material respects with and not
in default or violation of Applicable Laws, including (to the extent applicable to the Company and its Subsidiaries) the Foreign Corrupt
Practices Act, the Investment Advisers Act, the Securities Act, the Securities Exchange Act, ERISA, and any other Applicable Law, (ii)
are, and have been since January 1, 2023, conducting operations at all times in compliance with applicable money laundering laws administered
or enforced by any Governmental Authority in jurisdictions where the Company and its Subsidiaries conduct business (collectively, the
&ldquo;<FONT STYLE="color: windowtext"><B>Anti-Money Laundering Laws</B></FONT>&rdquo;) and (iii) have established and maintained, since
January 1, 2023, a system of internal controls designed to provide compliance by the Company and its Subsidiaries with applicable financial
recordkeeping and reporting requirements of the Anti-Money Laundering Laws, except where, in the case of clause (ii) or (iii), the failure
to so comply has not had and would not reasonably be expected to have, either individually or in the aggregate, a Company Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January 1, 2023, neither the Company nor any of its Subsidiaries has engaged in, or is now engaged in, directly or indirectly,
any dealings or transactions with any Person, or in any country or territory, that, at the time of the dealing or transaction, is or was
the subject of any sanctions administered by the U.S. Department of Treasury&rsquo;s Office of Foreign Assets Control (OFAC) or the U.S.
Department of State (&ldquo;<FONT STYLE="color: windowtext"><B>Sanctions</B></FONT>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company and its Subsidiaries (i) are, and since January 1, 2023 have been, in material compliance with all applicable Sanctions
and export controls laws, (ii) have instituted, maintain and enforce policies and procedures designed to ensure material compliance with
all applicable Sanctions and export controls laws. Since January 1, 2023, the Company and its Subsidiaries have not been penalized for
or threatened to be charged with, or given notice of any violation of, or, to the knowledge of the Company, been under investigation with
respect to, any Sanctions or export controls laws, and no action, suit or proceeding by or before any court or governmental or regulatory
agency, authority or body or any arbitrator involving the Company or any of its Subsidiaries with respect to Sanctions or export controls
laws is pending, except where such proceedings or investigations would not reasonably be expected to have, either individually or in the
aggregate, a Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the Company nor any of its Subsidiaries is a party to any agreement or settlement with any Governmental Authority with
respect to any actual or alleged violation of any Applicable Law, except for agreements and settlements that are not material to the Company
and its Subsidiaries, taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the Company nor any of its Subsidiaries is precluded from acting as a fiduciary by operation of Section 411 of ERISA. The
accounts of each ERISA Client have been managed by the Company or its Subsidiaries in compliance in all material respects with all</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">applicable requirements
under ERISA, Section 4975 of the Code and any Similar Law. There is no pending or, to the knowledge of the Company, threatened audit or
investigation by the IRS, the Department of Labor or any other Governmental Authority with respect to the Company&rsquo;s provision of
services to any ERISA Clients. Neither the Company nor any of its Subsidiaries has engaged in any non-exempt &ldquo;prohibited transaction&rdquo;
under Section 406 of ERISA or Section 4975 of the Code or violated any Similar Law with respect to any ERISA Client that would reasonably
be expected to result in material liability to the Company or any of its Subsidiaries. Neither the Company nor any of its affiliates (as
defined in Section&nbsp;VI(d) of Prohibited Transaction Class Exemption 84-14 issued by the Department of Labor (the &ldquo;<FONT STYLE="color: windowtext"><B>QPAM
Exemption</B></FONT>&rdquo;)) fails to satisfy the conditions set forth in Part I(g) of the QPAM Exemption. Any revenue-sharing arrangements
entered into by the Company or any of its Subsidiaries with respect to assets managed for any ERISA Clients are in compliance with Applicable
Law in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Regulatory Agency has initiated or has pending any proceeding or, to the knowledge of the Company, formal investigation into
the business or operations of the Company or any of its Subsidiaries since January 1, 2023, except where such proceedings or investigations
would not reasonably be expected to have, either individually or in the aggregate, a Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as would not be material to the Company and its Subsidiaries, taken as a whole, neither the Company nor any of its Subsidiaries
is subject to any cease-and-desist or other order or enforcement action issued by, or is a party to any written agreement, consent agreement
or memorandum of understanding with, or is a party to any commitment letter or similar undertaking to, or is subject to any order or directive
by, or has been ordered to pay any civil money penalty by, or has been since January 1, 2023, a recipient of any supervisory letter from,
or since January 1, 2023, has adopted any policies, procedures or board resolutions at the request or suggestion of, any Regulatory Agency
or other Governmental Authority that currently restricts in any material respect or would reasonably be expected to restrict in any material
respect the conduct of its business (each, whether or not set forth in the Company Disclosure Schedule, a &ldquo;<FONT STYLE="color: windowtext"><B>Company
Regulatory Agreement</B></FONT>&rdquo;), nor have the Company nor any of its Subsidiaries been advised by any Regulatory Agency or other
Regulatory Agency since January 1, 2023 or have knowledge that such agency is considering issuing, ordering or requesting any Company
Regulatory Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">Section&nbsp;4.15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Digital Asset<FONT STYLE="font-style: normal">. Except as would not be material to the Company and its Subsidiaries, taken
as a whole, as of the date hereof and the Effective Time, the Company (or one of its Subsidiaries) will own all (i) cash held in crypto-currency
wallets or similar mediums of custody for Digital Assets or exchange accounts and (ii) Digital Assets held by the Company and its Subsidiaries,
including at least 5,021 Bitcoin, free and clear of all Liens.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.16.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>FDA Matters; Medical Device Matters; Compliance</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company and each of its Subsidiaries are and have been in compliance in all material respects with all Health Care Laws by
which any Product is bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January&nbsp;1, 2023, neither the Company nor any of its Subsidiaries have introduced any Product into commercial distribution
that was, upon its shipment, adulterated or misbranded in material violation of any Applicable Law, including 21 U.S.C. &sect; 331.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 36; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January&nbsp;1, 2023, all Products are and have been labeled, promoted, marketed, and advertised in all material respects
in accordance with their intended use, intended purpose, and Health Care Permit, if applicable. Since January&nbsp;1, 2023, neither the
Company nor any of its Subsidiaries has received any material notice or other material communication from the FDA or any other Governmental
Authority: (A)&nbsp;contesting a Health Care Permit, including any premarket clearance, or approval;&nbsp;(B)&nbsp;contesting the uses
of or the labeling and promotion of any Product; or (C)&nbsp;otherwise alleging a material violation of any Health Care Law applicable
to any Product.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January&nbsp;1, 2023, none of the Company or any of its Subsidiaries, any of its or their respective directors, officers
or employees, or to the knowledge of the Company any distributors, resellers, suppliers, consultants, agents, clinical investigators,
or other third parties acting on behalf of the Company or any of its Subsidiaries have received written notice of or been subject to,
or have any reason to believe it will receive written notice or be subject to: (i)&nbsp;any material adverse inspectional finding, nor
any data integrity review, corporate integrity agreement, monitoring agreement, deferred prosecution agreement, consent decree, settlement
order or other similar agreement, investigation, penalty, fine, reprimand, sanction, assessment, request for corrective or remedial action,
warning letter, regulatory letter, untitled letter, It Has Come To Our Attention Letter, FDA Form 483, request for additional information,
notice of action for import detentions or refusals, institutional review board or ethics committee alleging material noncompliance with
any Health Care Laws; (ii) other material compliance or enforcement notices, orders, complaints, communications or other material correspondences
from FDA or any other Governmental Authority (including any notified body) related to any Product, property, or asset, including matters
that are civil, criminal, or regulatory in nature; (iii)&nbsp;any material communication from a Governmental Authority regarding prior
or ongoing preclinical or clinical studies, including requiring or threatening a clinical hold or the termination, suspension, or material
modification of such studies; or (iv)&nbsp;any other communications requesting additional information pertaining to potential material
violations of any Health Care Laws, or indicating an investigation into actual or potential material violations of any Health Care Laws.
Since January&nbsp;1, 2023, no such order, action, or communication described in any of&nbsp;clauses (i),&nbsp;(ii),&nbsp;(iii), or&nbsp;(iv)&nbsp;above
has been received or occurred, or is currently anticipated, contemplated, proposed, or to the knowledge of the Company, pending.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All Products as currently marketed are the subject of an appropriate Health Care Permit, as required, and duly held by the Company,
unless such Product is otherwise exempt from such Health Care Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No suspension, cancellation, modification, revocation, restriction, limitation, or nonrenewal of any Health Care Permit is pending,
or, to the knowledge of the Company, threatened or anticipated to be threatened or pending, and, to the knowledge of the Company, there
is no reason why any such Health Care Permit may be varied, suspended, cancelled, revoked, or not renewed on the same terms. No material
Health Care Permit is held in the name of any employee, officer, director, stockholder, agent, or otherwise on behalf of the Company.
Since January&nbsp;1, 2023, neither the Company nor any of its Subsidiaries have ever been denied a Health Care Permit due to Product&nbsp;non-conformities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Product is currently and, since January&nbsp;1, 2023, no Product has been subject to any field action, including any recall,
correction, removal, market withdrawal or any other</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 37; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">corrective action,
including those that would be required to be reported to the FDA or documented under 21 C.F.R. Part 806 (collectively, a &ldquo;<B>Field
Action</B>&rdquo;), nor is any Field Action currently under consideration by the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January&nbsp;1, 2023, neither the Company nor any of its Subsidiaries has entered into any consent decree or order pursuant
to any Health Care Law, and the Company and its Subsidiaries are not, and since January&nbsp;1, 2023, have not been, party or subject
to any judgment pursuant to any Health Care Law. To the knowledge of the Company, there is not, and, since January&nbsp;1, 2023 there
has not been, any act, omission, event, or circumstance that could give rise to or lead to any such action pursuant to any Health Care
Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January&nbsp;1, 2023, none of the Company, any of its Subsidiaries, any of the its or their respective&nbsp;directors, officers
or employees, or to the knowledge of the Company any distributors, resellers, consultants, suppliers, agents or any other third party
acting for or on behalf of the Company or its Subsidiaries, have (i)&nbsp;made an untrue statement of material fact or fraudulent statement
to FDA or any other Governmental Authority (including orally, or in any records or documentation prepared, maintained, or submitted to
Governmental Authorities), including with respect to any Product or the business of the Company and its Subsidiaries; (ii)&nbsp;failed
to disclose a material fact with respect to any Product required to be disclosed to any Governmental Authority; (iii)&nbsp;been the subject
of any material investigation by the FDA, National Institutes of Health, Office of the Inspector General for the Department of Health
and Human Services, Department of Justice, or any other comparable Governmental Authority, including with respect to data or healthcare
program fraud; or (iv)&nbsp;committed any other act, made any statement or failed to make any statement, that (in any such case) establishes
a reasonable basis for the FDA to invoke its Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities Final Policy,
or for any Governmental Authority to invoke any similar policy. To the knowledge of the Company, none of the above listed individuals
or entities are subject or, since January&nbsp;1, 2023, have been subject to any actual, threatened, or pending investigation by the FDA
pursuant to its Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities Final Policy, or by any Governmental Authority
pursuant to any similar policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January&nbsp;1, 2023, neither the Company nor any of its Subsidiaries nor any of their employees, nor, to the knowledge of
the Company, any of its agents and distributors acting on its or their behalf (i)&nbsp;has materially violated or caused a material violation
of any federal or state health care fraud and abuse or false claims statute or regulation, including the Anti-Kickback Statute (42 U.S.C.
&sect;&nbsp;1320a-7b),&nbsp;the False Claims Act, and related regulations, that is applicable to the Company or any of its Subsidiaries,
(ii)&nbsp;has been debarred, excluded, suspended or threatened with debarment or exclusion under any Law, including under 21 U.S.C. &sect;
335a, 42 U.S.C. &sect;&nbsp;1320a-7,&nbsp;and relevant regulations in 42 C.F.R. Part 1001 or (iii)&nbsp;has been assessed or threatened
with assessment of civil money penalties pursuant to 21 U.S.C. &sect; 335b, 21 C.F.R. Part 17 or 42 U.S.C. Part 1003.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To the knowledge of the Company, there is not pending any civil, criminal, or administrative actions or suits alleging any: (i)&nbsp;hazard
or defect in design, manufacture, service, handling, materials, workmanship with respect to any Product, (ii)&nbsp;failure to warn or
breach of any express or implied warranty or representation; or (iii)&nbsp;concern with the safety, efficacy or performance of any Product.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.17.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Material Contracts</I>. (a) Section&nbsp;&lrm;4.17(a) of the Company Disclosure Schedule sets forth a list as of the date of this
Agreement of each of the following Contracts (other than Company Employee Plans and such Contracts solely among the Company and any of
its wholly owned Subsidiaries) to which the Company or any of its Subsidiaries is a party or by which it is bound (each such Contract
listed or required to be so listed, and each of the following Contracts to which the Company or any of its Subsidiaries becomes a party
or by which it becomes bound after the date of this Agreement, a &ldquo;<FONT STYLE="color: windowtext"><B>Company Material Contract</B></FONT>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Contract to which any of the top ten (10) customers or top ten (10) vendors of the Company (determined on the basis of the
consolidated revenue or consolidated expenses, as applicable, of the Company and its Subsidiaries, taken as a whole, for the fiscal year
ended December 31, 2024) is a party (excluding any immaterial non-disclosure agreements that are ancillary to Contracts pursuant to which
payments are made to the Company or its Subsidiaries);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Contract that (A) limits or purports to limit, in any material respect, the freedom of the Company or any of its Subsidiaries
to engage or compete in any line of business or with any Person or in any area or that would so limit or purport to limit, in any material
respect, the freedom of Parent, the Company or any of their respective Affiliates after the Effective Time, (B)&nbsp;contains any material
exclusivity or material &ldquo;most favored nation&rdquo; obligations, material rights of first refusal, material rights of first offer,
material put or call rights or other restrictions or similar provisions that are binding on the Company or any of its Subsidiaries (or,
after the Effective Time, that would be binding on Parent or any of its Affiliates) or (C)&nbsp;otherwise limits or restricts, in any
material respect, the Company or any of its Subsidiaries (or, after the Effective Time, Parent or any of its Affiliates) from hiring or
soliciting any Person for employment;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(A) any standard form Contract pursuant to which the Company or any of its Subsidiaries provides the Company Product or other Product
to any client and (B) any material Contract (or group of Contracts that, in the aggregate, are material) pursuant to which the Company
or any of its Subsidiaries provides the Company Product or other Product to any client that is not on any such standard form or includes
any material deviations from any such standard form;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Contract reasonably expected to result in payments made or received by the Company and its Subsidiaries in excess of $1,500,000
in any year that provides for any referral arrangement, commission sharing arrangement or co-marketing arrangement, including any finder&rsquo;s
agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any material Contract for which the execution, delivery and performance by the Company of this Agreement or the consummation of
any of the Transactions would (A) require any consent or other action (including notice by the Company) thereunder, (B) constitute a default,
or an event that, with or without notice or lapse of time or both, would constitute a default, thereunder, (C) cause or permit the termination,
cancellation, acceleration or other change of any material right or obligation (including triggering of a price adjustment, right of renegotiation
or other remedy) or the loss of any material benefit</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 39; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">to which the Company
or any of its Subsidiaries is entitled thereunder or (D) require any material payment by the Company or any of its Subsidiaries thereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>promissory notes, loan agreements, indentures, evidences of indebtedness or other instruments providing for or relating to the
lending of money, (A) if as borrower or guarantor, in excess of $1,500,000, and (B) if as lender, in excess of $1,500,000;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any material joint venture, profit-sharing, partnership, stockholders, investors rights, registration rights or similar Contract;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Contracts or series of related Contracts entered into within the last three (3) years relating to the acquisition or disposition
of the business, assets or securities of any Person or any business for a price in excess of $1,500,000 (in each case, whether by merger,
sale of stock, sale of assets or otherwise);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any Contracts or other transactions with any (A) executive officer or director of the Company, (B) record or, to the knowledge
of the Company, beneficial owner of five percent (5%) or more of the voting securities of the Company, or (C) affiliates or &ldquo;associates&rdquo;
(or members of any of their &ldquo;immediate family&rdquo;) (as such terms are respectively defined in Rule 12b-2 and Rule 16a-1 of the
Securities Exchange Act) of any such executive officer, director or beneficial owner (each of the foregoing, a &ldquo;<FONT STYLE="color: windowtext"><B>Related
Party</B></FONT>&rdquo; and each such Contract, a &ldquo;<FONT STYLE="color: windowtext"><B>Related Party Contract</B></FONT>&rdquo;);
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any other Contract required to be filed by the Company pursuant to Item 601(b)(10) of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has made available to Parent a true and complete copy of each Company Material Contract. All of the Company Material
Contracts are, subject to the Bankruptcy and Equity Exceptions, valid and binding obligations of the Company or a Subsidiary of the Company
(as the case may be) and, to the knowledge of the Company, each of the other parties thereto, and in full force and effect and enforceable
in accordance with their respective terms against the Company or its Subsidiaries (as the case may be) and, to the knowledge of the Company,
each of the other parties thereto (except for such Company Material Contracts that expire after the date of this Agreement in accordance
with their respective terms), except where the failure to be valid and binding obligations and in full force and effect and enforceable
has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. To the
knowledge of the Company, no Person is seeking to terminate or challenging the validity or enforceability of any Company Material Contract,
except such terminations or challenges which have not had and would not reasonably be expected to have, individually or in the aggregate,
a Company Material Adverse Effect. Neither the Company nor any of its Subsidiaries, nor to the knowledge of the Company, any of the other
parties thereto has violated any provision of, or committed or failed to perform any act which (with or without notice, lapse of time
or both) would constitute a default under any provision of, and neither the Company nor any of its Subsidiaries has received written notice
that it has violated or defaulted under, any Company Material Contract, except for those violations and defaults (or potential defaults)
which have not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.18.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Taxes</I>. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All Tax Returns required by Applicable Law to be filed with any Taxing Authority by, or on behalf of, the Company or any of its
Subsidiaries have been filed when due (giving effect to all extensions) in accordance with all Applicable Law, and all such Tax Returns
are true and complete.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company and each of its Subsidiaries has paid (or has had paid on its behalf), or has withheld and remitted to the appropriate
Taxing Authority, all Taxes due and payable, or (i) where payment is not yet due, has established (or has had established on its behalf
and for its sole benefit and recourse) in accordance with GAAP an adequate accrual or (ii) where payment is being contested in good faith
pursuant to appropriate procedures, has established (or has had established on its behalf and for its sole benefit and recourse) in accordance
with GAAP an adequate reserve, in each case for all Taxes through the end of the last period for which the Company and its Subsidiaries
ordinarily record items on their respective books and records.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the Company nor any of its Subsidiaries (or any member of any affiliated, consolidated, combined or unitary group of which
the Company or any of its Subsidiaries is or has been a member) has granted any extension or waiver of the limitation period applicable
to the assessment or collection of any federal income Tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There is no Proceeding (including any audit) pending or, to the Company&rsquo;s knowledge, threatened in writing against or with
respect to the Company or its Subsidiaries in respect of any Tax or Tax asset.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There are no requests for rulings or determinations in respect of any Tax or Tax asset pending between the Company or any of its
Subsidiaries and any Taxing Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>During the two (2)-year period ending on the date of this Agreement, the Company was not a distributing corporation or a controlled
corporation in a transaction intended to be governed by Section 355 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There are no Liens for Taxes (other than Permitted Liens) upon any of the assets of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No claim has been made in writing by any Taxing Authority in a jurisdiction where the Company or any of the Company&rsquo;s Subsidiaries
does not file Tax Returns that the Company or any such Subsidiary is or may be subject to taxation by, or required to file any Tax Return
in, that jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the Company nor any of its Subsidiaries (i) has been a member of an affiliated, consolidated, combined or unitary group
other than one of which the Company or any of its Subsidiaries was the common parent, (ii) is party to any Tax Sharing Agreement (other
than any such agreement solely between the Company and its Subsidiaries), or (iii) has any liability for the Taxes of any Person (other
than the Company or any of its Subsidiaries) under Treasury Regulation Section 1.1502-6 (or any similar provision of state, local or non-U.S.
law) or any Tax Sharing Agreement, or as a transferee or successor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 41; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="color: windowtext">Neither the Company nor any of its Subsidiaries has taken or agreed to take any action or has knowledge
of any fact or circumstance that could reasonably be expected to prevent the Mergers, taken together, from qualifying as a &ldquo;reorganization&rdquo;
within the meaning of Section 368(a) of the Code and the Treasury Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.19.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Employees and Employee Benefit Plans</I>. (a) The Company Employee Plans that the Company has made available to Parent are true
and correct copies of such Company Employee Plans.&nbsp;&nbsp;For each material Company Employee Plan, the Company has made available
to Parent a copy of such plan (or a description, if such plan is not written) and all amendments thereto, together with a copy of (if
applicable) (i) each trust, insurance or other funding arrangement, (ii) each summary plan description and summary of material modifications,
(iii) the most recently filed IRS Forms 5500, (iv) the most recent favorable determination or opinion letter from the IRS, (v) the most
recently prepared actuarial reports and financial statements in connection with each such Company Employee Plan, and (vi) all material
documents and correspondence relating thereto received from or provided to any Governmental Authority during the past year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company has provided to Parent a list containing with respect to each Key Employee: (i) name, (ii) date of hire, (iii) position,
(iv) employment location, (v) base salary or wage rate, (vi) the current incentive opportunities of such employee and (vii) the legal
entity that employs such employee.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the Company nor any of its ERISA Affiliates (nor any predecessor of any such entity) sponsors, maintains, administers or
contributes to (or has any obligation to contribute to), or in the past six years has, sponsored, maintained, administered or contributed
to (or had any obligation to contribute to), any plan subject to Title IV of ERISA, including any multiemployer plan, as defined in Section
3(37) of ERISA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Company Employee Plan that is intended to be qualified under Section 401(a) of the Code has received a favorable determination
or opinion letter from the IRS or has applied to the IRS for such a letter within the applicable remedial amendment period or such period
has not expired and, to the knowledge of the Company, no circumstances exist that would reasonably be expected to result in any such letter
being revoked or not being reissued or a penalty under the IRS Closing Agreement Program if discovered during an IRS audit or investigation.
Each trust created under any such Company Employee Plan is exempt from tax under Section 501(a) of the Code and has been so exempt since
its creation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse
Effect, since January 1, 2023, each Company Employee Plan has been maintained in compliance with its terms and all Applicable Law. Except
as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, no Proceeding
(other than routine claims for benefits and including an audit) is pending against or involves or, to the Company&rsquo;s knowledge, is
threatened against or reasonably expected to involve, any Company Employee Plan before any court or arbitrator or any Governmental Authority.
To the knowledge of the Company, since January 1, 2023, no events have occurred with respect to any Company Employee Plan that would reasonably
be expected to result in the assessment of any excise taxes or penalties against the Company or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 42; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">any of its Subsidiaries,
except for events that have not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>With respect to each director, officer, employee or independent contractor (including each former director, officer, employee or
independent contractor) of the Company or any of its Subsidiaries, the consummation of the Transactions will not, either alone or together
with any other event: (i) entitle any such individual to any payment or benefit, including any bonus, retention, severance, retirement
or job security payment or benefit, (ii) accelerate the time of payment or vesting or trigger any payment or funding (through a grantor
trust or otherwise) of compensation or benefits under, or materially increase the amount payable or trigger any other obligation under,
any Company Employee Plan or (iii) limit or restrict the right of the Company or any of its Subsidiaries or, after the Closing, Parent
to merge, amend or terminate any Company Employee Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither the Company nor any of its Subsidiaries has any current or projected liability for, and no Company Employee Plan provides
or promises, any post-employment or post-retirement medical, dental, disability, hospitalization, life or similar benefits (whether insured
or self-insured) to any director, officer, employee or individual independent contractor (including any former director, officer, employee
or individual independent contractor) of the Company or any of its Subsidiaries (other than coverage mandated by Applicable Law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There has been no amendment to, written interpretation of or announcement (whether or not written) by the Company or any of its
Affiliates relating to, or making a change in employee participation or coverage under, any Company Employee Plan that would materially
increase the expense of maintaining such plan above the level of expense incurred in respect thereof for the fiscal year ended on the
Company Balance Sheet Date, except as required in order to comply with Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Without limiting the generality of Section 4.19(e), no amount paid or payable (whether in cash, in property, or in the form of
benefits) by the Company or any of its Subsidiaries in connection with the Transactions (either solely as a result thereof or as a result
of such transactions in conjunction with any other event) will be an &ldquo;excess parachute payment&rdquo; within the meaning of Section
280G of the Code. Neither the Company nor any of its Subsidiaries has any obligation to gross-up, indemnify or otherwise reimburse any
current or former Company Service Provider for any tax incurred by such individual.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as would not be expected to have, individually or in the aggregate, a Company Material Adverse Effect, each Company Employee
Plan, and any award thereunder, that is or forms part of a &ldquo;nonqualified deferred compensation plan&rdquo; within the meaning of
Section 409A of the Code has been timely amended (if applicable) to comply and has been operated in compliance with, and the Company and
its Subsidiaries have complied in practice and operation with, all applicable requirements of Section 409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>With respect to any Company Employee Plan covered by Subtitle B, Part 4 of Title I of ERISA or Section 4975 of the Code, no non-exempt
prohibited transaction has occurred that has caused or would reasonably be expected to cause the Company or any of its Subsidiaries to
incur any material liability under ERISA or the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 43; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.20.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Labor Matters</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as would not be material to the Company and its Subsidiaries, taken as a whole, neither the Company nor any of its Subsidiaries
is, or since January 1, 2023 has been, a party to or subject to, or is currently negotiating in connection with entering into, any collective
bargaining agreement, and there have not been any, and to the Company&rsquo;s knowledge there are no threatened, organizational campaigns,
card solicitations, petition or other unionization activity seeking recognition of a collective bargaining unit relating to any current
or former Company Service Provider. Except as has not had and would not reasonably be expected to have, individually or in the aggregate,
a Company Material Adverse Effect, there are no unfair labor practice complaints pending or, to the Company&rsquo;s knowledge, threatened
against the Company or any of its Subsidiaries before the National Labor Relations Board or any other Governmental Authority or any current
union representation questions involving any current or former Company Service Provider with respect to the Company or its Subsidiaries.
Except as would not be material to Company and its Subsidiaries, taken as a whole, there is no labor strike, slowdown, stoppage, picketing,
interruption of work or lockout pending or, to the Company&rsquo;s knowledge, threatened against or affecting the Company or any of its
Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January 1, 2023, (i), no allegations of sexual harassment or other sexual misconduct have been made against any employee
of the Company with the title of executive director or above through the Company&rsquo;s anonymous employee hotline or any formal human
resources communication channels at the Company, and (ii) there are no Actions pending or, to the Company&rsquo;s knowledge, threatened
related to any allegations of sexual harassment or other sexual misconduct by any employee of the Company with the title of executive
director or above. Since January 1, 2023, neither the Company nor any of its Subsidiaries have entered into any settlement agreements
related to allegations of sexual harassment or other sexual misconduct by any employee of the Company with the title of executive director
or above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company and each of its Subsidiaries is, and has been since January 1, 2023, in material compliance with WARN and has no liabilities
or other obligations thereunder. Neither the Company nor any of its Subsidiaries has taken any action that would reasonably be expected
to cause Parent or any of its Affiliates to have any material liability or other obligation following the Closing Date under WARN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.21.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Intellectual Property</I>. (a) Except as has not had and would not reasonably be expected to have, individually or in the aggregate,
a Company Material Adverse Effect, none of the registrations (including patents and domain name registrations) and applications for registration
for the Company&rsquo;s Owned Intellectual Property (the &ldquo;<FONT STYLE="color: windowtext"><B>Company Registered IP</B></FONT>&rdquo;)
has lapsed, expired, been abandoned or been adjudged invalid or unenforceable, and, to the knowledge of the Company, all Company Registered
IP is valid, enforceable and subsisting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse
Effect, (i) the Company and its Subsidiaries are the sole and exclusive owners of all of the Company&rsquo;s Owned Intellectual Property
and hold all of their right, title and interest in and to all of the Company&rsquo;s Owned Intellectual Property free and clear of all
Liens (other than non-exclusive licenses granted by the Company or one of its Subsidiaries in the ordinary course of business and Permitted
Liens), (ii) immediately following</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 44; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">the Closing, the Company
and its Subsidiaries will own or have a valid and enforceable license to use any and all of the Intellectual Property necessary to, or
used or held for use in, the conduct of the respective businesses of the Company and its Subsidiaries as currently conducted, and (iii)&nbsp;to
the knowledge of the Company, there exist no material restrictions on the use of any of the Company&rsquo;s Owned Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse
Effect, no current or former employee, contractor or consultant of the Company or any of its Subsidiaries owns any rights in or to any
of the Company&rsquo;s Owned Intellectual Property and, to the extent that any such Intellectual Property has been developed or created
by any Third Party (including any current or former employee, contractor or consultant) for or on behalf of the Company or any of its
Subsidiaries, the Company or one of its Subsidiaries, as applicable, has a written agreement with such Third Party with respect thereto,
and thereby either (i) has obtained ownership of and is the exclusive owner of, or (ii) has obtained a valid right to exploit, sufficient
for the conduct of the business of the Company and its Subsidiaries as currently conducted, such Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse
Effect, (i) to the knowledge of the Company, since January 1, 2023, neither the Company nor any of its Subsidiaries nor the conduct of
their respective businesses has infringed, misappropriated, diluted or otherwise violated any Intellectual Property rights of any Third
Party, (ii)&nbsp;there is no Proceeding pending or, to the knowledge of the Company, threatened against or affecting the Company or any
of its Subsidiaries (A) alleging that the Company or any of its Subsidiaries has infringed, misappropriated, diluted or otherwise violated
any Intellectual Property rights of any Third Party or (B) based upon, or challenging or seeking to deny or restrict, the rights of the
Company or any Subsidiary of the Company in any of the Company&rsquo;s Owned Intellectual Property, and (iii) to the knowledge of the
Company, no Third Party has infringed, misappropriated, diluted or otherwise violated any of the Company&rsquo;s Owned Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse
Effect, (i) the Company and its Subsidiaries have provided reasonable notice of its privacy and personal data collection and use policies
on its websites and through other customer and public communications and the Company and its Subsidiaries have complied with such policies,
contractual requirements and all Applicable Law relating to (A) the privacy of the users of the Company&rsquo;s and its Subsidiaries&rsquo;
respective products, services and websites and (B) the collection, use, processing, storage and disclosure of any personally-identifiable
information (including personal health information and any and all &ldquo;personal data&rdquo; as that term is defined in any applicable
data protection Law and any and all other information, the collection, use, processing, storage and disclosure of which is regulated by
an Applicable Law in relation to data protection or data privacy) and other data or information collected, used, processed, stored or
disclosed by the Company or any of its Subsidiaries (or, to the knowledge of the Company, any Third Party that collects, uses, processes,
stores or discloses such data or information on behalf of the Company or any of its Subsidiaries), (ii) there is no Proceeding pending
or, to the knowledge of the Company, threatened against the Company or any of its Subsidiaries (or, to the knowledge of the Company, against
any Third Party working on behalf of the Company or any of its Subsidiaries) alleging any violation of such policies,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 45; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">contractual requirements
or Applicable Law, (iii)&nbsp;none of this Agreement or the consummation of the Transactions will violate any such policy, contractual
requirements or Applicable Law and (iv) the Company and its Subsidiaries (and any Third Party working on behalf of the Company and its
Subsidiaries) have taken commercially reasonable steps consistent with normal industry practice to protect the types of information referred
to in this Section&nbsp;&lrm;4.21(e) against loss and unauthorized access, use, modification, disclosure or other misuse, and, to the
knowledge of the Company, there has been no unauthorized access, use, modification, disclosure or other misuse of such data or information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse
Effect, (i) the Company&rsquo;s IT Assets perform in a manner that permits the Company and its Subsidiaries to conduct their respective
businesses as currently conducted, (ii)&nbsp;the Company and its Subsidiaries take commercially reasonable actions, consistent with current
industry standards, to protect the confidentiality, integrity and security of the Company&rsquo;s IT Assets (and all information and transactions
stored or contained therein or transmitted thereby) against any unauthorized use, access, interruption, modification or corruption, including
the implementation of commercially reasonable data backup, disaster avoidance and recovery procedures and business continuity procedures,
and (iii) to the knowledge of the Company, there has been no unauthorized use, access, interruption, modification or corruption of the
Company&rsquo;s IT Assets (or any information or transactions stored or contained therein or transmitted thereby).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.22.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Properties</I>. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect, (i) the Company and its Subsidiaries have good, valid and marketable fee simple title (or its jurisdictional
equivalent) to, or valid leasehold interests in, as the case may be, each parcel of real property owned or used by the Company or any
of its Subsidiaries, free and clear of all Liens, except for Permitted Liens, (ii) each lease, sublease or license (each, a &ldquo;<FONT STYLE="color: windowtext"><B>Lease</B></FONT>&rdquo;)
under which the Company or any of its Subsidiaries leases, subleases or licenses any real property is, subject to the Bankruptcy and Equity
Exceptions, a valid and binding obligation of the Company or a Subsidiary of the Company (as the case may be) and, to the knowledge of
the Company, each of the other parties thereto, and in full force and effect and enforceable in accordance with its terms against the
Company or its Subsidiaries (as the case may be) and, to the knowledge of the Company, each of the other parties thereto (except for such
Leases that are terminated after the date of this Agreement in accordance with their respective terms; <I>provided </I>that if such termination
is at the option of the Company or any of its Subsidiaries such termination must be in the ordinary course of business), (iii) neither
the Company nor any of its Subsidiaries, nor, to the knowledge of the Company, any of the other parties thereto has violated or committed
or failed to perform any act which (with or without notice, lapse of time or both) would constitute a default under any provision of any
Lease and (iv) neither the Company nor any of its Subsidiaries has received written notice that it has breached, violated or defaulted
under any Lease, nor has the Company or any of its Subsidiaries delivered notice to any other party to a Lease that such other party has
breached, violated or defaulted under any Lease that remains uncured as of the date hereof. Except as has not had and would not reasonably
be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the real property owned or used by the Company
or any of its Subsidiaries and any plants, buildings, structures and equipment thereon owned or leased by the Company and its Subsidiaries
have no defects, are in good operating condition and repair and have been maintained consistent with</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 46; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">standards generally followed in the industry (given
due account to the age and length of use of same, ordinary wear and tear excepted), are adequate and suitable for their present use. Except
as has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the
Company and its Subsidiaries are in possession of and have good title to, or valid leasehold interests in or valid rights under contract
to use, the material machinery, equipment, furniture, fixtures and other tangible material personal property and assets used by the Company
or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.23.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Environmental Matters</I>. (a) Except as has not had and would not reasonably be expected to have, individually or in the aggregate,
a Company Material Adverse Effect:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>no notice, notification, demand, request for information, citation, summons or order has been received, no complaint has been filed,
no penalty has been assessed, and no Proceeding (including a review) is pending or, to the knowledge of the Company, threatened by any
Governmental Authority or other Person relating to the Company or any of its Subsidiaries that relates to, or arises under, any Environmental
Law, Environmental Permit or Hazardous Substance;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company and its Subsidiaries are, and since January 1, 2023 have been, in compliance with all Environmental Laws and all Environmental
Permits and hold all applicable Environmental Permits; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>there are no liabilities or obligations of the Company or any of its Subsidiaries of any kind whatsoever, whether accrued, contingent,
absolute, determined, determinable or otherwise arising under or relating to any Environmental Law, Environmental Permit or Hazardous
Substance and there is no existing condition, situation or set of circumstances that could reasonably be expected to result in any such
liability or obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as set forth on Section&nbsp;&lrm;4.23(b) of the Company Disclosure Schedule, neither the Company nor any of its Subsidiaries
owns, leases or operates any real property, or conducts any operations, in New Jersey or Connecticut.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.24.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Antitakeover Statutes</I>. The Company has no &ldquo;rights plan,&rdquo; &ldquo;rights agreement,&rdquo; or &ldquo;poison pill&rdquo;
in effect. Assuming the representations and warranties set forth in Section&nbsp;&lrm;5.25 are true and correct, neither the restrictions
set forth in Section 203 of the Delaware Law nor any other &ldquo;control share acquisition,&rdquo; &ldquo;fair price,&rdquo; &ldquo;moratorium&rdquo;
or other antitakeover laws enacted under U.S. state or federal laws apply to this Agreement or any of the Transactions with respect to
the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.25.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Opinion of Financial Advisor</I>. The Board of Directors of the Company has received the oral opinion (to be confirmed by delivery
of a written opinion promptly after the date hereof) of LionTree Advisors LLC, financial advisor to the Company, to the effect that, as
of the date of such opinion and subject to the assumptions, qualifications, limitations and other matters set forth therein, the Exchange
Ratio pursuant to this Agreement is fair, from a financial point of view, to holders of Company Stock (other than Parent and its Affiliates).
A written copy of such opinion will be delivered promptly after the date hereof to Parent for informational purposes only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 47; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.26.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Finders&rsquo; Fees</I>. Except for LionTree Advisors LLC, a true and complete copy of whose engagement agreement has been provided
to Parent prior to the date of this Agreement, there is no investment banker, broker, finder or other intermediary that has been retained
by or is authorized to act on behalf of the Company or any of its Subsidiaries who might be entitled to any fee or commission from the
Company or any of its Affiliates in connection with the Transactions or to whom the Company or Parent or any of their respective Affiliates
owes (or would owe) any other material obligations following the Closing (other than customary indemnification obligations), and the foregoing
fees and expenses shall not exceed the amount set forth in Section 4.26 of the Company Disclosure Schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.27.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Ownership of Parent Common Stock</I>. Neither the Company nor any of its Subsidiaries beneficially owns, directly or indirectly,
any shares of Parent Common Stock or other securities convertible into, exchangeable for or exercisable for shares of Parent Common Stock&nbsp;&nbsp;and
neither the Company nor any of its Subsidiaries has any rights to acquire any shares of Parent Common Stock. There are no voting trusts
or other agreements or understandings to which the Company or any of its Subsidiaries is a party with respect to the voting of the capital
stock or other equity interest of Parent or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.28.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Ownership of Company Stock</I>. No Subsidiary of the Company (i) beneficially owns, directly or indirectly, any shares of Company
Stock or other securities convertible into, exchangeable for or exercisable for shares of Company Stock&nbsp;&nbsp;or (ii) has any rights
to acquire any shares of Company Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;4.29.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Other Company Representations and Warranties</I>. Except for the representations and warranties made by the Company in this
Article&nbsp;&lrm;4 (as qualified by the applicable items disclosed in the Company Disclosure Schedule in accordance with Section&nbsp;&lrm;11.05
and the introduction to this Article&nbsp;&lrm;4), neither the Company nor any other Person makes or has made any representation or warranty,
expressed or implied, at law or in equity, with respect to or on behalf of the Company or its Subsidiaries, or the accuracy or completeness
of any information regarding the Company or its Subsidiaries or any other matter furnished or provided to Parent or made available to
Parent in any &ldquo;data rooms,&rdquo; &ldquo;virtual data rooms,&rdquo; management presentations or in any other form in expectation
of, or in connection with, this Agreement or the Transactions. The Company and its Subsidiaries disclaim any other representations or
warranties, whether made by the Company or any of its Subsidiaries or any of their respective Affiliates or Representatives. The Company
acknowledges and agrees that, except for the representations and warranties made by Parent in Article&nbsp;&lrm;5 (as qualified by the
applicable items disclosed in the Parent Disclosure Schedule in accordance with Section&nbsp;&lrm;11.05 and the introduction to Article&nbsp;&lrm;5),
neither Parent nor any other Person is making or has made any representations or warranty, expressed or implied, at law or in equity,
with respect to or on behalf of Parent or its Subsidiaries, or the accuracy or completeness of any information regarding Parent or its
Subsidiaries or any other matter furnished or provided to Parent or made available to the Company in any &ldquo;data rooms,&rdquo; &ldquo;virtual
data rooms,&rdquo; management presentations or in any other form in expectation of, or in connection with, this Agreement, or the transactions
contemplated hereby or thereby. The Company specifically disclaims that it is relying upon or has relied upon any such other representations
or warranties that may have been made by any Person, and acknowledges and agrees that Parent and its Affiliates have specifically disclaimed
and do hereby specifically disclaim any such other representations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 48; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">and warranties. Notwithstanding the foregoing,
this Section&nbsp;&lrm;4.29 shall not limit Parent&rsquo;s, Merger Sub&rsquo;s or the Company&rsquo;s remedies in the case of fraud.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article&nbsp;5</FONT><U><BR>
Representations and Warranties of Parent</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to <U>Section&nbsp;&lrm;11.05</U>,
except (i) other than with respect to the representations and warranties in <U>Section&nbsp;&lrm;5.01</U>, <U>Section&nbsp;&lrm;5.02</U>,
<U>Section&nbsp;&lrm;5.05</U>, <U>Section&nbsp;&lrm;5.23</U>, <U>Section&nbsp;&lrm;5.24</U> and <U>Section&nbsp;&lrm;5.25</U>, as disclosed
in any publicly available Parent SEC Document filed after January 1, 2019 and prior to the date hereof or (ii) as set forth in the Parent
Disclosure Schedule, Parent represents and warrants to the Company as of the date hereof (or, as it relates to Merger Sub, as of the time
it executes and delivers the joinder contemplated by Section 7.06) and as of the Closing (in each case except to the extent that any such
representation and warranty speaks as of a particular date, in which case such representation and warranty shall be true and correct as
of such earlier date) that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.01.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Corporate Existence and Power</I>. Parent is a corporation duly incorporated, validly existing and in good standing under the laws
of the State of Nevada. Merger Sub is a corporation duly incorporated, validly existing and in good standing under the laws of the State
of Delaware. Each of Parent and Merger Sub has all corporate powers required to own or lease all of its properties or assets and to carry
on its business as now conducted. Each of Parent and Merger Sub is duly qualified to do business and is in good standing in each jurisdiction
where such qualification is necessary, except for those jurisdictions where failure to be so qualified has not had and would not reasonably
be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. Prior to the date of this Agreement, Parent has
made available to the Company true and complete copies of the articles or certificate of incorporation and bylaws of each of Parent and
Merger Sub, in each case, as in effect on the date of this Agreement (or, in the case of Merger Sub, as of the time it executes and delivers
the joinder contemplated by Section 7.06) (collectively, the &ldquo;<FONT STYLE="color: windowtext"><B>Parent Organizational Documents</B></FONT>&rdquo;).
Since the date of its formation, Merger Sub has not engaged in any activities other than in connection with or as contemplated by this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.02.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Corporate Authorization</I>. (a) The execution, delivery and performance by each of Parent and Merger Sub of this Agreement and
the consummation by Parent and Merger Sub of the Transactions are within the corporate powers of each of Parent and Merger Sub and, except
for the required approval and adoption of this Agreement by the stockholder of Merger Sub, have been duly authorized by all necessary
corporate action on the part of Parent and Merger Sub. This Agreement has been duly executed and delivered by each of Parent and Merger
Sub and (assuming due authorization, execution and delivery by the other parties hereto) constitutes a valid and binding agreement of
each of Parent and Merger Sub that is a party thereto enforceable against such Person in accordance with its terms (subject to the Bankruptcy
and Equity Exceptions).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At a meeting duly called and held, the Board of Directors of Parent has unanimously (i) determined that this Agreement and the
Transactions (including the Parent Share Issuance) are advisable, fair to and in the best interests of Parent and Parent&rsquo;s stockholders
and (ii) approved, adopted and declared advisable this Agreement and the Transactions (including the Parent Share Issuance). The Board
of Directors of Merger Sub has unanimously adopted resolutions (i) determining that this Agreement and the Transactions are advisable,
fair to and in the best interests</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 49; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">of the sole stockholder
of Merger Sub, (ii) approving, adopting and declaring advisable this Agreement and the Transactions, (iii) directing that this Agreement
be submitted for approval and adoption by the sole stockholder of Merger Sub, and (iv) recommending approval and adoption of this Agreement
(including the Merger) by the sole stockholder of Merger Sub. The Board of Directors of neither Parent nor Merger Sub has subsequently
rescinded, modified or withdrawn any of the foregoing resolutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.03.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Governmental Authorization</I>. The execution, delivery and performance by each of Parent and Merger Sub of this Agreement and
the consummation by each of Parent and Merger Sub of the Transactions to which such Person is a party, require no action by or in respect
of, Consents of, or Filings with, any Governmental Authority other than (i) the filing of the Certificate of Merger with the Delaware
Secretary of State, and appropriate documents with the relevant authorities of other states in which the Company is qualified to do business,
(ii) compliance with any applicable requirements of the HSR Act, (iii) compliance with any applicable requirements of the Securities Act,
the Securities Exchange Act and any other applicable U.S. state or federal securities laws or pursuant to the listing requirements of
Nasdaq and (iv) any other actions, Consents or Filings the absence of which has not had and would not reasonably be expected to have,
individually or in the aggregate, a Parent Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.04.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Non-contravention</I>. The execution, delivery and performance by each of Parent and Merger Sub of this Agreement and the consummation
of the Transactions to which it is a party do not and will not (i) contravene, conflict with, or result in any violation or breach of
any provision of the Parent Organizational Documents, (ii) assuming compliance with the matters referred to in Section&nbsp;&lrm;5.03
and receipt of the Company Stockholder Approval, contravene, conflict with or result in any violation or breach of any provision of any
Applicable Law, (iii) assuming compliance with the matters referred to in Section&nbsp;&lrm;5.03 and receipt of the Company Stockholder
Approval, require any Consent or other action by any Person under, constitute a default, or an event that, with or without notice or lapse
of time or both, would constitute a default under, give rise to a payment obligation or other liability under, or cause or permit the
termination, cancellation, acceleration or other change of any right or obligation or the loss of any benefit to which Parent or any of
its Subsidiaries is entitled under, any provision of any Contract binding upon Parent or any of its Subsidiaries, any governmental Consents
(including Consents required by Contract) affecting, or relating in any way to, the of Parent or any of its Subsidiaries or any of its
or their respective assets or businesses or any Parent Permit, or (iv) result in the creation or imposition of any Lien on any asset of
Parent or any of its Subsidiaries, with only such exceptions, in the case of each of clauses&nbsp;(ii) through (iv), as has not had and
would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.05.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Capitalization</I>. (a) The authorized capital stock of Parent as of the date hereof consists of (i) 444,000,000,000 shares of
Parent Class A Common Stock, (ii) 21,000,000,000 shares of Parent Class B Common Stock, and (iii) 21,000,000,000 shares of Parent Preferred
Stock. As of the close of business on September 12, 2025 there were outstanding (i) 364,825,582 shares of Parent Class A Common Stock,
(ii) 248,911,654 shares of Parent Class B Common Stock, (iii) no shares of Parent Preferred Stock,&nbsp;&nbsp;(iv) 765,030,718 shares
of Parent Class A Common Stock subject to Parent Warrants, (v) restricted stock units with respect to an aggregate of 32,689,740 shares
of Parent Common Stock (&ldquo;<B>Parent RSU Awards</B>&rdquo;) that have met time vesting requirements, but have not yet been issued,
(vi) restricted stock awards with respect to an</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 50; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">aggregate of 3,555,938 shares of Parent Common
Stock that have not yet met time vesting requirements, (vii) Parent RSU Awards with respect to an aggregate of 7,759,679 shares of Parent
Common Stock that have been granted as of September 12, 2025, but have not yet met time vesting requirements, and (viii) Parent RSU Awards
with respect to an aggregate of 9,240,736 shares of Parent Common Stock that were granted after September 12, 2025 or have been committed
to be granted, and have not yet met time vesting requirements. All outstanding shares of capital stock of Parent have been, and all shares
that may be issued pursuant to any employee stock option or other compensation plan or arrangement will be, when issued in accordance
with the respective terms thereof, duly authorized and validly issued, fully paid and nonassessable and free of preemptive rights. The
shares of capital stock of Parent to be issued as part of the Merger Consideration have been duly authorized and, when issued and delivered
in accordance with the terms of this Agreement, will have been validly issued and will be fully paid and nonassessable and the issuance
thereof will be free of preemptive rights. Except as set forth in this Section &lrm;5.05(a) and for changes since September 12, 2025 resulting
from (A) the vesting and settlement of Parent RSU Awards outstanding on such date or issued after such date or (B) the issuance of Parent
RSU Awards after such date, as of the date hereof, there are no issued, reserved for issuance or outstanding (i) shares of capital stock
or other voting securities of, or other ownership interest in, Parent, (ii) securities of Parent or any of its Subsidiaries convertible
into or exchangeable for shares of capital stock or other voting securities of, or other ownership interests in, Parent, (iii) warrants,
calls, options or other rights to acquire from Parent or any of its Subsidiaries, or other obligations of Parent or any of its Subsidiaries
to issue, any capital stock or other voting securities of, or other ownership interests in, or securities convertible into or exchangeable
for capital stock or other voting securities of, or other ownership interests in, Parent, or (iv) restricted shares, stock appreciation
rights, performance units, contingent value rights, &ldquo;phantom&rdquo; stock or similar securities or rights issued by or with the
approval of Parent or any of its Subsidiaries that are derivative of, or provide economic benefits based, directly or indirectly, on the
value or price of, any capital stock or other voting securities of, or other ownership interests in, Parent (the items in clauses (i)
through (iv) being referred to collectively as the &ldquo;<B>Parent Securities</B>&rdquo;). Parent owns all of the issued and outstanding
capital stock of Merger Sub.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All outstanding shares of capital stock of Parent have been, and all shares that may be issued pursuant to any equity compensation
plan or arrangement will be, when issued in accordance with the respective terms thereof, duly authorized, validly issued, fully paid
and nonassessable and free of preemptive rights. No Subsidiary of Parent owns any shares of capital stock of Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There are no outstanding bonds, debentures, notes or other indebtedness of Parent having the right to vote (or convertible into,
or exchangeable for, securities having the right to vote) on any matters on which stockholders of Parent may vote. There are no outstanding
obligations of Parent or any of its Subsidiaries to repurchase, redeem or otherwise acquire any Parent Securities. Neither Parent nor
any of its Subsidiaries is a party to any agreement with respect to the voting of any Parent Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.06.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subsidiaries</I>. (a) Each Subsidiary of Parent is a corporation or other entity duly incorporated or organized, validly existing
and in good standing under the laws of its jurisdiction of incorporation or organization and has all corporate or other organizational
powers, as applicable, required to carry on its business as now conducted, except for those jurisdictions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 51; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">where failure to be so organized, validly existing
and in good standing or to have such power has not had and would not reasonably be expected to have, individually or in the aggregate,
a Parent Material Adverse Effect. Each such Subsidiary is duly qualified to do business and is in good standing in each jurisdiction where
such qualification is necessary, except for those jurisdictions where failure to be so qualified has not had and would not reasonably
be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As of the date hereof, all of the outstanding capital stock or other voting securities of, or ownership interests in, each Significant
Subsidiary (as defined in Rule 1-02(a) of Regulation S-X) of Parent are owned by Parent, directly or indirectly, free and clear of any
Lien and free of any other limitation or restriction (including any restriction on the right to vote, sell or otherwise dispose of such
capital stock or other voting securities or other ownership interests) (other than restrictions arising under applicable Securities Laws).
As of the date hereof, there are no issued, reserved for issuance or outstanding (i) securities of Parent or any of its Subsidiaries convertible
into or exchangeable for shares of capital stock or other voting securities of, or other ownership interests in, any Subsidiary of Parent,
(ii) warrants, calls, options or other rights to acquire from Parent or any of its Subsidiaries, or other obligations of Parent or any
of its Subsidiaries to issue, any capital stock or other voting securities of, or other ownership interests in, or any securities convertible
into or exchangeable for any capital stock or other voting securities of, or other ownership interests in, any Subsidiary of Parent, or
(iii) restricted shares, stock appreciation rights, performance shares or units, contingent value rights, &ldquo;phantom&rdquo; stock
or similar securities or rights issued by or with the approval of Parent or any of its Subsidiaries that are derivative of, or provide
economic benefits based, directly or indirectly, on the value or price of, any capital stock or other voting securities of, or other ownership
interests in, any Subsidiary of Parent (the items in clauses&nbsp;(i) through (iii) being referred to collectively as the &ldquo;<FONT STYLE="color: windowtext"><B>Parent
Subsidiary Securities</B></FONT>&rdquo;), other than Parent Subsidiary Securities directly or indirectly owned by Parent or any of its
wholly owned Subsidiaries. As of the date hereof, there are no outstanding obligations of Parent or any of its Subsidiaries to repurchase,
redeem or otherwise acquire any Parent Subsidiary Securities or make any material investment in any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.07.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Regulatory Reports, SEC Filings and the Sarbanes-Oxley Act</I>. (a) Parent and each of its Subsidiaries have timely filed with
or furnished all material Filings, together with any material amendments, required to be made with respect thereto, that they were required
to file or furnish (as applicable) since January 1, 2023 with any Regulatory Agency, including any Filing required to be filed or furnished
(as applicable) pursuant to the laws, rules or regulations of the United States, any state, any foreign entity, or any Regulatory Agency,
and have paid all fees and assessments due and payable in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As of its filing date (and as of the date of any amendment), each Filing filed with or furnished to the SEC by Parent since May
7, 2025 (together with any exhibits and schedules thereto and other information incorporated therein, and as amended from time to time,
the &ldquo;<FONT STYLE="color: windowtext"><B>Parent SEC Documents</B></FONT>&rdquo;) and filed prior to the date of this Agreement has
complied, and each Parent SEC Document filed subsequent to the date of this Agreement (assuming, in the case of each of the Registration
Statement and the Information Statement/Proxy Statement/Prospectus, that the representation and warranty set forth in Section&nbsp;&lrm;4.09
is true and correct) will comply, in all material respects with the applicable requirements of the Nasdaq, the Securities Act, the Securities
Exchange Act and the Sarbanes-Oxley Act, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 52; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As of its filing date (or, if amended or superseded by a filing prior to the date of this Agreement, on the date of such amended
or superseding filing), each Parent SEC Document filed prior to the date of this Agreement did not, and each Parent SEC Document filed
subsequent to the date of this Agreement (assuming, in the case of each of the Registration Statement and the Information Statement/Proxy
Statement/Prospectus, that the representation and warranty set forth in Section&nbsp;&lrm;4.09 is true and correct) will not, contain
any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in
light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Parent SEC Document that is a registration statement, as amended or supplemented, as applicable, filed pursuant to the Securities
Act, as of the date such registration statement or amendment became effective, did not contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
in which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Parent is, and since January 1, 2023 has been, in compliance in all material respects with (i) the applicable provisions of the
Sarbanes-Oxley Act and (ii) the applicable listing and corporate governance rules and regulations of the Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Parent and its Subsidiaries have established and maintained since January 1, 2023, and continue and maintain, a system of internal
control. Such internal controls are sufficient to provide reasonable assurance regarding the reliability of Parent&rsquo;s financial reporting
and the preparation of Parent&rsquo;s consolidated financial statements for external purposes in accordance with GAAP. Parent disclosed,
based on its most recent evaluation of such internal controls prior to the date of this Agreement, to Parent&rsquo;s auditors and the
audit committee of the Board of Directors of Parent (x) all significant deficiencies and material weaknesses in the design or operation
of internal controls that are reasonably likely to adversely affect Parent&rsquo;s ability to record, process, summarize and report financial
information and (y) any fraud, whether or not material, that involves management or other employees who have a significant role in internal
controls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January 1, 2023, each of the principal executive officer and principal financial officer of Parent (or each former principal
executive officer and principal financial officer of Parent, as applicable) has made all certifications required by Rule 13a-14 and 15d-14
under the Securities Exchange Act and Sections 302 and 906 of the Sarbanes-Oxley Act and any related rules and regulations promulgated
by the SEC and the Nasdaq, and the statements contained in any such certifications are true and complete.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.08.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Financial Statements and Financial Matters</I>. (a) The audited consolidated financial statements and unaudited consolidated interim
financial statements of Parent included or incorporated by reference in the Parent SEC Documents present fairly in all material respects,
in conformity with GAAP applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto), the
consolidated financial position of Parent and its Subsidiaries as of the dates thereof and their consolidated results of operations and
cash flows for the periods then ended (subject to normal, recurring and immaterial year-end audit adjustments in the case of any unaudited
interim financial statements). Such consolidated financial statements have been prepared from, and are in accordance with, the books and
records of Parent and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 53; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>From January 1, 2023 to the date of this Agreement, Parent has not received written notice from the SEC or any other Governmental
Authority indicating that any of its accounting policies or practices are or may be the subject of any review, inquiry, investigation
or challenge by the SEC or any other Governmental Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.09.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Disclosure Documents</I>. The information relating to Parent and its Subsidiaries that is, or is to be, provided by Parent, any
of its Subsidiaries or any of their respective Representatives for inclusion or incorporation by reference in the Registration Statement
or the Information Statement/Proxy Statement/Prospectus will not (i) in the case of the Registration Statement, at the time the Registration
Statement or any amendment or supplement thereto is filed with the SEC, at the time it becomes effective under the Securities Act and
at the time of the Company Stockholder Meeting, and (ii) in the case of the Information Statement/Proxy Statement/Prospectus, at the time
the Information Statement/Proxy Statement/Prospectus or any amendment or supplement thereto is first mailed to the stockholders of the
Company and at the time of the Company Stockholder Meeting, contain any untrue statement of a material fact required to be stated therein
or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they
were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Absence of Certain Changes</I>. (a) Since the Parent Balance Sheet Date, (i) the business of Parent and its Subsidiaries has been
conducted in all material respects in the ordinary course of business consistent with past practice and (ii) there has not been any event,
circumstance, development, change, occurrence or effect that has had or would reasonably be expected to have, individually or in the aggregate,
a Parent Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since the Parent Balance Sheet Date through the date of this Agreement, there has not been any action taken by Parent or any of
its Subsidiaries that, if taken during the period from the date of this Agreement through the Effective Time without the Company&rsquo;s
consent, would constitute a breach of Section&nbsp;&lrm;7.01.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Undisclosed Material Liabilities</I>. There are no liabilities or obligations of Parent or any of its Subsidiaries of any kind
whatsoever, whether accrued, contingent, absolute, determined, determinable or otherwise, other than (i) liabilities or obligations disclosed
and provided for in the Parent Balance Sheet or in the notes thereto, (ii) liabilities or obligations incurred in the ordinary course
of business consistent with past practice since the Parent Balance Sheet Date, and (iii) other liabilities or obligations that have not
had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. There are no off-balance
sheet arrangements of any type pursuant to any off-balance sheet arrangement required to be disclosed pursuant to Item 303(a)(4) of Regulation
S-K that have not been so described in the Parent SEC Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Litigation</I>. There is no Proceeding pending or, to the knowledge of Parent, threatened against or affecting Parent, any of its
Subsidiaries, any present or former officers, directors or employees of Parent or any of its Subsidiaries in their respective capacities
as such, or any of the respective properties of Parent or any of its Subsidiaries, before (or, in the case of threatened Proceedings,
that would be before) any arbitrator or Governmental Authority, that has had or would reasonably be expected to have, individually or
in the aggregate, a Parent Material Adverse Effect or that in any manner challenges or seeks to prevent, enjoin, alter or materially</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 54; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">delay any of the Transactions. There is no Order
outstanding or threatened against or affecting Parent, any of its Subsidiaries, any present or former officers, directors or employees
of Parent or any of its Subsidiaries in their respective capacities as such, or any of the respective properties of any of Parent or any
of its Subsidiaries, that has had or would reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse
Effect or that would, or would reasonably be expected to, prevent, enjoin, alter or materially delay any of the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Permits</I>. (a) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent
Material Adverse Effect, Parent and each of its Subsidiaries hold all governmental Consents necessary for the operation of their respective
businesses (the &ldquo;<FONT STYLE="color: windowtext"><B>Parent Permits</B></FONT>&rdquo;). Parent and each of its Subsidiaries are and
since January 1, 2023, have been in compliance with the terms of Parent Permits, except for failures to comply that have not had and would
not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. There is no Proceeding pending,
or, to the knowledge of Parent, threatened that seeks, or, to the knowledge of Parent, any existing condition, situation or set of circumstances
that would reasonably be expected to result in, the revocation, cancellation, termination, non-renewal or adverse modification of any
Parent Permit except where such revocation, cancellation, termination, non-renewal or adverse modification has not had and would not reasonably
be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as set forth on Section &lrm;5.13(b) of the Parent Disclosure Schedule, neither Parent nor any of its Subsidiaries has any
material business, conducts any material operations or engages in any material activities, in each case, outside of the U.S. and its territories.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Compliance with Applicable Laws</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each of Parent and its Subsidiaries, (i) except as would not be material to Parent and its Subsidiaries, taken as a whole, are,
and have been have since January 1, 2023, in compliance with and not in default or violation of Applicable Laws, including but (to the
extent applicable to Parent and its Subsidiaries) all Applicable Laws related to data protection or privacy, the USA PATRIOT Act, the
Foreign Corrupt Practices Act, the Investment Advisers Act, the Securities Act, the Securities Exchange Act, ERISA, and any other Applicable
Law, (ii) are, and have been since January 1, 2023, conducting operations at all times in compliance Anti-Money Laundering Laws and (iii)
have established and maintained, since January 1, 2023, a system of internal controls designed to provide compliance by Parent and its
Subsidiaries with applicable financial recordkeeping and reporting requirements of the Anti-Money Laundering Laws, except where, in each
case, the failure to so comply has not had and would not reasonably be expected to have, either individually or in the aggregate, a Parent
Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January 1, 2023, neither Parent nor any of its Subsidiaries has engaged in, or is now engaged in, directly or indirectly,
any dealings or transactions with any Person, or in any country or territory, that, at the time of the dealing or transaction, is or was
the subject of Sanctions which would reasonably be expected to have a Parent Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Parent and its Subsidiaries (i) are, and since January 1, 2023 have been, in material compliance with all applicable Sanctions
and export controls laws, (ii) have instituted, maintain</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 55; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">and enforce policies
and procedures designed to ensure material compliance with all applicable Sanctions and export controls laws. Since January 1, 2023, Parent
and its Subsidiaries have not been penalized for or threatened to be charged with, or given notice of any violation of, or, to the knowledge
of Parent, been under investigation with respect to, any Sanctions or export controls laws, and no action, suit or proceeding by or before
any court or governmental or regulatory agency, authority or body or any arbitrator involving Parent or any of its Subsidiaries with respect
to Sanctions or export controls laws is pending, except where such proceedings or investigations would not reasonably be expected to have,
either individually or in the aggregate, a Parent Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither Parent nor any of its Subsidiaries is a party to any agreement or settlement with any Governmental Authority with respect
to any actual or alleged violation of any Applicable Law, except for agreements and settlements that are not material to Parent and its
Subsidiaries, taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Regulatory Agency has initiated or has pending any proceeding or, to the knowledge of Parent, investigation into the business
or operations of Parent or any of its Subsidiaries since January 1, 2023, except where such proceedings or investigations would not reasonably
be expected to have, either individually or in the aggregate, a Parent Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as would not have a Parent Material Adverse Effect, neither Parent nor any of its Subsidiaries is subject to any cease-and-desist
or other order or enforcement action issued by, or is a party to any written agreement, consent agreement or memorandum of understanding
with, or is a party to any commitment letter or similar undertaking to, or is subject to any order or directive by, or has been ordered
to pay any civil money penalty by, or has been since January 1, 2023, a recipient of any supervisory letter from, or since January 1,
2023, has adopted any policies, procedures or board resolutions at the request or suggestion of, any Regulatory Agency or other Governmental
Authority that currently restricts in any material respect or would reasonably be expected to restrict in any material respect the conduct
of its business (each, whether or not set forth in the Parent Disclosure Schedule, a &ldquo;<FONT STYLE="color: windowtext"><B>Parent
Regulatory Agreement</B></FONT>&rdquo;), nor have Parent nor any of its Subsidiaries been advised since January 1, 2023 or have knowledge,
of any pending or threatened regulatory investigation or that any Regulatory Agency or other Governmental Agency is considering issuing,
initiating, ordering or requesting any Parent Regulatory Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Material Contracts.</I> Each &ldquo;material contract&rdquo; (as such term is defined in Item 601(b)(10) of Regulation S-K under
the Securities Exchange Act but excluding any Parent Employee Plan) to which Parent or any of its Subsidiaries is a party or by which
it is bound (each, a &ldquo;<FONT STYLE="color: windowtext"><B>Parent Material Contract</B></FONT>&rdquo;) is, subject to the Bankruptcy
and Equity Exceptions, a valid and binding obligation of Parent or a Subsidiary of Parent (as the case may be) and, to the knowledge of
Parent, each of the other parties thereto, and in full force and effect and enforceable in accordance with their respective terms against
Parent or its Subsidiaries (as the case may be) and, to the knowledge of Parent, each of the other parties thereto (except for such Parent
Material Contracts that are terminated after the date of this Agreement in accordance with their respective terms; <I>provided</I> that
if such termination is at the option of Parent or any of its Subsidiaries, such termination must be in the ordinary course of business),
except where the failure to be valid and binding obligations and in full force and effect and enforceable has not had and would not </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 56; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">reasonably be expected to have, individually
or in the aggregate, a Parent Material Adverse Effect. To the knowledge of Parent, no Person is seeking to terminate or challenging
the validity or enforceability of any Parent Material Contract, except such terminations or challenges which have not had and would
not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. Neither Parent nor any of
its Subsidiaries, nor to the knowledge of Parent, any of the other parties thereto has violated any provision of, or committed or
failed to perform any act which (with or without notice, lapse of time or both) would constitute a default under any provision of,
and neither Parent nor any of its Subsidiaries has received written notice that it has violated or defaulted under, any Parent
Material Contract, except for those violations and defaults (or potential defaults) which have not had and would not reasonably be
expected to have, individually or in the aggregate, a Parent Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.16.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Taxes</I>. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material
Adverse Effect:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All Tax Returns required by Applicable Law to be filed with any Taxing Authority by, or on behalf of, Parent or any of its Subsidiaries
have been filed when due (giving effect to all extensions) in accordance with all Applicable Law, and all such Tax Returns are true and
complete.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Parent and each of its Subsidiaries has paid (or has had paid on its behalf), or has withheld and remitted to the appropriate Taxing
Authority, all Taxes due and payable, or (i) where payment is not yet due, has established (or has had established on its behalf and for
its sole benefit and recourse) in accordance with GAAP an adequate accrual or (ii) where payment is being contested in good faith pursuant
to appropriate procedures, has established (or has had established on its behalf and for its sole benefit and recourse) in accordance
with GAAP an adequate reserve, in each case for all Taxes through the end of the last period for which Parent and its Subsidiaries ordinarily
record items on their respective books and records.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="color: windowtext">Neither Parent nor any of its Subsidiaries (or any member of any affiliated, consolidated, combined
or unitary group of which Parent or any of its Subsidiaries is or has been a member) has granted any extension or waiver of the limitation
period applicable to the assessment or collection of any federal income Tax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There is no Proceeding (including any audit) pending or, to Parent&rsquo;s knowledge, threatened in writing against or with respect
to Parent or its Subsidiaries in respect of any Tax or Tax asset.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There are no requests for rulings or determinations in respect of any Tax or Tax asset pending between Parent or any of its Subsidiaries
and any Taxing Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>During the two (2)-year period ending on the date of this Agreement, Parent was not a distributing corporation or a controlled
corporation in a transaction intended to be governed by Section 355 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>There are no Liens for Taxes (other than Permitted Liens) upon any of the assets of Parent or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 57; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No claim has been made in writing by any Taxing Authority in a jurisdiction where Parent or any of Parent&rsquo;s Subsidiaries
does not file Tax Returns that Parent or any such Subsidiary is or may be subject to taxation by, or required to file any Tax Return in,
that jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither Parent nor any of its Subsidiaries (i) has been a member of an affiliated, consolidated, combined or unitary group other
than one of which Parent or any of its Subsidiaries was the common parent, (ii) is party to any Tax Sharing Agreement (other than any
such agreement solely between Parent and its Subsidiaries), or (iii) has any liability for the Taxes of any Person (other than Parent
or any of its Subsidiaries) under Treasury Regulation Section 1.1502-6 (or any similar provision of state, local or non-U.S. law) or any
Tax Sharing Agreement, or as a transferee or successor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither Parent <FONT STYLE="color: windowtext">nor any of its Subsidiaries has taken or agreed to take any action or has knowledge
of any fact or circumstance that could reasonably be expected to prevent the Mergers, taken together, from qualifying as a &ldquo;reorganization&rdquo;
within the meaning of Section 368(a) of the Code and the Treasury Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All of the equity interests in Second Merger Sub will be owned by Parent, and Second Merger Sub will be, since formation, disregarded
as an entity (within the meaning of Section 301.7701-3 of the Treasury Regulations) separate from Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.17.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Employees and Employee Benefit Plans</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Neither Parent nor any of its ERISA Affiliates (nor any predecessor of any such entity) sponsors, maintains, administers or contributes
to (or has any obligation to contribute to), or in the past six years has, sponsored, maintained, administered or contributed to (or had
any obligation to contribute to), any plan subject to Title IV of ERISA, including any multiemployer plan, as defined in Section 3(37)
of ERISA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each Parent Employee Plan that is intended to be qualified under Section 401(a) of the Code has received a favorable determination
or opinion letter from the IRS or has applied to the IRS for such a letter within the applicable remedial amendment period or such period
has not expired and, to the knowledge of Parent, no circumstances exist that would reasonably be expected to result in any such letter
being revoked or not being reissued or a penalty under the IRS Closing Agreement Program if discovered during an IRS audit or investigation.
Each trust created under any such Parent Employee Plan is exempt from tax under Section 501(a) of the Code and has been so exempt since
its creation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse
Effect, since January 1, 2023, each Parent Employee Plan has been maintained in compliance with its terms and all Applicable Law. Except
as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, no Proceeding
(other than routine claims for benefits and including an audit) is pending against or involves or, to Parent&rsquo;s knowledge, is threatened
against or reasonably expected to involve, any Parent Employee Plan before any court or arbitrator or any Governmental Authority. To the
knowledge of Parent, since January 1, 2023, no events have occurred with respect to any Parent Employee Plan that would reasonably be
expected to result in the assessment</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 58; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">of any excise taxes
or penalties against Parent or any of its Subsidiaries, except for events that have not had and would not reasonably be expected to have,
individually or in the aggregate, a Parent Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>With respect to any Parent Employee Plan covered by Subtitle B, Part 4 of Title I of ERISA or Section 4975 of the Code, no non-exempt
prohibited transaction has occurred that has caused or would reasonably be expected to cause Parent or any of its Subsidiaries to incur
any material liability under ERISA or the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.18.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Labor Matters</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as would not be material to Parent and its Subsidiaries, taken as a whole, neither Parent nor any of its Subsidiaries is,
or since January 1, 2023 has been, a party to or subject to, or is currently negotiating in connection with entering into, any collective
bargaining agreement, and there have not been any, and to Parent&rsquo;s knowledge there are no threatened, organizational campaigns,
card solicitations, petition or other unionization activity seeking recognition of a collective bargaining unit relating to any current
or former Parent Service Provider. Except as has not had and would not reasonably be expected to have, individually or in the aggregate,
a Parent Material Adverse Effect, there are no unfair labor practice complaints pending or, to Parent&rsquo;s knowledge, threatened against
the Parent or any of its Subsidiaries before the National Labor Relations Board or any other Governmental Authority or any current union
representation questions involving any current or former Parent Service Provider with respect to Parent or its Subsidiaries. Except as
would not be material to Parent and its Subsidiaries, taken as a whole, there is no labor strike, slowdown, stoppage, picketing, interruption
of work or lockout pending or, to the Parent&rsquo;s knowledge, threatened against or affecting Parent or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Since January 1, 2023, (i), no allegations of sexual harassment or other sexual misconduct have been made against any Parent Service
Provider with the title of managing director or above and (ii) there are no Actions pending or, to Parent&rsquo;s knowledge, threatened
related to any allegations of sexual harassment or other sexual misconduct by any Parent Service Provider with the title of managing director
or above. Since January 1, 2023, neither Parent nor any of its Subsidiaries have entered into any settlement agreements related to allegations
of sexual harassment or other sexual misconduct by any Parent Service Provider with the title of managing director or above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Parent and each of its Subsidiaries is, and has been since January 1, 2023, in material compliance with WARN and has no liabilities
or other obligations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.19.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Intellectual Property</I>. (a) Except as has not had and would not reasonably be expected to have, individually or in the aggregate,
a Parent Material Adverse Effect, none of the registrations (including patents and domain name registrations) and applications for registration
for Parent&rsquo;s Owned Intellectual Property (the &ldquo;<FONT STYLE="color: windowtext"><B>Parent Registered IP</B></FONT>&rdquo;)
has lapsed, expired, been abandoned or been adjudged invalid or unenforceable, and, to the knowledge of Parent, all Parent Registered
IP is valid, enforceable and subsisting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse
Effect, (i) Parent and its Subsidiaries are the sole</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 59; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">and exclusive owners
of all of Parent&rsquo;s Owned Intellectual Property and hold all of their right, title and interest in and to all of Parent&rsquo;s Owned
Intellectual Property free and clear of all Liens (other than non-exclusive licenses granted by Parent or one of its Subsidiaries in the
ordinary course of business and Permitted Liens), (ii) immediately following the Closing, Parent and its Subsidiaries will own or have
a valid and enforceable license to use any and all of the Intellectual Property necessary to, or used or held for use in, the conduct
of the respective businesses of Parent and its Subsidiaries as currently conducted, and (iii)&nbsp;to the knowledge of Parent, there exist
no material restrictions on the use of any of Parent&rsquo;s Owned Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse
Effect, no current or former employee, contractor or consultant of Parent or any of its Subsidiaries owns any rights in or to any of Parent&rsquo;s
Owned Intellectual Property and, to the extent that any such Intellectual Property has been developed or created by any Third Party (including
any current or former employee, contractor or consultant) for or on behalf of Parent or any of its Subsidiaries, Parent or one of its
Subsidiaries, as applicable, has a written agreement with such Third Party with respect thereto, and thereby either (i) has obtained ownership
of and is the exclusive owner of, or (ii) has obtained a valid right to exploit, sufficient for the conduct of the business of Parent
and its Subsidiaries as currently conducted, such Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse
Effect, (i) to the knowledge of Parent, since January 1, 2023, neither Parent nor any of its Subsidiaries nor the conduct of their respective
businesses has infringed, misappropriated, diluted or otherwise violated any Intellectual Property rights of any Third Party, (ii)&nbsp;there
is no Proceeding pending or, to the knowledge of Parent, threatened against or affecting Parent or any of its Subsidiaries (A) alleging
that Parent or any of its Subsidiaries has infringed, misappropriated, diluted or otherwise violated any Intellectual Property rights
of any Third Party or (B) based upon, or challenging or seeking to deny or restrict, the rights of Parent or any Subsidiary of Parent
in any of Parent&rsquo;s Owned Intellectual Property, and (iii) to the knowledge of Parent, no Third Party has infringed, misappropriated,
diluted or otherwise violated any of Parent&rsquo;s Owned Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse
Effect, (i) Parent and its Subsidiaries have provided reasonable notice of its privacy and personal data collection and use policies on
its websites and through other customer and public communications and Parent and its Subsidiaries have complied with such policies, contractual
requirements and all Applicable Law relating to (A) the privacy of the users of Parent&rsquo;s and its Subsidiaries&rsquo; respective
products, services and websites and (B) the collection, use, processing, storage and disclosure of any personally-identifiable information
(including personal health information and any and all &ldquo;personal data&rdquo; as that term is defined in European Union&rsquo;s General
Data Protection Regulation and any and all other information, the collection, use, processing, storage and disclosure of which is regulated
by an Applicable Law in relation to data protection or data privacy) and other data or information collected, used, processed, stored
or disclosed by Parent or any of its Subsidiaries (or, to the knowledge of the Parent, any Third Party that collects, uses, processes,
stores or discloses such data or information on behalf of Parent or any of its Subsidiaries), (ii) there is no Proceeding pending or,
to the knowledge of Parent, threatened against Parent or any of its Subsidiaries (or, to the knowledge of the Parent, against any</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 60; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">Third Party working
on behalf of Parent or any of its Subsidiaries) alleging any violation of such policies, contractual requirements or Applicable Law, (iii)&nbsp;none
of this Agreement or the consummation of the Transactions will violate any such policy, contractual requirements or Applicable Law and
(iv) Parent and its Subsidiaries (and any Third Party working on behalf of Parent and its Subsidiaries) have taken commercially reasonable
steps consistent with normal industry practice to protect the types of information referred to in this Section&nbsp;&lrm;5.19(e) against
loss and unauthorized access, use, modification, disclosure or other misuse, and, to the knowledge of Parent, there has been no unauthorized
access, use, modification, disclosure or other misuse of such data or information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse
Effect, (i) Parent&rsquo;s IT Assets perform in a manner that permits Parent and its Subsidiaries to conduct their respective businesses
as currently conducted, (ii)&nbsp;Parent and its Subsidiaries take commercially reasonable actions, consistent with current industry standards,
to protect the confidentiality, integrity and security of Parent&rsquo;s IT Assets (and all information and transactions stored or contained
therein or transmitted thereby) against any unauthorized use, access, interruption, modification or corruption, including the implementation
of commercially reasonable data backup, disaster avoidance and recovery procedures and business continuity procedures, and (iii) to the
knowledge of the Parent, there has been no unauthorized use, access, interruption, modification or corruption of Parent&rsquo;s IT Assets
(or any information or transactions stored or contained therein or transmitted thereby).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.20.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Properties</I>. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent
Material Adverse Effect, (i) Parent and its Subsidiaries have good, valid and marketable fee simple title (or its jurisdictional equivalent)
to, or valid leasehold interests in, as the case may be, each parcel of real property owned or used by Parent or any of its Subsidiaries,
free and clear of all Liens, except for Permitted Liens, (ii) each Lease under which Parent or any of its Subsidiaries leases, subleases
or licenses any real property is, subject to the Bankruptcy and Equity Exceptions, a valid and binding obligation of Parent or a Subsidiary
of Parent (as the case may be) and, to the knowledge of Parent, each of the other parties thereto, and in full force and effect and enforceable
in accordance with its terms against Parent or its Subsidiaries (as the case may be) and, to the knowledge of Parent, each of the other
parties thereto (except for such Leases that are terminated after the date of this Agreement in accordance with their respective terms;
<I>provided </I>that if such termination is at the option of Parent or any of its Subsidiaries such termination must be in the ordinary
course of business), (iii) neither Parent nor any of its Subsidiaries, nor, to the knowledge of Parent, any of the other parties thereto
has violated or committed or failed to perform any act which (with or without notice, lapse of time or both) would constitute a default
under any provision of any Lease, and (iv) neither Parent nor any of its Subsidiaries has received written notice that it has breached,
violated or defaulted under any Lease, nor has Parent or any of its Subsidiaries delivered notice to any other party to a Lease that such
other party has breached, violated or defaulted under any Lease that remains uncured as of the date hereof. Except as has not had and
would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, the real property owned
or used by Parent or any of its Subsidiaries and any plants, buildings, structures and equipment thereon owned or leased by Parent and
its Subsidiaries have no defects, are in good operating condition and repair and have been maintained consistent with standards generally
followed in the industry (given due account to the age and length of use of same, ordinary wear and tear excepted), are adequate and suitable</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 61; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">for their present use. Except as has not had and
would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, Parent and its Subsidiaries
are in possession of and have good title to, or valid leasehold interests in or valid rights under contract to use, the material machinery,
equipment, furniture, fixtures and other tangible material personal property and assets used by Parent or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.21.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Environmental Matters</I>. Except as has not had and would not reasonably be expected to have, individually or in the aggregate,
a Parent Material Adverse Effect:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>no notice, notification, demand, request for information, citation, summons or order has been received, no complaint has been filed,
no penalty has been assessed, and no Proceeding (including a review) is pending or, to the knowledge of Parent, threatened by any Governmental
Authority or other Person relating to Parent or any of its Subsidiaries that relates to, or arises under, any Environmental Law, Environmental
Permit or Hazardous Substance;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Parent and its Subsidiaries are, and since January 1, 2023 have been, in compliance with all Environmental Laws and all Environmental
Permits and hold all applicable Environmental Permits; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>there are no liabilities or obligations of Parent or any of its Subsidiaries of any kind whatsoever, whether accrued, contingent,
absolute, determined, determinable or otherwise arising under or relating to any Environmental Law, Environmental Permit or Hazardous
Substance and there is no existing condition, situation or set of circumstances that could reasonably be expected to result in any such
liability or obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.22.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Antitakeover Statutes</I>. Parent has no &ldquo;rights plan,&rdquo; &ldquo;rights agreement,&rdquo; or &ldquo;poison pill&rdquo;
in effect. Assuming the representations and warranties set forth in Section&nbsp;&lrm;4.27 are true and correct, no &ldquo;control share
acquisition,&rdquo; &ldquo;fair price,&rdquo; &ldquo;moratorium&rdquo; or other antitakeover laws enacted under U.S. state or federal
laws apply to this Agreement or any of the Transactions with respect to Parent and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.23.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Finders&rsquo; Fees</I>. There is no investment banker, broker, finder or other intermediary that has been retained by or is authorized
to act on behalf of Parent or any of its Subsidiaries who might be entitled to any fee or commission from Parent or any of its Affiliates
in connection with the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.24.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Ownership of Company Stock</I>. Neither Parent nor any Subsidiary of Parent beneficially owns, directly or indirectly, any shares
of Company Stock or other securities convertible into, exchangeable for or exercisable for shares of Company Stock&nbsp;&nbsp;and neither
Parent nor any of its Subsidiaries has any rights to acquire any shares of Parent Common Stock. There are no voting trusts or other agreements
or understandings to which Parent or any Subsidiary of Parent is a party with respect to the voting of the capital stock or other equity
interest of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;5.25.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Other Parent Representations and Warranties</I>. Except for the representations and warranties made by Parent in this Article&nbsp;&lrm;5
(as qualified by the applicable items disclosed in the Parent Disclosure Schedule in accordance with Section&nbsp;&lrm;11.05 and the introduction
to this Article&nbsp;&lrm;5), neither Parent nor any other Person makes or has made any</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 62; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">representation or warranty, expressed or implied,
at law or in equity, with respect to or on behalf of Parent or its Subsidiaries, or the accuracy or completeness of any information regarding
Parent or its Subsidiaries or any other matter furnished or provided to the Company or made available to the Company in any &ldquo;data
rooms,&rdquo; &ldquo;virtual data rooms,&rdquo; management presentations or in any other form in expectation of, or in connection with,
this Agreement or the Transactions. Parent and its Subsidiaries disclaim any other representations or warranties, whether made by Parent
or any of its Subsidiaries or any of their respective Affiliates or Representatives. Parent acknowledges and agrees that, except for the
representations and warranties made by the Company in Article&nbsp;&lrm;4 (as qualified by the applicable items disclosed in the Company
Disclosure Schedule in accordance with Section&nbsp;&lrm;11.05 and the introduction to Article&nbsp;&lrm;4), neither the Company nor any
other Person is making or has made any representations or warranty, expressed or implied, at law or in equity, with respect to or on behalf
of the Company or its Subsidiaries, or the accuracy or completeness of any information regarding the Company or its Subsidiaries or any
other matter furnished or provided to Parent or made available to Parent in any &ldquo;data rooms,&rdquo; &ldquo;virtual data rooms,&rdquo;
management presentations or in any other form in expectation of, or in connection with, this Agreement, or the transactions contemplated
hereby or thereby. Parent specifically disclaims that it is relying upon or has relied upon any such other representations or warranties
that may have been made by any Person, and acknowledges and agrees that the Company and its Affiliates have specifically disclaimed and
do hereby specifically disclaim any such other representations and warranties. Notwithstanding the foregoing, this Section&nbsp;&lrm;5.25
shall not limit Parent&rsquo;s, Merger Sub&rsquo;s or the Company&rsquo;s remedies in the case of fraud.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article&nbsp;6</FONT><U><BR>
Covenants of the Company</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;6.01.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Conduct of the Company</I>. From the date of this Agreement until the earlier of the Effective Time and the valid termination of
this Agreement, except (x) as required by Applicable Law, (y) as set forth in Section&nbsp;&lrm;6.01 of the Company Disclosure Schedule,
or (z) as otherwise required or expressly permitted by this Agreement, unless Parent shall otherwise consent in writing (e-mail being
sufficient) (which consent shall not be unreasonably withheld, conditioned or delayed), the Company shall, and shall cause each of its
Subsidiaries to, conduct its business in the ordinary course of business consistent with past practice and use its commercially reasonable
efforts to (A) preserve intact its business organization and relationships with customers, members, suppliers, lenders, licensors, licensees,
Governmental Authorities with jurisdiction over the Company&rsquo;s operations and other Third Parties having material business relationships
with the Company and its Subsidiaries and (B) maintain in effect all material Company Permits. Without limiting the generality of the
foregoing, from the date of this Agreement until the earlier of the Effective Time and the valid termination of this Agreement, except
(x) as required by Applicable Law, (y) as set forth in Section&nbsp;&lrm;6.01 of the Company Disclosure Schedule, or (z) as otherwise
required or expressly permitted by this Agreement, without Parent&rsquo;s prior written consent (which consent shall not be unreasonably
withheld, conditioned or delayed (other than with respect to Section 6.01(c) or Section 6.01(d)), the Company shall not, and shall cause
each of its Subsidiaries not to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>adopt or propose any change to its certificate of incorporation, bylaws or other organizational documents (whether by merger, consolidation
or otherwise) (including the Company Organizational Documents);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 63; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) merge or consolidate with any other Person, (ii) acquire (including by merger, consolidation, or acquisition of stock or assets)
any interest in any corporation, partnership, other business organization or any division thereof or any assets, securities or property,
other than (A)&nbsp;acquisitions of assets, securities or property in the ordinary course of business consistent with past practice in
an amount not to exceed $500,000 in the aggregate for all such acquisitions, (B) acquisitions of Bitcoin consistent with the Company&rsquo;s
investment policy in effect as of the date hereof, and (C) transactions (1) solely among the Company and one or more of its wholly owned
Subsidiaries or (2) solely among the Company&rsquo;s wholly owned Subsidiaries, or (iii) adopt or publicly propose a plan of complete
or partial liquidation, dissolution, recapitalization, restructuring or other reorganization, or resolutions providing for or authorizing
such a liquidation, dissolution, recapitalization, restructuring or other reorganization;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) split, combine or reclassify any Company Securities (whether by merger, consolidation or otherwise) (other than transactions
(1)&nbsp;solely among the Company and one or more of its wholly owned Subsidiaries or (2) solely among the Company&rsquo;s wholly owned
Subsidiaries), (ii) amend any term or alter any rights of any of Company Securities (whether by merger, consolidation or otherwise), (iii)
declare, set aside or pay or make any dividend or any other distribution (whether in cash, stock, property or any combination thereof)
in respect of any Company Securities or Company Subsidiary Securities (other than dividends or distributions by a Subsidiary of the Company
to the Company or a wholly owned Subsidiary of the Company) (in the case of this clause&nbsp;(iii), other than dividends or distributions
by a Subsidiary of the Company to the Company or a Subsidiary of the Company), or (iv)&nbsp;redeem, repurchase, cancel or otherwise acquire
or offer to redeem, repurchase, or otherwise acquire any Company Securities or Company Subsidiary Securities, other than repurchases of
shares of Company Stock in connection with the exercise of Company Options in accordance with the terms the Company Stock Plans and of
such Company Equity Awards;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>issue, deliver or sell, or authorize the issuance, delivery or sale of, any Company Securities or Company Subsidiary Securities,
other than (i) the issuance of any shares of Company Stock upon the exercise of Company Options in accordance with the terms of the Company
Stock Plans and such Company Equity Awards or (ii) the issuance of any Company Subsidiary Securities to the Company or any wholly owned
Subsidiary of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>authorize, make or incur any capital expenditures or obligations or liabilities in connection therewith, other than (i) as contemplated
by the capital expenditure budget that has been made available to Parent prior to the date of this Agreement and is set forth on Section
&lrm;6.01(e) of the Company Disclosure Schedule and (ii) any other capital expenditures not to exceed $500,000 in the aggregate;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>sell, lease, license, sublicenses, transfer or otherwise dispose of (by merger, consolidation, sale of stock or assets or otherwise),
or fail to take any action necessary to maintain, enforce or protect, directly or indirectly, any Subsidiary or any division thereof or
of the Company or any assets, securities, interests, businesses or property, other than (i) in the ordinary course of business consistent
with past practice for fair market value in an amount not to exceed $500,000 in the aggregate (<I>provided</I>, that this clause (i) shall
not apply to Bitcoin), or (ii) transactions (A) solely among the Company and one or more of its wholly owned Subsidiaries or (B) solely
among the Company&rsquo;s wholly owned Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 64; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>sell, assign, license, sublicense, abandon, allow to lapse, transfer or otherwise dispose of (by merger, consolidation, sale of
stock or assets or otherwise), create or incur any Lien (other than a Permitted Lien) on or otherwise fail to take any action necessary
to maintain, enforce or protect, directly or indirectly, any of the Company&rsquo;s material Owned Intellectual Property or Licensed Intellectual
Property, other than in the ordinary course of business consistent with past practice (i)&nbsp;pursuant to non-exclusive licenses or (ii)&nbsp;for
the purpose of disposing of obsolete or worthless assets;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) make any loans or extensions of credit in excess of $1,000,000 in a single transaction or renewals of loans or extensions of
credit in excess of $1,000,000, in each case, or make any advances or capital contributions to, or investments in, any other Person, other
than loans, advances or capital contributions (A) by the Company to one or more of its wholly owned Subsidiaries or (B) by any Subsidiary
of the Company to the Company or any wholly owned Subsidiary of the Company, or (ii) incur, assume, suffer to exist or otherwise be liable
with respect to, or guarantee or repurchase, or enter into any Contract with respect to (in each case, whether evidenced by a note or
other instrument, pursuant to an issuance of debt securities, financing lease, sale-leaseback transaction or otherwise), any indebtedness
for borrowed money;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>create or incur any Lien (except for a Permitted Lien) on any material asset other than Liens created or incurred under the Company
Notes and Liens on assets subject to capital leases entered into in the ordinary course of business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) enter into any Company Material Contract (including (x) by amendment of any Contract that is not a Company Material Contract
such that such Contract becomes a Company Material Contract or (y) through acquisition of a subsidiary that is bound by a Company Material
Contract) (in each case, other than in the ordinary course of business with respect to a Company Material Contract solely of a type described
in Section 4.17(a)(i), Section 4.17(a)(iv), Section 4.17(a)(v), Section 4.17(a)(vii) and, to the extent permitted under Section 6.01(b)(ii)(C),
Section 4.17(ix)), (ii)&nbsp;terminate, renew, extend or amend in any material respect any Company Material Contract or waive any material
right thereunder (other than in the ordinary course of business with respect to a Company Material Contract described in Section 4.17(a)(i)
and not described in any other clause of Section 4.17(a));</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>terminate, amend or modify any material Company Permit in a manner material and adverse to the Company and its Subsidiaries, taken
as a whole;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>except as required by any Company Employee Plan as in effect as of the date hereof, (i) grant any change in control, retention,
severance or termination pay to (or amend any existing arrangement with) any of their respective current or former Company Service Providers,
(ii) except as in the ordinary course of business consistent with past practices with Company Service Providers other than Key Employees,
enter into any employment, offer letter, term sheet, deferred compensation or other similar agreement (or any amendment to any such existing
agreement) with any of their respective current or former Company Service Providers, (iii) establish, adopt, amend or enter into any material
Company Employee Plan, other than in connection with routine, immaterial or ministerial amendments to health and welfare plans that do
not materially increase benefits or result in a material increase in administrative costs, (iv) grant any equity or equity-based awards
to, or discretionarily accelerate the vesting or payment of any such awards held by,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 65; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">any current or former
Company Service Provider, (v) increase the compensation, bonus or other benefits payable to any of their respective current or former
Company Service Providers, (vi) hire any Key Employees or (vii) terminate (other than for cause) any Key Employees or provide any Key
Employees with the right to resign with &ldquo;good reason&rdquo; or term of similar meaning;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>make any material change in any method of accounting or accounting principles or practice, except for any such change required
by reason of a change in GAAP or Regulation S-X under the Securities Exchange Act (&ldquo;<FONT STYLE="color: windowtext"><B>Regulation
S-X</B></FONT>&rdquo;), as approved by its independent public accountants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>enter into any material new line of business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) make or change any material Tax election; (ii) change any annual Tax accounting period; (iii) adopt or change any material
method of Tax accounting; (iv) enter into any material closing agreement with respect to Taxes; or (v) settle or surrender (including
by entering into a closing agreement) any material Tax claim, audit or assessment;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>settle or compromise, or offer or propose to settle or compromise, any claim, action, suit, dispute, investigation, regulatory
examination, arbitration, or other Proceeding, whether pending or threatened, (i) involving or against the Company or any of its Subsidiaries,
other than in the ordinary course of business consistent with past practice (<I>provided</I> that any individual settlement or compromise
or any series of related settlements or compromises involving payments by the Company and its Subsidiaries in excess of $250,000 individually
or $1,000,000 in the aggregate (in each case, net of any amounts that may be paid under one or more existing insurance policies) or providing
for any non-monetary relief shall be deemed not to be in the ordinary course of business), (ii) that relates to the Transactions or (iii)
initiated by a stockholder of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>enter into or materially expand any business outside of the U.S. and its territories; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>agree, resolve, authorize, commit or propose to do any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;6.02.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Access to Information; Confidentiality</I>. (a) From the date of this Agreement to the earlier of the Effective Time or the termination
of this Agreement, upon reasonable notice and subject to Applicable Law, (A) the Company shall, and shall cause each of its Subsidiaries
to, afford to Parent and its Representatives (for purposes of this Section 6.02, as defined in the Confidentiality Agreement), reasonable
access, during normal business hours, to all of its offices, properties, books, contracts and records and (B) each party shall, and shall
cause each of its respective Subsidiaries to, (i) make available to the other party and its respective Representatives all other information
concerning such Person&rsquo;s businesses, properties and personnel as such party may reasonably request (including in connection with
the preparation of the Registration Statement) and (iii) and instruct its respective Representatives to reasonably cooperate with such
party&rsquo;s investigation; <I>provided</I> that, notwithstanding anything to the contrary, neither Parent nor any of its Representatives
shall be required to provide the Company or any of its Representatives any projections, forecasts, estimates or predictions in respect
of revenues, earnings or other financial or operating metrics for any period or otherwise provide financial information that is not prepared
internally in the ordinary course of business. All information furnished pursuant to this Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 66; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">shall be subject to the mutual confidentiality
agreement, dated as of September 19, 2025, between Parent and the Company (the &ldquo;<B>Confidentiality Agreement</B>&rdquo;).&nbsp;&nbsp;No
information or knowledge obtained in any investigation pursuant to this Section 6.02 shall affect or be deemed to modify any representation
or warranty made by the Company or Parent pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything to the contrary in this Section&nbsp;&lrm;6.02, Section&nbsp;&lrm;8.01 or Section&nbsp;&lrm;8.02, neither
party nor any of its respective Subsidiaries shall be required to provide access to its offices, properties, books, contracts, records
or personnel if such access would unreasonably disrupt its operations, or provide access to or to disclose information where such access
or disclosure could reasonably be expected to result in the loss the attorney-client privilege of such party or any of its Subsidiaries
or contravene any Applicable Law or Contract entered into prior to the date of this Agreement; <I>provided</I> that each party shall,
and shall cause its respective Subsidiaries to, use commercially reasonable efforts to make appropriate substitute disclosure arrangements
under circumstances in which such restrictions apply; <I>provided, however</I>, that in no event shall either party have access to individual
performance or evaluation records, medical histories or other similar information that in the reasonable opinion of the other party the
disclosure of which would reasonably be expected to subject such party or any of its Subsidiaries to risk of liability. Each of Parent
and the Company agrees that it will not, and will instruct its Representatives not to, use any information obtained pursuant to this Section
&lrm;6.02 for any competitive or other purpose unrelated to the consummation of the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each party shall instruct its external auditors to cooperate with the other party&rsquo;s external auditors as soon as reasonably
practicable to agree on the necessary processes and procedures that are required to be undertaken by each of them in relation to the preparation
of the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;6.03.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No Solicitation by the Company</I>. (a) From the date of this Agreement until the earlier of the Effective Time and the termination
of this Agreement in accordance with its terms, except as otherwise set forth in this Section&nbsp;&lrm;6.03, the Company shall not, and
shall cause its Subsidiaries, and its and its Subsidiaries&rsquo; officers, directors and employees, investment bankers, attorneys, accountants,
consultants and other agents, advisors and representatives (collectively, &ldquo;<FONT STYLE="color: windowtext"><B>Representatives</B></FONT>&rdquo;),
not to, directly or indirectly, (i) solicit, initiate or take any action to knowingly facilitate or knowingly encourage the submission
of any Company Acquisition Proposal, (ii) enter into or participate in any discussions or negotiations with, furnish any information relating
to the Company or any of its Subsidiaries or afford access to the business, properties, assets, books or records of the Company or any
of its Subsidiaries to, otherwise knowingly cooperate in any way with, or knowingly assist, participate in, facilitate or knowingly encourage
any effort by, any Third Party that the Company knows, or should reasonably be expected to know, is seeking to make, or has made, a Company
Acquisition Proposal, (iii) (A) (x) fail to make, (y) withdraw or (z) qualify, amend or modify in any manner adverse to Parent, the Company
Board Recommendation (it being understood that any failure to publicly and without qualification either (x) recommend against such Company
Acquisition Proposal or (y) reaffirm the Company Board Recommendation, in each case, within ten (10) Business Days after a Company Acquisition
Proposal is made public or any request by Parent to do so will be treated as a withdrawal of the Company Board Recommendation that is
adverse to Parent for purposes hereof), (B) fail to make, or to include in the Information Statement/Proxy Statement/Prospectus, the Company
Board Recommendation or (C)&nbsp;recommend, adopt or approve or publicly propose to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 67; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">recommend, adopt or approve any Company Acquisition
Proposal (any of the foregoing in this clause&nbsp;(iii), a &ldquo;<B>Company Adverse Recommendation Change</B>&rdquo;), (iv) take any
action to make any &ldquo;moratorium,&rdquo; &ldquo;control share acquisition,&rdquo; &ldquo;fair price,&rdquo; &ldquo;supermajority,&rdquo;
&ldquo;affiliate transactions&rdquo; or &ldquo;business combination statute or regulation&rdquo; or other similar anti-takeover laws and
regulations of the State of Delaware, including Section 203 of the Delaware Law, inapplicable to any Third Party or any Company Acquisition
Proposal, or (v)&nbsp;fail to enforce, amend or grant any waiver or release under any standstill or similar agreement with respect to
any class of equity securities of the Company or any of its Subsidiaries (<I>provided </I>that if the Board of Directors of the Company
determines in good faith that failure to take such action would be reasonably likely to be inconsistent with its fiduciary duties under
Applicable Law, then (I) the Company may waive any such standstill or similar agreement to the extent necessary to permit the Person bound
by such provision or agreement to make a Company Acquisition Proposal to the Board of Directors of the Company and (II) concurrently with
such waiver by the Company, any standstill or similar provisions in the Confidentiality Agreement shall immediately and automatically
cease to be of any force or effect). Any breach or willful breach of the restrictions on the Company set forth in this Section 6.03(a)
by any Subsidiary of the Company or any of its or their respective Representatives shall be deemed to be a breach or willful breach (as
applicable) of this Section 6.03(a) by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding Section&nbsp;&lrm;6.03(a), if at any time prior to the receipt of the Company Stockholder Approval (the &ldquo;<FONT STYLE="color: windowtext"><B>Company
Approval Time</B></FONT>&rdquo;) (and in no event after the Company Approval Time), the Board of Directors of the Company receives a <I>bona
fide</I> written Company Acquisition Proposal made after the date hereof which has not resulted from a material breach of this Section&nbsp;&lrm;6.03,
the Board of Directors of the Company may, subject to compliance with this Section&nbsp;&lrm;6.03(b), Section&nbsp;&lrm;6.03(c) and Section&nbsp;&lrm;6.03(e),
(i) engage in negotiations or discussions with any Third Party that, subject to the Company&rsquo;s compliance with Section&nbsp;&lrm;6.03(a),
has made after the date of this Agreement an unsolicited <I>bona fide</I> written Company Acquisition Proposal that the Board of Directors
of the Company determines in good faith, after consultation with its financial advisor and outside legal counsel to the Company, constitutes
or would reasonably be expected to lead to a Company Superior Proposal, and (ii) thereafter furnish to such Third Party and its Representatives
and financing sources nonpublic information relating to the Company or any of its Subsidiaries pursuant to a confidentiality agreement
with terms (including &ldquo;standstill&rdquo; or similar terms) no less favorable to the Company than those contained in the Confidentiality
Agreement, a copy of which shall be provided, promptly after its execution, to Parent for informational purposes; <I>provided</I> that
all such non-public information (to the extent that such information has not been previously provided or made available to Parent) is
provided or made available to Parent, as the case may be, prior to or substantially concurrently with the time it is provided or made
available to such Third Party, but in each case referred to in the foregoing clauses&nbsp;(i) through (ii) only if the Board of Directors
of the Company determines in good faith, after consultation with the Company&rsquo;s outside legal counsel and its financial advisor,
that the failure to take such action would reasonably be expected to be inconsistent with its fiduciary duties under Applicable Law. Nothing
contained herein shall prevent the Board of Directors of the Company from (A) complying with Rule 14e-2(a) under the Securities Exchange
Act with regard to a Company Acquisition Proposal, so long as any action taken or statement made to so comply is consistent with this
Section&nbsp;&lrm;6.03 or (B) making any required disclosure to the stockholders of the Company if the Board of Directors of the Company
determines in good faith, after consultation with its outside legal counsel, that failure to take such action would reasonably be expected
to be</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 68; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">inconsistent with
Applicable Law; <I>provided</I> that any Company Adverse Recommendation Change involving or relating to a Company Acquisition Proposal
may only be made in accordance with the provisions of this Section&nbsp;&lrm;6.03(b), Section&nbsp;&lrm;6.03(c) and Section&nbsp;&lrm;6.03(e)
and, even if permitted by this sentence, shall have the consequences set forth in this Agreement. For the avoidance of doubt, issuing
a &ldquo;stop, look and listen&rdquo; disclosure or similar communication of the type contemplated by Rule 14d-9(f) under the Securities
Exchange Act shall not be a Company Adverse Recommendation Change.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In addition to the requirements set forth in Section&nbsp;&lrm;6.03(b), the Board of Directors of the Company shall not take any
of the actions referred to in clauses&nbsp;(i) through (iii) of Section&nbsp;&lrm;6.03(b), other than interacting with the Person who
made such Company Acquisition Proposal and its Representatives solely to clarify the terms and conditions thereof, unless the Company
shall have first delivered to Parent written notice advising Parent that the Company intends to take such action. In addition, the Company
shall notify Parent promptly (but in no event later than twenty-four (24) hours) after receipt by the Company (or any of its Representatives)
of (i) any Company Acquisition Proposal or (ii) any written request for information relating to the Company or any of its Subsidiaries
or for access to the business, properties, assets, books or records of the Company or any of its Subsidiaries by any Third Party that,
to the knowledge of the Company or any member of its Board of Directors, is considering making, is reasonably likely to make or has made,
a Company Acquisition Proposal, which notice shall be provided in writing and shall identify the relevant Third Party and, to the extent
known, the material terms and conditions of, any such Company Acquisition Proposal (including any material changes thereto). The Company
shall keep Parent reasonably informed, on a reasonably current basis, of the status and details of any such Company Acquisition Proposal
(including any changes thereto) and shall promptly (but in no event later than twenty-four (24) hours after receipt) provide to Parent
copies of all material correspondence and written materials sent or provided to the Company or any of its Affiliates that describes any
material terms or conditions of any Company Acquisition Proposal (as well as written summaries of any material oral communications addressing
such matters).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything in this Agreement to the contrary, at any time prior to the Company Approval Time (and in no event after
the Company Approval Time), the Board of Directors of the Company may effect a Company Adverse Recommendation Change involving or relating
to the occurrence of a Company Intervening Event if the Board of Directors of the Company determines in good faith, after consultation
with the Company&rsquo;s outside legal counsel and financial advisor, that the failure to take such action would reasonably be expected
to be inconsistent with its fiduciary duties under Applicable Law; <I>provided</I> that (i) the Company shall (A)&nbsp;promptly notify
Parent in writing of its intention to take such action (which notice shall set forth in reasonable detail a description of the Company
Intervening Event and the rationale for the Company Adverse Recommendation Change) and (B) negotiate in good faith with Parent (to the
extent Parent wishes to so negotiate) for five (5) Business Days following such notice regarding revisions to the terms of this Agreement
proposed by Parent, and (ii) the Board of Directors of the Company shall not effect any Company Adverse Recommendation Change involving
or relating to a Company Intervening Event unless, after the five (5) Business Day period described in the foregoing clause&nbsp;(B),
the Board of Directors of the Company determines in good faith by majority vote, after consultation with the Company&rsquo;s outside legal
counsel and financial advisor, that the failure to take such action would be reasonably likely to be inconsistent with its fiduciary duties
under Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 69; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Without limiting or affecting Section&nbsp;&lrm;6.03(a), Section&nbsp;&lrm;6.03(b) or Section&nbsp;&lrm;6.03(c), the Board of Directors
of the Company shall not make a Company Adverse Recommendation Change involving or relating to a Company Superior Proposal unless (i)
the Company promptly notifies Parent, in writing at least four (4) Business Days before taking such action, that the Company intends to
take such action, which notice attaches the most current version of any proposed agreement or a reasonably detailed summary of all material
terms of such Company Superior Proposal and the identity of the Third Party making such Company Superior Proposal, (ii) if requested by
Parent, during such four (4) Business Day period, the Company and its Representatives have discussed and negotiated in good faith with
Parent regarding any proposal by Parent to amend the terms of this Agreement in response to such Company Superior Proposal and (iii) after
such four (4) Business Day period, the Board of Directors of the Company, after discussions with the Company&rsquo;s outside legal counsel
and financial advisor, determines in good faith, taking into account any proposal by Parent to amend the terms of this Agreement, that
such Company Acquisition Proposal continues to constitute a Company Superior Proposal (it being understood and agreed that in the event
of any amendment to the financial terms or other material terms of any such Company Superior Proposal, a new written notification from
the Company consistent with that described in clause (i) of this Section &lrm;6.03(e) shall be required and a new notice period under
clause (i) of this Section &lrm;6.03(e) shall commence, during which notice period the Company shall be required to comply with the requirements
of this Section &lrm;6.03(e) anew, except that such new notice period shall be for two (2) Business Days (as opposed to four (4) Business
Days)). After delivery of such written notice pursuant to the immediately preceding sentence until the termination of this Agreement in
accordance with its terms, the Company shall promptly keep Parent informed of all material developments affecting the material terms of
any such Company Superior Proposal (and the Company shall provide Parent with copies of any additional written materials received that
relate to such Company Superior Proposal).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For purposes of this Agreement, &ldquo;<FONT STYLE="color: windowtext"><B>Company Superior Proposal</B></FONT>&rdquo; means any
<I>bona fide</I>, written, Company Acquisition Proposal (other than a Company Acquisition Proposal which has resulted from a violation
of this Section&nbsp;&lrm;6.03) (with all references to &ldquo;20%&rdquo; in the definition of Company Acquisition Proposal being deemed
to be references to &ldquo;50%&rdquo; and clauses&nbsp;(ii)(2), (iii)(2) and (iv)(B)(2) being disregarded) on terms that the Board of
Directors of the Company determines in good faith by majority vote, after consultation with a financial advisor of nationally recognized
reputation and the Company&rsquo;s outside legal counsel, and taking into account all the terms and conditions of the Company Acquisition
Proposal (including the identity of the Person making the Company Acquisition Proposal and the expected timing and likelihood of consummation,
any governmental or other approval requirements (including divestitures and entry into other commitments and limitations), break-up fees,
expense reimbursement provisions, conditions to consummation, availability of necessary financing and all other financial, regulatory,
legal and other aspects of such Company Acquisition Proposal), would result in a transaction (i) that, if consummated, is more favorable
to the Company&rsquo;s stockholders from a financial point of view than the Transactions (taking into account any proposal by Parent to
amend the terms of this Agreement proposed pursuant to Section &lrm;6.03(e)), (ii) that is reasonably capable of being completed on the
terms proposed (taking into account the identity of the Person making the Company Acquisition Proposal, any approval requirements and
all other financial, regulatory, legal and other aspects of such Company Acquisition Proposal) and (iii) for which financing, if a cash
transaction (whether in whole or in part), is then fully committed and reasonably determined to be available by the Board of Directors
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 70; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>&ldquo;<FONT STYLE="color: windowtext"><B>Company Intervening Event</B></FONT>&rdquo; means any material event, circumstance, development,
change, occurrence or effect occurring or arising after the date of this Agreement that (i) was not known or reasonably foreseeable, or
the material consequences of which were not known or reasonably foreseeable, in each case to the Board of Directors of the Company as
of or prior to the date of this Agreement and (ii) does not relate to (A) the receipt, existence, or terms of a Company Acquisition Proposal
or (B) any event, development, or change in circumstances resulting from a breach of this Agreement by the Company or any action taken
pursuant to or in compliance with &lrm;Section&nbsp;8.01; <I>provided</I> that, in any case, in no event shall any of the following events
constitute a Company Intervening Event: (1) any decline, in and of itself, in the market price or trading volume of Parent Common Stock,
any changes in credit ratings and any changes in any analysts&rsquo; recommendations or ratings with respect to Parent or any of its Subsidiaries
(but not including, in each case, the underlying causes thereof); (2) any failure, in and of itself, by Parent or any of its Subsidiaries
to meet any internal or published projections, forecasts, estimates or predictions in respect of revenues, earnings or other financial
or operating metrics for any period (but not including, in each case, the underlying causes thereof); (3) any increase or decrease in
the value of Bitcoin and (4) compliance with or performance under this Agreement or the transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company shall, and shall cause its Affiliates and its and its Affiliates&rsquo; respective Representatives to, cease immediately
and cause to be terminated any and all existing activities, discussions or negotiations, if any, with any Third Party conducted prior
to the date of this Agreement with respect to any Company Acquisition Proposal and shall use its reasonable best efforts to cause any
such Third Party (and its agents or advisors) in possession of confidential information about the Company that was furnished by or on
behalf of the Company to such Persons to return or destroy all such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding (i) any Company Adverse Recommendation Change, (ii)&nbsp;the making of any Company Acquisition Proposal or (iii)
anything in this Agreement to the contrary, until termination of this Agreement, (x) in no event may the Company or any of its Subsidiaries
(A) enter into any agreement in principle, letter of intent, term sheet, merger agreement, acquisition agreement, option agreement, joint
venture agreement, partnership agreement or other similar instrument constituting or relating to a Company Acquisition Proposal&nbsp;&nbsp;(an
&ldquo;<FONT STYLE="color: windowtext"><B>Alternate Company Acquisition Agreement</B></FONT>&rdquo;) (other than a confidentiality agreement
in accordance with Section&nbsp;&lrm;6.03(b) or an Alternate Company Acquisition Agreement with respect to a Company Superior Proposal
pursuant to Section 6.03(b)), (B) except as required by Applicable Law, make, facilitate or provide information in connection with any
SEC or other Filings in connection with the transactions contemplated by any Company Acquisition Proposal or (C) seek any Consents in
connection with the transactions contemplated by any Company Acquisition Proposal and (y) the Company shall otherwise remain subject to
all of its obligations under this Agreement, including, for the avoidance of doubt, the obligation to hold the Company Stockholder Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;6.04.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Indenture</I>. The Company shall timely provide or cause to be provided, in accordance with the provisions of the Company&rsquo;s
indenture, dated January 28, 2025, as supplemented by the supplemental indentures relating thereto (the &ldquo;<FONT STYLE="color: windowtext"><B>Indenture</B></FONT>&rdquo;)
relating to the Company&rsquo;s 4.25% Convertible Senior Notes due 2030 (the &ldquo;<FONT STYLE="color: windowtext"><B>Company Notes</B></FONT>&rdquo;),
to the trustee under the Indenture, any notices, announcements, certificates or legal opinions required by the Indenture to be provided
in connection with the Merger prior to the Effective Time. In the event</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 71; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Parent requests that any of the Company Notes
be amended, redeemed or satisfied and discharged prior to or at the Effective Time, Parent shall make available to the Company prior to
or at the Effective Time, as applicable, all funds necessary to satisfy any obligations of the Company to the holders of the Company Notes
that may arise including (i) any funds necessary to repurchase, redeem or otherwise acquire any of the Company Notes and (ii)&nbsp;principal,
interest and any applicable premiums or consent payments in connection with the repurchase, redemption or acquisition of the Company Notes.
Parent shall, promptly upon written request by the Company, reimburse the Company for all reasonable and documented out-of-pocket costs,
fees and expenses (including attorneys&rsquo; fees and expenses) to the extent such costs, fees and expenses are incurred by the Company,
its Subsidiaries or their respective Representatives in connection with the Company complying with its obligations under this Section
6.05. Parent and its counsel shall be given a reasonable opportunity to review and comment on any notice, announcement, certificate or
legal opinion referred to in this Section 6.05, in each case, before such document is provided to the trustee under the Indenture, and
such documents shall be reasonably acceptable to Parent. The Company shall not redeem the Company Notes without the prior written consent
of Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">Section&nbsp;6.05.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Financing Cooperation<FONT STYLE="font-style: normal">. Prior to the Closing, the Company and Merger Sub shall provide,
and shall cause their respective Subsidiaries and Representatives to provide, cooperation in connection with the arrangement and consummation
of any financing or filing of any registration statement, in each case as may be requested by Parent, including (i) taking all actions
reasonably necessary to consummate equity financing issued by Parent (provided that neither the Company nor Merger Sub shall be obligated
to take any such action that is not conditioned upon the occurrence of Closing), (ii) furnishing any financial data or other information
of the type required or customarily included in a registration statement on Form S-1 for non-reporting companies or by Regulation S-X
and Regulation S-K under the 1933 Act for registered offerings of equity securities at such time, and of the type and form customarily
included in offering documents for an offering of equity securities that is registered with the SEC, (iii) furnishing other documents
and information regarding the Company or its Subsidiaries required or customarily requested in connection with the delivery of any customary
negative assurance opinion, (iv) reasonably assisting with the preparation of any customary offering documents or memoranda, prospectuses
and similar documents and to be used in connection with any financing, (v) causing the Company&rsquo;s auditors to deliver drafts of customary
comfort letters, including as to customary negative assurances and change period, confirming that such auditors are prepared to issue
any such comfort letter reasonably requested in connection with any financing, and obtaining consents of the Company&rsquo;s auditors
for use of their reports in any customary materials relating to any financing and to be named as experts in connection with any filings
pursuant to the Securities Act or the Exchange Act, and (vi) executing and delivering (or obtaining from its advisors), customary certificates,
legal opinions or other documents and instruments relating to other matters ancillary to any financing as may be reasonably requested
by the Parent therewith; provided, that nothing herein shall require such cooperation to the extent it would materially and unreasonably
interfere with the business or operations of the Company. Neither Company nor Merger Sub shall be required to take any such action that
would subject them to liability, to pay any commitment or other similar fee, make any other payment or incur any out of pocket expenses
(other than costs that will be reimbursed by Parent, provided such expense reimbursement invoices are supported by reasonable documentation
of the expenses set forth therein) or incur any other liability or provide or agree to provide any indemnity in connection with the financing
or any of the foregoing, </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 72; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-style: normal">in
each case prior to the Closing. The Company hereby consents to the reasonable use of the Company&rsquo;s logos in connection with any
financing.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article&nbsp;7</FONT><U><BR>
Covenants of Parent</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;7.01.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Conduct of Parent</I>. From the date of this Agreement until the earlier of the Effective Time and the valid termination of this
Agreement, except (x) as required by Applicable Law, (y) as set forth in Section&nbsp;&lrm;7.01 of the Parent Disclosure Schedule, or
(z) as otherwise required or expressly permitted by this Agreement, unless the Company shall otherwise consent in writing (e-mail being
sufficient) (which consent shall not be unreasonably withheld, conditioned or delayed), Parent shall not, and shall cause each of its
Subsidiaries not to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>adopt or propose any change to the Parent Organizational Documents (whether by merger, consolidation or otherwise) in a manner
that would be materially adverse to the Company&rsquo;s stockholders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) merge or consolidate with any other Person or (ii) acquire (including by merger, consolidation, acquisition of stock or assets
or entry into joint venture) any interest in any corporation, partnership, other business organization or any division thereof or any
assets, securities or property, except as would not, individually or in the aggregate, reasonably be expected to prevent or delay beyond
the End Date the clearing of the Information Statement/Proxy Statement/Prospectus by the SEC and the effectiveness of the Registration
Statement under the Securities Act, in each case as set forth in <U>Section 8.02</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>adopt or propose a plan of complete or partial merger, liquidation, consolidation, recapitalization, restructuring or other reorganization
or dissolution with respect to Parent or Merger Sub, or resolutions providing for or authorizing such a merger, liquidation, consolidation,
recapitalization, restructuring or other reorganization or dissolution with respect to Parent or Merger Sub;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>declare, set aside or pay or make any dividend or make any other distribution (whether in cash, stock, property or any combination
thereof) in respect of Parent Common Stock or any shares of any Subsidiary of Parent&rsquo;s capital stock or other securities, other
than dividends or distributions by a Subsidiary of Parent to Parent or a Subsidiary of Parent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>agree, resolve, authorize, commit or propose to do any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the avoidance of doubt,
nothing in this Agreement shall restrict Parent&rsquo;s ability to continue to pursue its plan to issue senior cumulative variable rate
perpetual preferred equity instruments or to raise additional capital or issue or grant any equity securities, including through an at-the-money
offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;7.02.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Obligations of Merger Sub</I>. From the date of Merger Sub&rsquo;s execution and delivery of the joinder contemplated by Section
7.06 until the Effective Time, Parent shall at all times be the direct owner of all of the outstanding shares of capital stock of Merger
Sub. Parent shall take all action necessary to cause Merger Sub to perform its obligations under this Agreement and to consummate the
Merger on the terms and conditions set forth in this Agreement. Promptly</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 73; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">following the execution of this Agreement and
Merger Sub&rsquo;s execution and delivery of the joinder contemplated by Section 7.06, Parent shall, in its capacity as&nbsp;&nbsp;the
sole stockholder of Merger Sub, execute and deliver a written consent approving and adopting this Agreement in accordance with Delaware
Law and provide a copy of such written consent to the Company, and thereafter neither Parent nor any of its Subsidiaries shall amend,
modify or withdraw such consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;7.03.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Director and Officer Liability</I>. (a) For a period of six (6)&nbsp;years after the Effective Time, the Surviving Corporation
and Parent shall (with respect to Parent, only to the extent that the Surviving Corporation is permitted to do so under Applicable Law),
jointly and severally, indemnify and hold harmless and shall advance expenses as incurred, in each case to the extent (subject to Applicable
Law) such Persons are indemnified as of the date of this Agreement by the Company pursuant to the Company Organizational Documents, the
governing or organizational documents of any Subsidiary of the Company and any indemnification agreements in existence as of the date
hereof, each present and former director and officer of the Company and its Subsidiaries (in each case, when acting in such capacity)
(collectively, the &ldquo;<FONT STYLE="color: windowtext"><B>Company Indemnified Parties</B></FONT>&rdquo;) against any costs or expenses
(including reasonable attorneys&rsquo; fees), judgments, fines, losses, damages or liabilities incurred in connection with any threatened
or actual Proceeding, whether civil, criminal, administrative or investigative, whether arising before or after the Effective Time, arising
out of the fact that such person is or was a director, officer or employee of the Company or any of its Subsidiaries and pertaining to
matters existing or occurring at or prior to the Effective Time, including the Transactions;&nbsp;<I>provided</I>, that in the case of
advancement of expenses, any Company Indemnified Party to whom expenses are advanced provides an undertaking to repay such advances if
it is ultimately determined that such Company Indemnified Party is not entitled to indemnification;&nbsp;<I>provided</I>, <I>further</I>,
that such indemnification shall be subject to any limitation imposed from time to time under Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>For a period of six (6)&nbsp;years after the Effective Time, Parent shall cause to be maintained in effect <FONT STYLE="color: windowtext">policies
of directors&rsquo; and officers&rsquo; liability insurance with terms, conditions, retentions and limits of liability that are at least
as favorable to the Company Indemnified Parties as such policies m</FONT>aintained by the Company as of the date hereof with respect to
claims arising from facts or events which occurred at or before the Effective Time;&nbsp;<I>provided</I>,&nbsp;<I>however</I>, that the
Surviving Corporation shall not be obligated to expend, on an aggregate basis, an amount in excess of 350% of the current annual premium
paid as of the date hereof by the Company for such insurance (the &ldquo;<FONT STYLE="color: windowtext"><B>Premium Cap</B></FONT>&rdquo;),
and if such premiums for such insurance would at any time exceed the Premium Cap or such coverage is not otherwise available, then Parent
shall cause to be maintained policies of insurance which, in Parent&rsquo;s good faith determination, provide the maximum coverage available
at an aggregate premium equal to the Premium Cap. In lieu of the obligations set forth in the foregoing sentence, Parent or the Company
may obtain at or prior to the Effective Time a six (6)-year &ldquo;tail&rdquo; policy under the Company&rsquo;s existing directors&rsquo;
and officers&rsquo; insurance policy providing equivalent coverage to that described in the preceding sentence if and to the extent that
the same may be obtained for an amount that, in the aggregate, does not exceed the Premium Cap.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The provisions of this Section&nbsp;&lrm;7.03 shall survive the Effective Time and are intended to be for the benefit of, and shall
be enforceable by, each Company Indemnified Party and his or her heirs and representatives. If Parent or the Surviving Corporation or
any of their respective successors or assigns (i)&nbsp;consolidates with or merges into any other person and is not</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 74; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">the continuing or
surviving entity of such consolidation or merger, or (ii)&nbsp;transfers all or substantially all of its assets to any other person, then
in each such case, Parent will cause, to the extent necessary, proper provision to be made so that the successors and assigns of Parent
or the Surviving Corporation, as applicable, will assume the obligations set forth in this Section&nbsp;&lrm;7.03.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;7.04.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Employee Matters</I>. (a)&nbsp;&nbsp;For the 12-month period beginning on the Closing Date (or such period as the employee continues
to be employed by Parent or one of its Subsidiaries), Parent shall provide, or shall cause the Company to continue providing, to each
individual who is an employee of the Company as of the Closing (each, an &ldquo;<B>Affected Employee</B>&rdquo;): (i)(A) base salary or
hourly wage rate, as applicable, and (B) annual target cash incentive compensation opportunities (including target bonuses and target
commissions) that are, in each case, at least equal to the base salary or hourly wage rate or annual target cash incentive compensation
opportunities (including target bonuses and target commissions) provided to such Affected Employee immediately prior to the Closing and
(ii) other compensation and benefits (excluding equity and equity based rights, non-qualified deferred compensation, severance, retention,
sign-on, change in control or other similar bonuses, defined benefit pension and retiree medical or welfare benefits) that are substantially
comparable, in the aggregate, to those provided to such Affected Employee immediately prior to the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event any Affected Employee first becomes eligible to participate under any Parent Employee Plan following the Effective
Time, Parent shall use its reasonable best efforts, or shall cause its Subsidiaries to use reasonable best efforts to: (i)&nbsp;waive,
or cause to be waived, any preexisting conditions, exclusions, limitations and waiting periods with respect to participation and coverage
requirements applicable to such Affected Employee under any Parent Employee Plan providing medical, dental or vision benefits to the same
extent such limitation would have been waived or satisfied under the applicable Company Employee Plan such Affected Employee participated
in immediately prior to coverage under such Parent Employee Plan and (ii) provide such Affected Employee with credit for any copayments
and deductibles paid under a Company Employee Plan during the calendar year in which the Closing Date occurs for purposes of satisfying
such year&rsquo;s co-payment and deductible limitations under the relevant Parent Employee Plan in which such Affected Employee is eligible
to participate from and after the Closing Date, to the same extent such credit was given under the Company Employee Plan such Affected
Employee participated in immediately prior to coverage under such Parent Employee Plan in satisfying any applicable deductible or out-of-pocket
requirements under such Parent Employee Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>As of the Effective Time, Parent shall, or shall cause its Subsidiaries to, recognize all service of each Affected Employee prior
to the Effective Time with the Company and its Subsidiaries (including any respective predecessors to the extent the Company has provided
Parent with all reasonably necessary records documenting such service with such predecessors) for vesting and eligibility purposes (but
not benefit accrual), except for equity compensation vesting purposes, under any benefit plan or arrangement of Parent, the Surviving
Corporation or any of their respective Subsidiaries providing benefits to such Affected Employee after the Effective Time to the same
extent such service credit was granted under any benefit plan or arrangement of the Company or any of its Subsidiaries. In no event shall
anything contained in this Section&nbsp;&lrm;7.04(c) result in any duplication of benefits for the same period of service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 75; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Effective as of immediately prior to the Effective Time, unless otherwise directed in writing by Parent at least five Business
Days prior to the Effective Time, the Company shall terminate the Company 401(k) Plan. In connection with the termination of such plan,
Parent shall permit each Affected Employee to make rollover contributions of &ldquo;eligible rollover distributions&rdquo; (within the
meaning of Section 401(a)(31) of the Code, excluding participant loans) in cash in an amount equal to the eligible rollover distribution
portion of the account balance distributed to each such Affected Employee from such plan to an &ldquo;eligible retirement plan&rdquo;
(within the meaning of Section 401(a)(31) of the Code) of Parent or any of its Subsidiaries (a &ldquo;<FONT STYLE="color: windowtext"><B>Parent
Qualified Plan</B></FONT>&rdquo;). If the Company 401(k) Plan is terminated as described herein, the Affected Employees shall be eligible
as soon as practicable following the Closing Date to commence participation in a Parent Qualified Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Without limiting the generality of Section&nbsp;&lrm;11.06, nothing contained in this Section&nbsp;&lrm;7.04 or elsewhere in this
Agreement, express or implied (i) shall cause either Parent or any of its Affiliates to be obligated to continue to employ any Person,
including any Affected Employees, for any period of time following the Effective Time, (ii) shall prevent Parent or its Affiliates from
revising, amending or terminating any Company Employee Plan or any other employee benefit plan, program or policy in effect from time
to time, (iii) shall be construed as an amendment of any Company Employee Plan or Parent Employee Plan, or (iv) shall create any third-party
beneficiary rights in any director, officer, employee or individual Person, including any present or former employee, officer, director
or individual independent contractor of the Company or any of its Subsidiaries (including any beneficiary or dependent of such individual).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;7.05.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Parent Stockholder Approval</I>. <FONT STYLE="font-style: normal">As promptly as reasonably practicable (and in any event within
two (2)&nbsp;Business Days) following the date of this Agreement (the &ldquo;<B><U>Parent Stockholder Approval Deadline</U></B>&rdquo;),
Parent shall deliver, or cause to be delivered, to the Company the duly executed Parent Stockholder Approval.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">Section&nbsp;7.06.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></FONT>Merger Sub. <FONT STYLE="font-style: normal">Promptly following the date hereof, Parent shall form a new Delaware corporation,
wholly owned by Parent (&ldquo;<B><U>Merger Sub</U></B>&rdquo;), and cause Merger Sub to execute and deliver to Parent and the Company
a joinder to this Agreement, agreeing to be party hereto as Merger Sub</FONT>.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article&nbsp;8</FONT><U><BR>
Covenants of Parent and the Company</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The parties hereto agree that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;8.01.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Reasonable Best Efforts</I>. (a) Subject to the terms and conditions of this Agreement, each of the Company and Parent shall use
reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, and assist and cooperate with the other
parties in doing, all things reasonably necessary, proper or advisable to consummate and make effective as promptly as practicable the
Transactions (including (i) preparing and filing, as promptly as practicable, with any Governmental Authority all documentation to effect
all necessary Filings pursuant to the HSR Act, which such Filings pursuant to the HSR Act shall be made within 20 Business Days after
the date of this Agreement (and, absent the prior written consent of the other party, not withdrawing any such Filings) and resubmitting
any such Filings as soon as is reasonably</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 76; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">practicable in the event such filings are rejected
for any reason whatsoever by the relevant Governmental Authority and (ii) using reasonable best efforts to obtain, as promptly as practicable,
all Consents required to be obtained from any Governmental Authority under the HSR Act that are necessary to consummate the Transactions).
To the extent permitted by Applicable Law, the Company and Parent shall deliver as promptly as practicable to the appropriate Governmental
Authorities any additional information and documentary material that may be requested by any Governmental Authority in connection with
the Transactions. Without limiting the foregoing, none of the Company or Parent or their respective Affiliates shall extend any waiting
period or comparable period under the HSR Act or enter into any agreement with any Governmental Authority not to consummate the Transactions,
except with the prior written consent of the other party (which shall not be unreasonably withheld, conditioned or delayed).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each of the Company and Parent shall, to the extent permitted by Applicable Law (i) promptly notify the other party of any written
communication made or received by the Company or Parent, as applicable, with any Governmental Authority relating to Antitrust Law (or
any other Filings made pursuant to this Section&nbsp;&lrm;8.01) and regarding this Agreement, the Merger or any of the other Transactions,
and, if permitted by Applicable Law and reasonably practical, permit the other party to review in advance any proposed written communication
to any such Governmental Authority and incorporate such other party&rsquo;s (and any of their respective outside counsel&rsquo;s) reasonable
comments to such proposed written communication, (ii) not agree to participate in any in-person meeting or substantive discussion with
any Governmental Authority in respect of any Filing, investigation or inquiry relating to Antitrust Law (or any other Filings made pursuant
to this Section&nbsp;&lrm;8.01) and regarding this Agreement or any of the Transactions unless, to the extent reasonably practicable,
it consults with such other party in advance and, to the extent permitted by such Governmental Authority, gives such other party the opportunity
to attend or participate, as applicable, and (iii) promptly furnish the other party with copies of all correspondence, filings and written
communications between it and its Affiliates and Representatives, on the one hand, and such Governmental Authority or its respective staff,
on the other hand, with respect to this Agreement and the Transactions. Any materials exchanged in connection with this Section&nbsp;&lrm;8.01
may be redacted or withheld as necessary to address reasonable privilege or confidentiality concerns, and to remove references concerning
the valuation of the Company or other competitively sensitive material; <I>provided</I>, that the parties may, as they deem advisable
and necessary, designate any materials provided to the other under this Section&nbsp;&lrm;8.01 as &ldquo;outside counsel only.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding anything to the contrary set forth in this Agreement, and in furtherance and not in limitation of the foregoing,
Parent shall, and shall cause its Subsidiaries to, use reasonable best efforts to resolve, avoid, or eliminate impediments or objections,
if any, that may be asserted by any Governmental Authority with respect to the Transactions so as to enable the Merger to occur prior
to the End Date; <I>provided</I> that nothing in this Section 8.01 or anything else in this Agreement shall require Parent, any of its
Affiliates or any of its Subsidiaries to (and neither the Company nor any of its Subsidiaries shall, or shall offer or agree to, do any
of the following without Parent&rsquo;s prior written consent): (i) propose, negotiate, commit to or effect, by consent decree, hold separate
orders or otherwise, the sale, divesture, disposition, or license of any assets, properties, products, rights, services or businesses
of Parent, Parent&rsquo;s Subsidiaries, Parent&rsquo;s Affiliates, or the Company or any of its Subsidiaries, or any interest therein,
or agree to any other structural or conduct remedy, (ii) otherwise take or commit to take any actions that would limit</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 77; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">Parent&rsquo;s, Parent&rsquo;s
Subsidiaries, Parent&rsquo;s Affiliates, or the Company&rsquo;s or its Subsidiaries&rsquo; freedom of action with respect to, or its or
their ability to retain any assets, properties, products, rights, services or businesses of Parent, Parent&rsquo;s Subsidiaries, Parent&rsquo;s
Affiliates, or the Company or any of its Subsidiaries, or any interest or interests therein; or (iii)&nbsp;agree to do any of the foregoing
(any of the actions described in this proviso, a &ldquo;<FONT STYLE="color: windowtext"><B>Burdensome Condition</B></FONT>&rdquo;). Notwithstanding
the foregoing, at the written request of Parent, the Company shall, and shall cause its Subsidiaries to, agree to take any action that
would constitute a Burdensome Condition so long as such action is conditioned upon the occurrence of the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>In the event any Proceeding by any Governmental Authority or other Third Party is commenced which questions the validity or legality
of, or otherwise challenges, the Transactions, or seeks damages in connection therewith, Parent and the Company shall, subject to the
provisions set forth in this Section&nbsp;&lrm;8.01(d), reasonably cooperate and use reasonable best efforts to defend against such Proceeding,
and if an injunction or other Order is issued in any such Proceeding, to use reasonable best efforts to have such injunction or other
Order lifted or extinguished, and to cooperate reasonably regarding any other impediment to the consummation of the Transactions; <I>provided</I>,
that, unless Parent elects to do so, nothing in this Agreement shall require Parent to commence any litigation against any Governmental
Authority or Third Party. Parent shall, in consultation with the Company, be entitled to direct the defense of the Transactions before
any Governmental Authority and to take the lead in the scheduling of, and strategic planning for, any meetings with, and the conducting
of negotiations with, Governmental Authorities regarding the expiration or termination of any applicable waiting period relating to the
Merger under the HSR Act, so long as Parent&rsquo;s actions in connection therewith are otherwise in accordance with Parent&rsquo;s obligations
under this Section&nbsp;&lrm;8.01.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company and Parent shall reasonably cooperate with each other and their respective Representatives in obtaining any other Consents
that may be required in connection with the Transactions. Notwithstanding anything to the contrary in this Agreement, nothing herein shall
obligate or be construed to obligate the Company or any of its Affiliates or Parent or any of its Affiliates to, and without Parent&rsquo;s
prior written consent neither the Company nor any of its Affiliates shall, make, or to cause to be made, any payment or other accommodation
to any Third Party in order to obtain such Consent of such Third Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;8.02.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Certain Filings; SEC Matters</I>. (a) As promptly as practicable following the date of this Agreement, (i) the Company and Parent
shall jointly prepare and file with the SEC a Information Statement/Proxy Statement relating to the Company Stockholder Meeting (together
with all amendments and supplements thereto, the &ldquo;<FONT STYLE="color: windowtext"><B>Information Statement/Proxy Statement/Prospectus</B></FONT>&rdquo;)
in preliminary form, and (ii) Parent shall prepare and file with the SEC a Registration Statement on Form S-4 which shall include the
Information Statement/Proxy Statement/Prospectus (together with all amendments and supplements thereto, the &ldquo;<FONT STYLE="color: windowtext"><B>Registration
Statement</B></FONT>&rdquo;) relating to the registration of the shares of the Parent Class A Common Stock to be issued to the stockholders
of the Company pursuant to the Parent Share Issuance. The Information Statement/Proxy Statement/Prospectus and Registration Statement
shall comply as to form in all material respects with the applicable provisions of the Securities Act and the Securities Exchange Act
and other Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 78; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each of the Company and Parent shall use its reasonable best efforts to have the Information Statement/Proxy Statement/Prospectus
cleared by the SEC as promptly as practicable after its filing, and Parent shall use its reasonable best efforts to have the Registration
Statement declared effective under the Securities Act as promptly as practicable after its filing and keep the Registration Statement
effective for so long as necessary to consummate the Merger. Each of the Company and Parent shall, as promptly as practicable after the
receipt thereof, provide the other party with copies of any written comments and advise the other party of any oral comments with respect
to the Information Statement/Proxy Statement/Prospectus and the Registration Statement received by such party from the SEC, including
any request from the SEC for amendments or supplements to the Information Statement/Proxy Statement/Prospectus and the Registration Statement,
and shall provide the other with copies of all material or substantive correspondence between it and its Representatives, on the one hand,
and the SEC, on the other hand. Notwithstanding the foregoing, prior to filing the Registration Statement or mailing the Information Statement/Proxy
Statement/Prospectus or responding to any comments of the SEC with respect thereto, each of the Company and Parent shall provide the other
party and its counsel a reasonable opportunity to review such document or response (including the proposed final version of such document
or response) and consider in good faith the comments of the other party in connection with any such document or response. None of the
Company, Parent or their respective Representatives shall agree to participate in any material or substantive meeting or conference (including
by telephone) with the SEC, or any member of the staff thereof, in respect of the Registration Statement or the Information Statement/Proxy
Statement/Prospectus unless it consults with the other party in advance and, to the extent permitted by the SEC, allows the other party
to participate. Parent shall advise the Company, promptly after receipt of notice thereof, of the time of effectiveness of the Registration
Statement, and the issuance of any stop order relating thereto or the suspension of the qualification of shares of Parent Common Stock
for offering or sale in any jurisdiction, and each of the Company and Parent shall use its reasonable best efforts to have any such stop
order or suspension lifted, reversed or otherwise terminated. Each of the Company and Parent shall use its reasonable best efforts to
take any other action required to be taken by it under the Securities Act, the Securities Exchange Act, Nevada Law, Delaware Law and the
rules of the Nasdaq in connection with the filing and distribution of the Information Statement/Proxy Statement/Prospectus and the Registration
Statement, and the solicitation of proxies from the stockholders of the Company thereunder. Subject to Section&nbsp;&lrm;6.03, the Information
Statement/Proxy Statement/Prospectus shall include the Company Board Recommendation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Parent shall use its reasonable best efforts to take, or cause to be taken, all actions, and to do or cause to be done all things,
necessary, proper or advisable under Applicable Laws and the rules and policies of Nasdaq and the SEC to enable the listing of the Parent
Common Stock being registered pursuant to the Registration Statement on Nasdaq no later than the Effective Time, subject to official notice
of issuance. Parent shall also use its reasonable best efforts to obtain all necessary state securities law or &ldquo;blue sky&rdquo;
permits and approvals required to carry out the Transactions (<I>provided</I> that in no event shall Parent be required to qualify to
do business in any jurisdiction in which it is not now so qualified or file a general consent to service of process).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Each of the Company and Parent shall, upon request, furnish to the other all information concerning itself, its Subsidiaries, directors,
officers and (to the extent reasonably available to the applicable party) stockholders and such other matters as may be reasonably necessary
or advisable in connection with any statement, Filing, notice or application made by or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 79; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">on behalf of the Company,
Parent or any of their respective Subsidiaries, to the SEC, Nasdaq in connection with the Transactions, including the Registration Statement
and the Information Statement/Proxy Statement/Prospectus. In addition, each of the Company and Parent shall use its reasonable best efforts
to provide information concerning it necessary to enable the Company and Parent to prepare required pro forma financial statements and
related footnotes in connection with the preparation of the Registration Statement and/or the Information Statement/Proxy Statement/Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If at any time prior to the Company Approval Time, any information relating to the Company or Parent, or any of their respective
Affiliates, officers or directors, should be discovered by the Company or Parent that should be set forth in an amendment or supplement
to either of the Registration Statement or the Information Statement/Proxy Statement/Prospectus, so that either of such documents would
not include any misstatement of a material fact or omit to state any material fact necessary to make the statements therein, in light
of the circumstances under which they were made, not misleading, the party that discovers such information shall promptly notify the other
party hereto and an appropriate amendment or supplement describing such information shall promptly be prepared and filed with the SEC
and, to the extent required under Applicable Law, disseminated to the stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;8.03.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Company Stockholder Meeting</I>. (a) Following the execution of this Agreement, the Company shall, in consultation with Parent,
set a record date for the Company Stockholder Meeting, which record date shall be prior to the date of effectiveness of the Registration
Statement, and commence a broker search pursuant to Section 14a-13 of the Securities Exchange Act in respect thereof at least twenty (20)
Business Days prior thereto. As promptly as practicable following the effectiveness of the Registration Statement, the Company shall,
in consultation with Parent, in accordance with Applicable Law and the Company Organizational Documents, (i) duly call and give notice
of a meeting of the stockholders of the Company entitled to vote on the Merger (the &ldquo;<FONT STYLE="color: windowtext"><B>Company
Stockholder Meeting</B></FONT>&rdquo;) at which meeting the Company shall seek the Company Stockholder Approval, (ii) cause the Information
Statement/Proxy Statement/Prospectus (and all other proxy materials for the Company Stockholder Meeting) to be mailed to its stockholders
and (iii) duly convene and hold the Company Stockholder Meeting. Subject to Section&nbsp;&lrm;6.03, the Company shall use its reasonable
best efforts to take, or cause to be taken, all actions, and do or cause to be done all things, necessary, proper or advisable on its
part to cause the Company Stockholder Approval to be received at the Company Stockholder Meeting or any adjournment or postponement thereof,
and shall comply with all legal requirements applicable to the Company Stockholder Meeting. The Company shall not, without the prior written
consent of Parent, adjourn, postpone or otherwise delay the Company Stockholder Meeting; <I>provided</I>, <I>however</I>, that Company
may postpone or adjourn the Company Stockholder Meeting to allow reasonable additional time for the filing and mailing of any supplemental
or amended disclosure that the Board of Directors of the Company has determined in good faith after consultation with outside counsel
is necessary under Applicable Law and for such supplemental or amended disclosure to be disseminated and reviewed by the Company&rsquo;s
stockholders prior to the Company Stockholder Meeting. If, on the date of the Company Stockholder Meeting, Parent reasonably determines
in good faith that the Company has not received proxies representing a sufficient number of shares of Company Stock to obtain the Company
Stockholder Approval, the Company shall at its election or upon the written request of Parent adjourn the Company Stockholder Meeting
until such date as shall be mutually agreed upon by the Company and Parent, </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 80; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">which date shall be not less than ten (10) days nor more than
twenty (20) days after the date of adjournment, and subject to the terms and conditions
of this Agreement, shall continue to use its reasonable best efforts, together with its proxy solicitor, to assist in the solicitation
of proxies from stockholders relating to the Company Stockholder Approval; <I>provided, further, </I>that the Company shall not be obligated
to adjourn the Company Stockholder Meeting more than twice at the request of Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Company shall coordinate with Parent regarding the record date and the meeting date for the Company Stockholder Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;8.04.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Public Announcements</I>. The initial press release concerning this Agreement and the Transactions shall be a joint press release
to be agreed upon by the Company and Parent. Following such initial press release, Parent and the Company shall consult with each other
before issuing any additional press release, making any other public statement or scheduling any press conference, conference call or
meeting with investors or analysts or making or distributing any broad-based employee communication, in each case, with respect to this
Agreement or the Transactions (collectively, a &ldquo;<B>Release</B>&rdquo;) and, except as may be required by Applicable Law or any listing
agreement with or rule of any national securities exchange or association, shall not issue any such press release, make any such other
public statement or schedule any such press conference, conference call or meeting before such consultation (and, to the extent applicable,
shall reasonably in advance provide copies of any such press release, statement or agreement (or any scripts for any conference calls)
to the other party and shall consider in good faith the comments of the other party); <I>provided</I> that the restrictions set forth
in this Section&nbsp;&lrm;8.04 shall not apply to any Release (a)&nbsp;made or proposed to be made by the Company in compliance with Section&nbsp;&lrm;6.03
with respect to the matters contemplated by Section&nbsp;&lrm;6.03, (b) if such Release does not disclose any non-public information regarding
the Transactions beyond the scope of any previously agreed Release to which the other party had been consulted or (c) in connection with
any dispute between the parties regarding this Agreement or the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;8.05.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notices of Certain Events</I>. Each of the Company and Parent shall promptly advise the other of (i) any notice or other material
communication from any Person alleging that the consent of such Person is or may be required in connection with the Transactions; (ii)
any notice or other communication from any Governmental Authority in connection with the Transactions; (iii) any Proceedings commenced
or, to its knowledge, threatened against, relating to or involving or otherwise affecting the Company or any of its Subsidiaries or Parent
and any of its Subsidiaries, as the case may be, that, if pending on the date of this Agreement, would have been required to have been
disclosed pursuant to any Section of this Agreement or that relate to the consummation of the Transactions; (iv) any change, event or
fact that has had or would be reasonably likely to have, individually or in the aggregate, a Company Material Adverse Effect, in the case
of the Company, or a Parent Material Adverse Effect, in the case of Parent; or (v) any change, event or fact that it believes would or
would be reasonably likely to cause or constitute a material breach of any of its representations, warranties or covenants contained in
this Agreement; <I>provided</I> that no such notification shall affect the representations, warranties, covenants or agreements of the
parties (or remedies with respect thereto) or the conditions to the obligations of the parties under this Agreement; <I>provided, further</I>,
that a failure to comply with this Section&nbsp;&lrm;8.05 shall not constitute the failure of any condition set forth in Article&nbsp;&lrm;9
to be satisfied unless the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 81; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">underlying change or event would independently
result in the failure of a condition set forth in Article&nbsp;&lrm;9 to be satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;8.06.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Section&nbsp;16 Matters</I>. Prior to the Effective Time, Parent and the Company shall take all such steps as may be required (to
the extent permitted under Applicable Law) to cause any dispositions of Company Stock (including derivative securities with respect to
Company Stock) or acquisitions of Parent Common Stock (including derivative securities with respect to Parent Common Stock) resulting
from the Transactions by each individual who is subject to the reporting requirements of Section 16(a) of the Securities Exchange Act
with respect to the Company, or will become subject to such reporting requirements with respect to Parent, to be exempt under Rule 16b-3
promulgated under the Securities Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;8.07.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Transaction Litigation</I>. The Company shall promptly notify Parent of any stockholder demands, litigations, arbitrations or other
similar Proceedings (including derivative claims) commenced against it and/or its respective directors or officers relating to this Agreement
or any of the Transactions or any matters relating thereto (collectively, &ldquo;<FONT STYLE="color: windowtext"><B>Transaction Litigation</B></FONT>&rdquo;)
and shall keep Parent informed regarding any such Transaction Litigation. The Company (i) shall give Parent the opportunity to participate
in, but not direct, the defense and settlement of any Transaction Litigation, (ii) keep Parent reasonably apprised on a prompt basis of
proposed strategy and other significant decisions with respect to any Transaction Litigation, and Parent may offer comments or suggestions
with respect to such Transaction Litigation, which the Company shall consider in good faith. The Company shall not settle or offer, compromise
or agree to settle or compromise, or take any other action to settle, compromise or moot, any Transaction Litigation without Parent&rsquo;s
prior written consent (which shall not be unreasonably withheld, conditioned or delayed).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;8.08.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Stock Exchange Delisting</I>. Each of the Company and Parent agrees to cooperate with the other party in taking, or causing to
be taken, all actions necessary to delist the Company Stock from Nasdaq and terminate its registration under the Securities Exchange Act;
<I>provided</I> that such delisting and termination shall not be effective until the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;8.09.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>State Takeover Statutes</I>. Each of Parent, Merger Sub and the Company shall (a) take all action necessary so that no &ldquo;moratorium,&rdquo;
&ldquo;control share acquisition,&rdquo; &ldquo;fair price,&rdquo; &ldquo;supermajority,&rdquo; &ldquo;affiliate transactions&rdquo; or
&ldquo;business combination statute or regulation&rdquo; or other similar state anti-takeover laws or regulations, or any similar provision
of the Company Organizational Documents or the Parent Organizational Documents, as applicable, is or becomes applicable to the Merger
or any of the other Transactions, and (b) if any such anti-takeover law, regulation or provision is or becomes applicable to the Merger
or any other Transactions, cooperate and grant such approvals and take such actions as are reasonably necessary so that the Transactions
may be consummated as promptly as practicable on the terms contemplated hereby and otherwise act to eliminate or minimize the effects
of such statute or regulation on the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;8.10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Tax Matters</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="color: windowtext">Notwithstanding anything to the contrary, and without limiting Section 6.01, the Company shall
not effect, outside of the ordinary course of business, any internal reorganization </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 82; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">or restructuring involving
the Company and/or any of its Subsidiaries without first giving Parent prior written notice thereof and consulting with Parent in good
faith with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="color: windowtext">Each of Parent and the Company shall use its reasonable best efforts (i) to cause the Merger and
the Second Merger, taken together as an integrated transaction, to qualify as a &ldquo;reorganization&rdquo; within the meaning of Section
368(a) of the Code with respect to which Parent, Second Merger Sub and the Company, as applicable, will each be a &ldquo;party to the
reorganization&rdquo; within the meaning of Section 368(b) of the Code and (ii) not to, and not permit or cause any of its respective
Subsidiaries or Affiliates to, take or cause to be taken any action reasonably likely to cause the Mergers, taken together, to fail to
qualify as a &ldquo;reorganization&rdquo; under Section 368(a) of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="color: windowtext">Parent shall use its reasonable best efforts to cause its officers and the officers of Merger Sub
and Second Merger Sub to execute and deliver to counsel of the Company letters of representation customary for transactions of this type
and reasonably satisfactory to counsel of the Company at such time and times as such counsel shall reasonably request, including at the
Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="color: windowtext">The Company shall use its reasonable best efforts to cause its officers to execute and deliver
to counsel of the Parent letters of representation customary for transactions of this type and reasonably satisfactory to counsel of Parent
at such time and times as such counsel shall reasonably request, including at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="color: windowtext">Parent and the Company intend to report, for U.S. federal income tax purposes, the Merger and the
Second Merger, taken together, as an integrated transaction described in Rev. Rul. 2001-46, 2001-2 C.B. 321 that qualifies as a &ldquo;reorganization&rdquo;
within the meaning of Section 368(a) of the Code, unless otherwise required by a change in Applicable Law. Notwithstanding any provision
in this Agreement to the contrary, none of Parent, the Company or any Subsidiary of either Parent or the Company shall have any liability
or obligation to any holder of Company Stock should the Mergers fail to qualify as a &ldquo;reorganization&rdquo; within the meaning of
Section 368(a) of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;8.11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="color: windowtext">Second Merger</FONT></I>(a). <FONT STYLE="color: windowtext">(a) Parent shall take all actions
necessary to: (i) promptly following the date of this Agreement, form Second Merger Sub, (ii) cause Merger Sub and Second Merger Sub to
perform their obligations contemplated by this Agreement and to consummate the Mergers on the terms and conditions set forth in this Agreement
and (iii) ensure that neither Merger Sub before the Effective Time nor Second Merger Sub prior to the Second Effective Time will conduct
any business, incur or guarantee any indebtedness or any other liabilities or make any investments, other than those activities incident
to their respective obligations under this Agreement or the transaction contemplated hereby.&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="color: windowtext">Parent shall take all actions necessary to cause, following the date of this Agreement but prior
to the consummation of the Mergers, the Board of Directors of Second Merger Sub to (i) determine that the Mergers contemplated hereby
(including the Second Merger) are advisable, fair to and in the best interests of Second Merger Sub and the sole stockholder of Second
Merger Sub, (ii) approve, adopt and declare advisable this Agreement and the Mergers contemplated hereby (including the Second Merger),
(iii) direct that this Agreement (including the Second Merger) be submitted for approval and adoption by the sole stockholder of Second
Merger </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 83; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">Sub and (iv) recommend
the approval and adoption of this Agreement (including the Second Merger) by the sole stockholder of Second Merger Sub.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="color: windowtext">Parent shall take all actions necessary to cause, immediately following the consummation of the
Merger on the terms and conditions set forth in this Agreement, the Surviving Corporation to be merged with and into Second Merger Sub
(the &ldquo;Second Effective Time&rdquo;), following which the separate existence of the Surviving Corporation shall cease and Second
Merger Sub shall continue as the Surviving Entity after the Second Merger and as a direct, wholly owned subsidiary of Parent (provided
that references to the Company or the Surviving Corporation for periods after the Second Effective Time shall include the Surviving Entity).
At the Second Effective Time, the effect of the Second Merger shall be as provided in this Agreement, the Certificate of Merger with respect
to the Second Merger and the applicable provisions of Delaware Law. Without limiting the generality of the foregoing, and subject thereto,
at the Second Effective Time, all the property, rights, privileges, agreements, powers and franchises, debts, liabilities, duties and
obligations of Second Merger Sub and Surviving Corporation shall become the property, rights, privileges, agreements, powers and franchises,
debts, liabilities, duties and obligations of the Surviving Entity, which shall include the assumption by the Surviving Entity of any
and all agreements, covenants, duties and obligations of Surviving Corporation to be performed after the Second Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;8.12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>At-the-Market Offering Facilities</I><FONT STYLE="font-style: normal">. Without limiting Section 6.01 (including Section 6.01(d)),
each of the Company and Parent will each keep the other reasonably informed in reasonable detail and in a timely fashion of any actual
or proposed ATM financing, and will coordinate and cooperate with one another (including, where reasonably requested, instructing its
Representatives and causing its Subsidiaries to provide customary cooperation) with a view to achieving the orderly, efficient and successful
execution of any such financing, including where reasonably requested, (i) providing reasonably available financial and other pertinent
information regarding the Company or Parent, as applicable, and their respective Subsidiaries, as is reasonably required for use in offering
documents and to enable such other party to prepare pro forma financial statements required by SEC rules (it being understood that each
party is solely responsible for the preparation of offering documents and pro forma financial statements to be used in such party&rsquo;s
own ATM financing program); (ii) using reasonable best efforts to cause its independent auditors to (A) provide drafts and executed versions
of customary auditors consents and customary comfort letters with respect to financial information relating to the Company or Parent,
as applicable, (B) provide assistance in the preparation of any pro forma financial statements and information (it being understand that
the each party is solely responsible for the preparation of such pro forma financial statements, and any other pro forma information,
including any pro forma adjustments, to be used in such party&rsquo;s own ATM financing program) and (C) participate in due diligence
sessions, as reasonably requested, with the sales agents in any ATM financing; and (iii) causing its management to participate in customary
due diligence sessions (including causing accounting due diligence sessions) with the sales agents in any ATM financing.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article&nbsp;9</FONT><U><BR>
Conditions to the Merger</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;9.01.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Conditions to the Obligations of Each Party</I>. The obligations of the Company, Parent and Merger Sub to consummate the Merger
are subject to the satisfaction (or, to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 84; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">the extent permitted by Applicable Law, waiver
by each such party; <I>provided</I> that the condition set forth in Section&nbsp;&lrm;9.01(a) shall not be waivable) of the following
conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company Stockholder Approval and Parent Stockholder Approval shall have been obtained in accordance with all Applicable Law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>no Applicable Law or Order preventing or making illegal the consummation of the Merger or any of the other Transactions shall be
in effect, and no litigation or similar legal action by any Governmental Authority (in any jurisdiction in which Parent, the Company or
any of their respective Subsidiaries conducts material operations) seeking to prohibit or restrain the Merger shall be pending;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Registration Statement shall have been declared effective under the Securities Act and no stop order suspending the effectiveness
of the Registration Statement shall be in effect and no proceedings for such purpose shall be pending; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the shares of Parent Class A Common Stock to be issued in the Parent Share Issuance shall have been approved for listing on Nasdaq,
subject to official notice of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;9.02.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Conditions to the Obligations of Parent and Merger Sub</I>. The obligations of Parent and Merger Sub to consummate the Merger are
subject to the satisfaction (or, to the extent permitted by Applicable Law, waiver by Parent) of the following further conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company shall have performed in all material respects all of its obligations hereunder required to be performed by it at or
prior to the Effective Time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>any applicable waiting period or periods under the HSR Act shall have expired or been terminated, without the imposition of a Burdensome
Condition (including any Burdensome Condition that would come into effect at the Closing), and no Applicable Law or Order shall be in
force and effect that would impose a Burdensome Condition (including any Burdensome Condition that would come in effect at the Closing)
and no litigation or similar legal action by any Governmental Authority (in any jurisdiction in which Parent, the Company or any of their
respective Subsidiaries conducts material operations) seeking to impose a Burdensome Condition shall be pending;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) the representations and warranties of the Company contained in Section&nbsp;&lrm;4.05(a) shall be true and correct, subject
only to <I>de minimis</I> exceptions, at and as of the date of this Agreement and at and as of the Closing as if made at and as of the
Closing (or, if such representations and warranties are given as of another specific date, at and as of such date); (ii) the representations
and warranties of the Company contained in Section&nbsp;&lrm;4.01, Section&nbsp;&lrm;4.02, Section&nbsp;&lrm;4.04(i), Section 4.05 (other
than 4.05(a)), &lrm;Section&nbsp;4.06(b), Section&nbsp;&lrm;4.24, Section&nbsp;&lrm;4.25 and Section&nbsp;&lrm;4.26 shall be true and
correct in all material respects at and as of the date of this Agreement and at and as of the Closing as if made at and as of the Closing
(or, if such representations and warranties are given as of another specific date, at and as of such date); (iii) the representations
and warranties of the Company contained in Section&nbsp;&lrm;4.10(a)(ii) shall be true and correct in all respects at and as of the date
of this Agreement and at and as of the Closing as if made at and as of the Closing; and (iv) the other representations and warranties
of the Company contained in this Agreement, disregarding all qualifications and exceptions contained therein relating to materiality</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 85; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">or Company Material
Adverse Effect, shall be true and correct at and as of the date of this Agreement and at and as of the Closing as if made at and as of
the Closing (or, if such representations and warranties are given as of another specific date, at and as of such date), except, in the
case of this clause&nbsp;(iv) only, where the failure of such representations and warranties to be true and correct has not had and would
not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>since the date of this Agreement, there shall not have occurred any event, circumstance, development, change, occurrence or effect
that has had or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Parent shall have received a certificate signed by an executive officer of the Company confirming the satisfaction of the conditions
set forth in Section&nbsp;&lrm;9.02(a), Section&nbsp;&lrm;9.02(c) and Section&nbsp;&lrm;9.02(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;9.03.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Conditions to the Obligations of the Company</I>. The obligations of the Company to consummate the Merger are subject to the satisfaction
(or, to the extent permitted by Applicable Law, waiver by the Company) of the following further conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>each of Parent and Merger Sub shall have performed in all material respects all of its obligations hereunder required to be performed
by it at or prior to the Effective Time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the waiting period or periods under the HSR Act shall have expired or been terminated;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>(i) the representations and warranties of Parent contained in Section&nbsp;&lrm;5.05(a) shall be true and correct, subject only
to <I>de minimis</I> exceptions, at and as of the date of this Agreement and at and as of the Closing as if made at and as of the Closing
(or, if such representations and warranties are given as of another specific date, at and as of such date); (ii) the representations and
warranties of Parent contained in Section&nbsp;&lrm;5.01, Section&nbsp;&lrm;5.02, Section&nbsp;&lrm;5.04(i), Section&nbsp;&lrm;5.22, Section&nbsp;&lrm;5.23
and Section&nbsp;&lrm;5.24 shall be true and correct in all material respects at and as of the date of this Agreement and at and as of
the Closing as if made at and as of the Closing (or, if such representations and warranties are given as of another specific date, at
and as of such date); (iii) the representations and warranties of Parent contained in Section&nbsp;&lrm;5.10(a)(ii) shall be true and
correct in all respects at and as of the date of this Agreement and at and as of the Closing as if made at and as of the Closing (or,
if such representations and warranties are given as of another specific date, at and as of such date); and (iv) the other representations
and warranties of Parent contained in this Agreement, disregarding all qualifications and exceptions contained therein relating to materiality
or Parent Material Adverse Effect, shall be true and correct at and as of the date of this Agreement and at and as of the Closing as if
made at and as of the Closing (or, if such representations and warranties are given as of another specific date, at and as of such date),
except, in the case of this clause&nbsp;(iv) only, where the failure of such representations and warranties to be true and correct has
not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 86; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>since the date of this Agreement, there shall not have occurred any vent, circumstance, development, change, occurrence or effect
that has had or would reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company shall have received a certificate signed by an executive officer of Parent confirming the satisfaction of the conditions
set forth in Section&nbsp;&lrm;9.03(a), Section&nbsp;&lrm;9.03(c) and Section&nbsp;&lrm;9.03(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article&nbsp;10</FONT><U><BR>
Termination</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;10.01.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Termination</I>. This Agreement may be terminated and the Merger and the other Transactions may be abandoned at any time prior
to the Effective Time (notwithstanding receipt of the Company Stockholder Approval):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by mutual written agreement of the Company and Parent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by either the Company or Parent, if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Merger has not been consummated on or before March 22, 2026 (the &ldquo;<FONT STYLE="color: windowtext"><B>End Date</B></FONT>&rdquo;);
<I>provided</I> that the right to terminate this Agreement pursuant to this Section&nbsp;&lrm;10.01(b)(i) shall not be available to any
party whose breach of any provision of this Agreement results in the failure of the Merger to be consummated by such time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>there shall be in effect any Applicable Law that permanently enjoins, prevents or prohibits the consummation of the Merger and,
if such Applicable Law is an Order, such Order shall have become final and non-appealable; <I>provided</I> that the right to terminate
this Agreement pursuant to this Section&nbsp;&lrm;10.01(b)(ii) shall not be available to any party which has not complied with its obligations
under this Agreement in respect of any such Applicable Law; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company Stockholder Approval shall not have been obtained upon a vote taken thereon at the Company Stockholder Meeting (including
any adjournment or postponement thereof); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by Parent, if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a Company Adverse Recommendation Change shall have occurred; <I>provided</I>, that in no event shall Parent be entitled to terminate
this Agreement pursuant to this Section&nbsp;&lrm;10.01(c)(i) following the receipt of the Company Stockholder Approval;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a breach of any representation or warranty or failure to perform any covenant or agreement on the part of the Company set forth
in this Agreement shall have occurred that would cause any condition set forth in Section&nbsp;&lrm;9.02(a) or Section&nbsp;&lrm;9.02(c)
not to be satisfied, and such breach or failure to perform (A) is incapable of being cured by the End Date or (B) has not been cured by
the Company within forty-five (45) days following written notice to the Company from Parent of such breach or failure to perform, but
Parent may terminate this Agreement under this Section&nbsp;&lrm;10.01(c)(ii) only so long as Parent is not</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 87; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">then in breach of any
of its representations, warranties, covenants or agreements set forth in this Agreement, which breach by Parent would cause any condition
set forth in Section&nbsp;&lrm;9.03(a) or Section&nbsp;&lrm;9.03(c) not to be satisfied; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Company shall have willfully breached any of their respective obligations under &lrm;Section&nbsp;6.03 or &lrm;Section&nbsp;8.03
in any material respect, other than in the case where (w) such breach is a result of an isolated action by a Representative of the Company
(other than a director or officer of the Company), (x) such breach was not caused by, or within the knowledge of, the Company, (y) the
Company takes appropriate actions to remedy such breach promptly upon discovery thereof, and (z) Parent is not harmed as a result thereof;
<I>provided</I> that in no event shall Parent be entitled to terminate this Agreement pursuant to this Section 10.01(c)(iv) following
the receipt of the Company Stockholder Approval; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by the Company, if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a breach of any representation or warranty or failure to perform any covenant or agreement on the part of Parent or Merger Sub
set forth in this Agreement shall have occurred that would cause any condition set forth in Section&nbsp;&lrm;9.03(a) or Section&nbsp;&lrm;9.03(c)
not to be satisfied, and such breach or failure to perform (A) is incapable of being cured by the End Date or (B) has not been cured by
Parent or Merger Sub, as applicable, within forty-five (45) days following written notice to Parent from the Company of such breach or
failure to perform, but the Company may terminate this Agreement under this Section&nbsp;&lrm;10.01(d)(i) only so long as the Company
is not then in breach of any of its representations, warranties, covenants or agreements set forth in this Agreement, which breach by
the Company would cause any condition set forth in Section&nbsp;&lrm;9.02(a) or Section&nbsp;&lrm;9.02(c) not to be satisfied; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Parent does not deliver, or cause to be delivered to the Company, the duly executed Parent Stockholder Approval in accordance with
<U>Section 7.05</U> by the Parent Stockholder Approval Deadline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The party desiring to terminate this Agreement
pursuant to this Section&nbsp;&lrm;10.01 (other than pursuant to Section&nbsp;&lrm;10.01(a)) shall give written notice of such termination
to the other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;10.02.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Effect of Termination</I>. If this Agreement is terminated pursuant to Section&nbsp;&lrm;10.01, this Agreement shall become void
and of no effect without liability of any party (or any stockholder or Representative of such party) to the other parties hereto, except
as provided in &lrm;Section&nbsp;10.03; <I>provided</I> that neither Parent nor the Company shall be released from any liabilities or
damages arising out of any (i) fraud by such party (ii) the willful breach by such party of any representation or warranty on the part
of such party set forth in this Agreement or (iii) the willful breach by such party of any covenant or agreement binding on such party
set forth in this Agreement. The provisions of this Section&nbsp;&lrm;10.02, &lrm;Section&nbsp;10.03 and Article&nbsp;&lrm;11 (other than
Section&nbsp;&lrm;11.13) shall survive any termination hereof pursuant to Section&nbsp;&lrm;10.01. In addition, the termination of this
Agreement shall not affect the parties&rsquo; respective obligations under the Confidentiality Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 88; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;10.03.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Termination Fees</I>. (a) If this Agreement is terminated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by Parent pursuant to &lrm;Section&nbsp;10.01(c)(i) or &lrm;Section&nbsp;10.01(c)(iii) or by the Company or Parent pursuant to
any other provision of Section 10.01 at a time when this Agreement was terminable by Parent pursuant to &lrm;Section&nbsp;10.01(c)(i)
or &lrm;Section&nbsp;10.01(c)(iii); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>by the Company or Parent pursuant to Section&nbsp;&lrm;10.01(b)(i) (without the Company Stockholder Approval having been obtained),
by the Company or Parent pursuant to Section&nbsp;&lrm;10.01(b)(iii), or by Parent pursuant to Section&nbsp;&lrm;10.01(c)(ii) (without
the Company Stockholder Approval having been obtained or, if such termination is after the Company Stockholder Approval has been obtained,
as a result of a willful breach by the Company) and: (A) at or prior to the time of termination of this Agreement, a Company Acquisition
Proposal shall have been publicly disclosed or announced (in each case, and not publicly withdrawn) or made known to the management or
board of directors of the Company (in each case, and not publicly withdrawn), or any Person shall have publicly announced (in each case,
and not publicly withdrawn) an intention (whether or not conditional) to make a Company Acquisition Proposal; and (B) on or prior to the
first (1<SUP>st</SUP>) anniversary of such termination of this Agreement: (1) a transaction relating to a Company Acquisition Proposal
is consummated; or (2) a definitive agreement relating to any Company Acquisition Proposal is entered into by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">then, in each case, the Company shall pay to Parent
(or a Person designated by Parent), in cash at the time specified in the following sentence, a fee in the amount of $49,000,000 (the &ldquo;<B>Company
Termination Fee</B>&rdquo;). The Company Termination Fee shall be payable as follows: (i) in the case of Section&nbsp;&lrm;10.03(a)(i),
in the event the Company Termination Fee is payable in connection with a termination of this Agreement (A) by Parent, within five (5)
Business Days of such termination, and (B) by the Company, substantially concurrently with, and as a condition to, such termination and
(ii) in the event the Company Termination Fee is payable under Section&nbsp;&lrm;10.03(a)(ii), substantially concurrently with, and as
a condition to, the earlier of the consummation of the applicable transaction and the entry into a definitive agreement with respect to
the applicable transaction. For purposes of Section&nbsp;&lrm;10.03(a)(ii)(B), &ldquo;<B>Company Acquisition Proposal</B>&rdquo; shall
have the meaning assigned thereto in Section&nbsp;&lrm;1.01, except that references in the definition to &ldquo;20%&rdquo; shall be replaced
by &ldquo;50%.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Any payment of the Company Termination Fee shall be made, at Parent&rsquo;s election, either (i) by wire transfer of immediately
available funds to an account designated in writing by Parent or (ii) in Bitcoin, at the then-current spot price one calendar day prior
to making such payment, to a wallet designated in writing by Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The parties agree and understand that (x) in no event shall the Company be required to pay the Company Termination Fee on more
than one occasion, and (y) in no event shall Parent be entitled, pursuant to this &lrm;Section&nbsp;10.03, to receive an amount greater
than an amount equal to (A) the Company Termination Fee <I>plus </I>(B) any Collection Expenses. Notwithstanding anything to the contrary
in this Agreement, except in the case of fraud, (i) in circumstances where the Company Termination Fee is payable or is paid pursuant
to this &lrm;Section&nbsp;10.03, such payment shall be the sole and exclusive remedy for damages of the Company, Parent or their respective</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 89; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">Subsidiaries and their
respective former, current or further partners, stockholders, managers, members, Affiliates and Representatives, as applicable, and none
of Parent, the Company, any of their respective Subsidiaries or any of their respective former, current or future partners, stockholders,
managers, members, Affiliates or Representatives, as applicable, shall have any further liability or obligation relating to or arising
out of this Agreement or the Transactions, and (ii)&nbsp;if Parent or Merger Sub receive any payments from the Company in respect of any
breach of this Agreement and thereafter Parent receives the Company Termination Fee pursuant to this &lrm;Section&nbsp;10.03, the amount
of such Company Termination Fee shall be reduced by the aggregate amount of such payments made by the Company prior to paying the Company
Termination Fee in respect of any such breaches. The parties acknowledge that the agreements contained in this &lrm;Section&nbsp;10.03
are an integral part of the Transactions, that, without these agreements, the parties would not enter into this Agreement and that any
amounts payable pursuant to this &lrm;Section&nbsp;10.03 do not constitute a penalty. Accordingly, if any party fails to promptly pay
any amount due pursuant to this &lrm;Section&nbsp;10.03, such party shall also pay any reasonable and documented costs and expenses (including
reasonable and documented legal fees and expenses) incurred by the party entitled to such payment in connection with a legal action to
enforce this Agreement that results in a judgment for such amount against the party failing to promptly pay such amount. Any amount not
paid when due pursuant to this &lrm;Section&nbsp;10.03 shall bear interest from the date such amount is due until the date paid at a rate
equal to the prime rate as published in <I>The Wall Street Journal, Eastern Edition</I> in effect on the date of such payment (such interest,
together with reasonable and documented costs and expenses of enforcement as provided in the immediately preceding sentence, &ldquo;<FONT STYLE="color: windowtext"><B>Collection
Expenses</B></FONT>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article&nbsp;11</FONT><U><BR>
Miscellaneous</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;11.01.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Notices</I>. All notices, requests and other communications to any party hereunder shall be in writing (including electronic mail
(&ldquo;<FONT STYLE="color: windowtext"><B>e-mail</B></FONT>&rdquo;) transmission, so long as a receipt of such e-mail is requested and
received) and shall be given,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">If to the Company, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Semler Scientific, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">2340-2348 Walsh Avenue,
Suite 2344</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Santa Clara, California 95051</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Attention:&nbsp;&nbsp;Renae
Cormier</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Email:&#9;rcormier@SemlerScientific.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">with a copy to (which shall not constitute
notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Goodwin Procter LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">620 Eighth Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">New York, New York 10018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Attention: &#9;Michael R. Patrone</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Marianne C. Sarrazi&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Email:&#9;MPatrone@goodwinlaw.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MSarrazin@goodwinlaw.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 2.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 90; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">If to Parent or Merger Sub and, post-closing,
the Surviving Corporation, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Strive, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">100 Crescent Ct,
Suite 1100</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Dallas, Texas 75201</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Attention:&nbsp;&nbsp;Logan
Beirne</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Email:&#9;logan.beirne@strive.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">with a copy to (which shall not constitute
notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left">Davis Polk &amp; Wardwell LLP<BR>
450 Lexington Avenue<BR>
New York, New York 10017<BR>
Attn:&#9;Brian Wolfe</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Evan Rosen<BR>
Email: &#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;brian.wolfe@davispolk.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;evan.rosen@davispolk.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">or to such other address or facsimile number as
such party may hereafter specify for the purpose by notice to the other parties hereto. All such notices, requests and other communications
shall be deemed received on the date of receipt by the recipient thereof if received prior to 5:00 p.m. on a business day in the place
of receipt. Otherwise, any such notice, request or communication shall be deemed to have been received on the next succeeding business
day in the place of receipt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;11.02.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Survival</I>. The representations, warranties, covenants and agreements contained in this Agreement and in any certificate or other
writing delivered pursuant hereto shall not survive the Effective Time, except for the covenants and agreements set forth in Article&nbsp;&lrm;2,
Section&nbsp;&lrm;7.03 and this Article&nbsp;&lrm;11, which shall survive the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;11.03.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Amendments and Waivers</I>. (a) Any provision of this Agreement may be amended or waived prior to the Effective Time if, but only
if, such amendment or waiver is in writing and is signed, in the case of an amendment, by each party to this Agreement or, in the case
of a waiver, by each party against whom the waiver is to be effective; <I>provided</I>, that after the Company Stockholder Approval has
been obtained, there shall be no amendment or waiver that would require the further approval of the stockholders of the Company under
Applicable Law without such approval having first been obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall
any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege.
The rights and remedies provided in this Agreement shall be cumulative and not exclusive of any rights or remedies provided by Applicable
Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;11.04.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Expenses</I>. Except as otherwise provided in this Agreement, all costs and expenses incurred in connection with this Agreement
shall be paid by the party incurring such cost or expense, except that expenses incurred with the filing fee for the Registration Statement
and the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 91; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">printing and mailing the Information Statement/Proxy
Statement/Prospectus and the Registration Statement shall be shared equally by Parent and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;11.05.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Disclosure Schedule References and SEC Document References</I>. (a) The parties hereto agree that each section or subsection of
the Company Disclosure Schedule or the Parent Disclosure Schedule, as applicable, shall be deemed to be an exception to and to qualify
(or, as applicable, a disclosure for purposes of), the corresponding section or subsection of this Agreement, irrespective of whether
or not any particular section or subsection of this Agreement specifically refers to the Company Disclosure Schedule or the Parent Disclosure
Schedule, as applicable. The parties hereto further agree that (other than with respect to any items disclosed in Section&nbsp;&lrm;4.17(a)
of the Company Disclosure Schedule, for which an explicit reference in any other section shall be required in order to apply to such other
section) disclosure of any item, matter or event in any particular section or subsection of either the Company Disclosure Schedule or
the Parent Disclosure Schedule shall be deemed disclosure with respect to any other section or subsection of the Company Disclosure Schedule
or the Parent Disclosure Schedule, as applicable, to which the relevance of such disclosure would be reasonably apparent to a reasonable
person without any independent knowledge regarding the matter(s) so disclosed, notwithstanding the omission of a cross-reference to such
other section or subsections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The parties hereto agree that in no event shall any disclosure (other than statements of historical fact) contained in any part
of any Company SEC Document or Parent SEC Document entitled &ldquo;Risk Factors,&rdquo; &ldquo;Forward-Looking Statements,&rdquo; &ldquo;Cautionary
Statement Regarding Forward-Looking Statements,&rdquo; &ldquo;Special Note on Forward Looking Statements&rdquo; or &ldquo;Forward Looking
Information&rdquo; or containing a description or explanation of &ldquo;Forward-Looking Statements&rdquo; or any other disclosures in
any Company SEC Document or Parent SEC Document that are cautionary, predictive or forward-looking in nature be deemed to be an exception
to (or a disclosure for purposes of) any representations and warranties of any party contained in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;11.06.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Binding Effect; Benefit; Assignment</I>. (a) The provisions of this Agreement shall be binding upon and shall inure solely to the
benefit of the parties hereto, except for: (i) only following the Effective Time, the right of (x) the Company&rsquo;s stockholders to
receive the Merger Consideration in respect of their shares of Company Stock pursuant to Section&nbsp;2.03 and (y) the holders of Company
Equity Awards to receive the Merger Consideration in respect of their Company Equity Awards pursuant to Section&nbsp;&lrm;2.05 and (ii)
the right of the Company Indemnified Parties to enforce the provisions of Section&nbsp;&lrm;7.03. Except as provided in Section&nbsp;&lrm;7.03
and in this Section &lrm;11.06, no provision of this Agreement is intended to confer any rights, benefits, remedies, obligations or liabilities
hereunder upon any Person other than the parties hereto and their respective successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>No party may assign, delegate or otherwise transfer (by operation of law or otherwise) any of its rights or obligations under this
Agreement without the prior written consent of each other party hereto, except that Parent may transfer or assign its rights and obligations
under this Agreement, in whole or from time to time in part, to any Person after the Closing, and Merger Sub may transfer or assign its
rights and obligations under this Agreement, in whole or from time to time in part, to any other wholly owned direct Subsidiary of Parent,
which Subsidiary shall be a Delaware corporation; <I>provided</I> that such transfer or assignment shall not relieve Parent or Merger
Sub of its obligations hereunder or enlarge, alter or change any obligation of any other</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 92; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">party hereto or due
to Parent or Merger Sub. Any assignment in contravention of the preceding sentence shall be null and void <I>ab initio</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;11.07.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Governing Law</I>. This Agreement and all actions (whether in contract or tort) based on, arising out of or relating to the negotiation,
execution or performance of this Agreement or the Transactions shall be governed by and construed in accordance with the laws of the State
of Delaware, regardless of the Applicable Law that might otherwise govern under applicable principles of conflicts of law rules thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;11.08.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Jurisdiction/Venue</I>. Each of the parties hereto agrees that any suit, action or proceeding seeking to enforce any provision
of, or based on any matter arising out of or in connection with, this Agreement or the Transactions (whether brought by any party or any
of its Affiliates or against any party or any of its Affiliates) shall be brought, tried and determined only in the Delaware Court of
Chancery and any state appellate court therefrom within the State of Delaware (or, only if the Delaware Court of Chancery declines to
accept jurisdiction over a particular matter, any federal court within the State of Delaware). Each of the parties hereto (i) irrevocably
consents to the service of the summons and complaint and any other process in any suit, action or proceeding relating to the Transactions,
on behalf of itself or its property, in accordance with Section&nbsp;&lrm;11.01 or in such other manner as may be permitted by Applicable
Law, and agrees that nothing in this Section&nbsp;&lrm;11.08 shall affect the right of any party to serve legal process in any other manner
permitted by Applicable Law, (ii) irrevocably and unconditionally consents and submits itself and its property in any suit, action or
proceeding to the exclusive general jurisdiction of the Delaware Court of Chancery and any state appellate court therefrom within the
State of Delaware (or, only if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any federal court
within the State of Delaware) in any suit, action or proceeding seeking to enforce any provision of, or based on any matter arising out
of or in connection with, this Agreement or the Transactions or for recognition and enforcement of any judgment in respect thereof, (iii)
agrees that it shall not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court,
(iv) waives any objection that it may now or hereafter have to the venue of any such suit, action or proceeding in any such court or that
such suit, action or proceeding was brought in an inconvenient court and agrees not to plead or claim the same and (v) agrees that it
shall not bring any action relating to this Agreement or the Transactions in any court other than the aforesaid courts. Each of Parent,
Merger Sub and the Company agrees that a final judgment in any suit, action or proceeding in such court as provided above shall be conclusive
and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;11.09.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>WAIVER OF JURY TRIAL</I>. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY
TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH
PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE
MERGER OR THE OTHER TRANSACTIONS. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (i) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY
HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 93; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER,
(ii) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (iii) EACH PARTY MAKES THIS WAIVER VOLUNTARILY AND (iv)
EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION&nbsp;&lrm;11.09.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;11.10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Counterparts; Effectiveness</I>. This Agreement may be signed in any number of counterparts, including by e-mail with .pdf attachments,
each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement
shall become effective when each party hereto shall have received a counterpart hereof signed and delivered (by e-mail or otherwise) by
all of the other parties hereto. Until and unless each party has received a counterpart hereof signed by the other party hereto, this
Agreement shall have no effect and no party shall have any right or obligation hereunder (whether by virtue of any other oral or written
agreement or other communication).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;11.11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Entire Agreement</I>. This Agreement (including, for the avoidance of doubt, the Company Disclosure Schedule and the Parent Disclosure
Schedule) and the Confidentiality Agreement constitute the entire agreement between the parties with respect to the subject matter of
this Agreement and supersedes all prior agreements and understandings, both oral and written, between the parties with respect to the
subject matter hereof. Notwithstanding anything in this Agreement to the contrary, the parties acknowledge and agree that, solely for
purposes of Section 251 of Delaware Law, the Company Disclosure Schedule is not incorporated by reference into, and shall not be deemed
to constitute a part of, this Agreement or the &ldquo;agreement of merger.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;11.12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Severability</I>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
or other Governmental Authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions
of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated so long as the economic
or legal substance of the Transactions is not affected in any manner materially adverse to any party. Upon such a determination, the parties
shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an
acceptable manner in order that the Transactions be consummated as originally contemplated to the fullest extent possible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Section&nbsp;11.13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;
</FONT>Specific Performance</I>. The parties acknowledge and agree that irreparable harm would occur and that the parties would not have
any adequate remedy at law (even if monetary damages were available) (i) for any breach of the provisions of this Agreement or (ii) in
the event that any of the provisions of this Agreement were not performed in accordance with their specific terms. It is accordingly agreed
that, except where this Agreement is terminated in accordance with Section&nbsp;&lrm;10.01, the parties shall be entitled to an injunction
or injunctions to prevent breaches of this Agreement and to specifically enforce the terms and provisions of this Agreement in the courts
referred to in Section&nbsp;&lrm;11.08, without proof of actual damages, and each party further agrees to waive any requirement for the
securing or posting of any bond in connection with such remedy. The parties further agree that (x) by seeking the remedies provided for
in this Section&nbsp;&lrm;11.13, a party shall not in any respect waive its right to seek any other form of relief that may be available
to a party under this Agreement, including, subject to Section&nbsp;&lrm;10.03(c), monetary damages and (y)&nbsp;nothing contained in
this Section&nbsp;&lrm;11.13 shall require any party to institute any</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 94; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">proceeding for (or limit any party&rsquo;s right
to institute any proceeding for) specific performance under this Section&nbsp;&lrm;11.13 before exercising any termination right under
Section&nbsp;&lrm;10.01 or pursuing damages nor shall the commencement of any action pursuant to this Section&nbsp;&lrm;11.13 or anything
contained in this Section&nbsp;&lrm;11.13 restrict or limit any party&rsquo;s right to terminate this Agreement in accordance with the
terms of Section&nbsp;&lrm;10.01 or pursue any other remedies under this Agreement that may be available then or thereafter. The parties
further agree not to assert that a remedy of specific enforcement is unenforceable, invalid, contrary to Applicable Law or inequitable
for any reason, and not to assert that a remedy of monetary damages would provide an adequate remedy for any such breach or that the parties
otherwise have an adequate remedy at law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Remainder of page intentionally left blank;
signature pages follow]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 95; Value: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed by their respective authorized officers as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><B>STRIVE, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify">/s/ Matthew Cole </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify">Name:</TD>
    <TD STYLE="width: 41%; text-align: justify">Matthew Cole</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">Chief Executive Officer</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 96 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">[<I>Signature Page to Agreement and Plan of Merger</I>]</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed by their respective authorized officers as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><B>SEMLER SCIENTIFIC, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify">/s/ Eric Semler</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 4%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify">Name:</TD>
    <TD STYLE="width: 41%; text-align: justify">Eric Semler</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">Chairman of the Board</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 97; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">[<I>Signature Page to Agreement and Plan of Merger</I>]</FONT></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>asst-20250922.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9a85s7xRiXgen8uCZHRMWaSKWaP9x5V6CZkxtmt1fUmKPy8sW1AcRSJ+V9+WYeQH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:ASST="http://assetentities.com/20250922" elementFormDefault="qualified" targetNamespace="http://assetentities.com/20250922">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://assetentities.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="asst-20250922_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="asst-20250922_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>asst-20250922_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>asst-20250922_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="asst-20250922.xsd#Cover" roleURI="http://assetentities.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://assetentities.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 22, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 22,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">STRIVE, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001920406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-1293236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200 Crescent Ct<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dallas<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">855<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">427-7360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ASST<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp234662_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://assetentities.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>asst-20250922.xsd</File>
    <File>asst-20250922_lab.xml</File>
    <File>asst-20250922_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="dp234662_8k.htm">dp234662_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp234662_8k.htm": {
   "nsprefix": "ASST",
   "nsuri": "http://assetentities.com/20250922",
   "dts": {
    "schema": {
     "local": [
      "asst-20250922.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "asst-20250922_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "asst-20250922_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "dp234662_8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 24
   },
   "report": {
    "R1": {
     "role": "http://assetentities.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-22",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp234662_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-22",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp234662_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://assetentities.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0000950103-25-011965-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-011965-xbrl.zip
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MUY:X8@,RIYDPRX-@ 3!E,J!D2.J0$GKI>7V7@.;R(4:P.:;,+0%VDTT*FIJ
M2+ : V@X:(MG2KT0,1,C$\?IG,9D]PO9@^UJZ=PR =AL0F&( J+"[@S HA2C
M0HV$W L8=SS98+Y?)%'/5-$6ND4#,MIDPU0%! =@#:"C5*/%?.9S)EGBW3P6
MH"8/B7H>O(<24.\6EA[;368 <4#H=#L$"!)!J!GE$Z0YC1A_9K7''69L*P;
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MV;?=Z;7[VOE/K]&VH+M'BLY=773J8U8.=FKO\J+RY1K.]H#OCOCX5VW2#\-
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M7CZ41"F#=-P(]+Y(^O]@2)]<T0@"3A" X"HOJ$ X5SE]%X_&_1C<&VIQ_:^
M.HG9P!<ZZ"GH;Y$-&!J,(YF7D#JCRR+X/T5 Y%R/W]W'Q7\'>*K+&&&*02!.
MJT7ZEHP\4%!_QO.5\JZ$04)Z=VB>@YX71)8GG C&RGV<0"J\M]#O M=1'J9[
M]:M[,*J&D#%<RQ7XI=RE!9(F@V(8$KXGENGV3S9U'JC2M9DA^!!7^2BO@Q2/
MM.:\%NY=277A,4^?DEXJ-)=F&&;$6XWFPH5,'EZ^T&6)3@09U(:,7 QY<2?U
M>/K"=N1(:K4J([0CR_62D(M)E6<G-\#/PY]<8D:Q2TQH[YC=Y4=XK!+SDA"8
MN(\C%TQ)RA=S$KKE$-DG'\N*,@Y[R5>FI.AQ+R#O''=8X\Q&"6<& \-#2[48
MHI&9QIJ?+6/!S)'4J[]O:E_,(U2(?SJ)+FPB+<Y?Y@S&$-8TB1,TDE1ZN7F4
MA$AZTP!SBIA+9,C=)MBSZK9DTT>*-XIG*(11\@Z9L&.X#4GY'VB6D#O..+%"
M0%"1J;R5YD4)(TM$62W_OA%"<TF$$%9@^? (:$H&F*(%5T<NX]C"M-E<9(4R
M5.\Q8I5@,$3R9G0LR!,N'+\&JV&61ZM9R:K7Q#  ,N, %2Z5178'^(F@.;3!
MK 9^(_5RY%1\$WGT3NX*#^"(7!!B'\OB+\8"OV1V+"T8GC;\O=NS*@2?$K#"
M7+X.8LWZ,4IEDLO7I1P; I3+-4Q=HI"RYGP-$NY (#TOB&*0#'SA%-T(1L_7
MAA6T_3!B7=2$C*PF).7G$VL*V42MY=)', 4]U$A.4_3SIQG.19(>DR! H0LY
MJ<G@4Y1XXJF4U)S(4YPV9"J64D94)J4<U8:..?W9"94/R22>29]1D.>+U%:D
M-6]LFHXUC[1$*ZXC$:!I<[GO6UNX3'R22Y<DE#.&D#V,$HR>\8;,62#Y1>%?
M2C1!:) ;;T1A>9I2E!8)DP9/UMR9"0TJ>K[DD]'^[TE"@N;4F1 #L_N?&AO-
M.['1>&IL3&&5AO\7<-'@9,J?.@'C(SG,@^\B>2\!E.0A"639,H^*]!9UBFF#
MGV+Z"Z*NZ_^D &OK'QM@+=2F1UP;SCJ!JV9"A]>R::9IM$9[GZM0FAGKAG8R
MQ80ZF^FYC9G.M%P:3",6S"#@O,:2-B.E@F0DL5+T,_I1@9>CQ(-D/L*#I!P5
M!1X7(6\D*_@N66,^7M94#=UI+P]B6!F0C\ RR$M5AF>2<-S_V=@UI_"N=/!9
M$<G8UVYLTX'"A>@-%160>>NX/$I;-W)IZQ*W(A:CKH\*>+';YMD*RYZ()J=)
M/7>[ GC]!.&YY?Z-3!@]3PB:EJ-.M;@9:7J'B5DL]%;TG#<MZ:G(42T3F6@
M:5JL5DNGYR0JPTQS^O 7EYDU2[RY3V7&D T^U^":5Z>-OU*!2=5IXPG5Z07"
MSZDP.JH8=\0T"E$%)DA>P(7#"1@YH\/%N<TMZ3G*=LLS!37Q8)DYCIM!T%41
M;%@51STRL%0'=1=D6N&A:]V?9 ,N\X110[+<=*ZS!!B^#>H=QE$PV=3A:=9^
MD( $="C)6.RTGMNB7D/0.Z%UXZ_R?&Z'F5=^<./+>0/F@0X@47R(H@XM5Z?$
MH7__X:HR'7P&]!?0T3^/=I>EK9<MPRA;ACC8[/.L;GD,"P;C_AA!"9:WJAS%
M9>!6$FX_#2,MLCQCY(:8">#[J&]'XB!QT3F9HLW>,U>:J'/H@C5DZ-+A"=1W
MS@UQ7./)^Y@)O=+"+IVTNH6EQ2.UOOWY?7K/%"_(8'S5_),$_XLRD4^8\+<2
M^2_=@]X40RQX+IBNO*)]Z[.Q%3HR!+P@)9Z[%UVY6D4ZR_+XHC)B*0@>QB+1
M@IRI+.8:,R"F/-*N+DQ&H@]9/$<L!5T6L-:W4TTAP8P2,/66\5T[F!'YIL4)
MXI@[<E">QP%*A.XM/S31JC?E3-+++T5+U\_,X=EB6UNMN' CE)CAB@\/7@E3
M3?<>9D._@BED%:PTY"AJ&ZI34]PUKL7X0X7K%#E0)U*%[UF_M43.!8^BCH!]
M)E24(>W*&E+N5X$2R3-2<SFP53W1GUL3,N=49*F6QWZY[$)H&21&P7[BQSFY
M]J'G<Y0FA/+D(&'-VG3H,MHW;S#?OZC/(?.!QRN$SA:;6+"5]WFE$1V">.NX
M9#$T-,)01#]!4B!ID24^+,LU*=EM=16MW&Q#-<?4/: 3RGJC*BP6H1\(_\ 6
MD@GWQ8VN,@FU<FUNUB)B^OQC07G<K)8Q7'ZT(V;[M$$&H?,T<#CC@(FF7 1K
MV0F["79[Y-+%J(!00K5*0IFCEFY(R12+#A;ZP "A._V$;D&%'^([^H!RSX"7
MB$IZ9?@'Q,(\(G',432]P,?G&*H,$YEW9F%$'^;K$$!0>&)K-!GF:?$\;"B/
M$R&ADI&!^\1S:# ?;D2,+>:2_49+%<7231RQU(&D!R*/L8 \DE/4'X:$2UB.
M!"H8,*%3XX$[3DRV2/0DOU+) 42>#E6]XZ1V/ANV9.["'ETL9$':-_=V9ZI(
MI'F"H_2,3FEZ.>\6-E0[HYK5Q! N%J_>D!N]>%C*3B/U-OOR[(YB)MP\BB9D
MOG*,QF-&TF"_+Q\65H.F1D2&,+;IS.[$"H&' >9]$UZP-)T6A4,4BX/LR.FH
MM]0XSE5'R0<=L*10W3P!30;3GZL9.9-FKA'.R'0<>(K6IYC"G0?+YM+UF!JM
M>J&",G:!&<KD1X[U.1%EDTTWER%K'IO*<)(")Z42D6FR-)E9.ENJ9PT'-!D]
MYHR5_Q8&1/Q7!YMC.BX!.D2DZ7VI4FA;=%@";:>4GP.$B=N(O"$7/1J\-BA'
M2TIQ$N:=3%_$'5;24^.B&D<SBE4-Q:Y0T(<"6]+;RXAEZ,GE9#GF!)!,T)97
MK1'<IV[D,:J2K1^"T4+]&DF0V+6 ?7J8C(RB4CQT_2C&![(!ES$RWI\*&<[O
MBE=8B$(:BTOKU^E4$.</D%HCO \.-1/)9++/]41X+BW3:B=*@ZKR\X6IUFQD
M5'8T-7D*89_JV@L6E)I#F#V$0![4-K1!A):*Y>?"X%;#I8(3*=2&)IUHZ=GD
M\KEA>.!$Z1HX4 3*=>U=-?W\7G[&;4XE#;\J3Z@)I46I1/3SBJ4;I]621JFL
MJK:D]]BGV;S=SE\0I-OX)P7IUO^Q0;J7PX-VRDM[NBF%AR'IZ#%POR,7OO70
M[S!\MGZ'7K$>+C)6,R7RE+!7]?@")&5FI/39[0#+N)L;*2HM;EKE.A:_JX/:
M%=4AD[8+K\(VG!MJ=O=>D>#-"YS1SPB'+(,4W+^4=QIW\$ZY=!UKU,K7SJG;
MS'?1!?<3W\4MY[0CM&I#[@AGNJ!(LFN+_$9VPB5QJH^50J@.0-=<I ^=-,$5
MK$DZC25UWJP1G)$YF/3,V)60ERKH($WWP@F^[AZ=];OF2?M=[_2-V3[];'XX
MN\"/9WVS=_JA.[@XZ9Y>F(?=3F_0.SNM&OS'L_X &A^:\*GS[NW9\6$7?C@[
M HB=''?[YJ#3,]O0[67_3??0O#@S^]TV_'W;A0]O>H.+?OL".H.WVQ==ZA_[
MZIW"5$YR3];.^V>?/F>_#\Z[G8O+@0%]M?N'.%GL&1Z<GPUPN'[[=-#N4#\?
MWW9/\>EG6&CG[*1KMC^T>\?MU\==&A+7>P:/^S"OX^Z'-J[TK'.) PW,H]XQ
M]/:Q=_&6^@=DJ)KM@?FQ>WR,?_'=-K0\I-8&P&MP>7Y^W.4OPYHOWL)TTOZJ
M.(7V)?Q$\_G8@VXZ9Z<7[=ZIV3LY/^M?X/ Z$-JOSRXO8.G]WH=N-0/:T\/2
M)1OX$%8#\#J$;;VX@)WY27R#9?QL"=T8)<2>:EA9I4DHB/P,[H(/KX@M5*7;
M087LS!'F( =TMS,HM5A!4W*+%SCN,'(Q.)VY/\0.O"!$E25A)  S#TGO<)@M
M2M[N<<\ 3!C:3N)XMK>V=G-S4X^871\'UXLWG:_6^;;P?S\'"6?(=)87LXA%
M G$:O(Z8H?@8E1&D7^=D@" '+%@CCZ_(G',JZQ9%Z;D-;>%6+)"D?/T/67P$
MJW>I_%P01O6(.U9!DJUE[Y^I&YU@YJ:^SU+9^ CAH3P=$HLR(ELW0(R,ESX;
M(A">0QOCYV)G4I12=?P$N(=S$?_DY:30*L2SP"K>#?#N":# 4CU+GN-%/Q,O
M^AV;K4;#[(#5A*HL*/E)B(>/$]RBYD:C434/+0\4 Z!0=@MTLKW9:C1%*H$-
M3R@986=S<]7<:&W7MM>W&N)AE SQ7"S/4  J0GMUCG&TI]YP-ZSA@?,D!-1;
M(T*VXYH;YO" (Q]'!GD"(!7:A-W9_<OZ#J4EF:;>9RD!%;$"AT:*_#\4#"$0
M/8X5J4KL"(D\YE^0YR/%:4+K;+DRO6[[BTBWI<7,9=J]*"Q+D7+A+G#0CA<'
MEJJB[CHG,XH+:Y=5&CF+F\=SLQQ8'$>1);K11,T2U+,55L"VS]'_;KLS2[EB
M8,K:@>+G;*LL>EXR=9&+2KZI%(RJK#9RC=6@ 0VE\UN61HVDE-21A8<K<N"*
M-'!1K3M@N\BW2<#<H>!FC!-CJ7&2$8F]!5'/G868=!#%2F:D&2>B6"Q?L:E6
M7%;]6_/.\%23B.XK>"Q([@N!1?/,R)MG5D$P'/:8KU14TQ=?%#A(^F3B&42X
M,F9RX_)R<YQ/JJBM6(L&:N->LI6R1=+"!L6F,W="RS$7F?CRW3;NO;D+3DDL
MX!]&$W>6VX=L2>^LQ@C\-7,8741I:)F&Q ^JL9%+((G$MB*KCW&)%=T:2*V=
ML\N^^?H,OJ#%==CK@S4D[;'.61\L"=#]S3=G'[K]T_9IIUNMF)7NIV[G\@+L
M"./LZ*C7 9L ?P7(7?9[%V #?3R%G][VSK%'>$I&R>ON:1?:]MK'XCF-<-(^
M;;\A(P=Z$.>:Y1Q@^)/S+E@B..&J/-2,SL:*9J$,N$TE;91SZ!E^K&1028?F
M#U,G7UKF),0[L:1\U;3J-??VWZ FO%IKA_8$"Z^L,6=LA6N.%5MKC4:CN;FY
ML;.Y2Q^;C8VMS=W69F,+]*/UM7C:VFQN;VVU:NM?P-IO;ECU23RM'&B6?\[?
M\7+-REV?R-=84"\6TQ/PS(39]GT,%ZALZI&>/LI-G@+E!B]<P)Y_Q^,9S6UQ
M_L+4_&^%CGRC!.^%$I(FFZ<N9> 9.-<[R8RGLJB-IBB?( H9I\2)"W7!$'ZO
MR*1+#S<D*T!+)571L!)AP9;:8[<V=/TU6$S-<:/9OSE%OAH#".EB[W]9T]E^
MI_?N5;K!=;-06!@/D UN+I,CIXMUL) BI5MAWA$J:W\U:N^V&AN-+?K8:J[O
MXIWHC9WM]9WM-6;!Y^WU9JNV<_5%J.*$VS+\M(C)1B$6:J> FIO9NXQ>_.U!
MDB-,8Q$DXGHGPBU^W$1P5B1W N,QLQQ!D1?,FBK>2G8XG3A.*\^+=]N$O)>1
M; M@N5JT#0S-=)&0THRN& :[FU_DY&06X>_-)(Q',@GSSV$2 BG(WHITHU*Z
M![@&J$],%=92<5O0_ZQQ:,TF>;=2WLZT]+>!#UTS[2SWA$=[#;G3]P^GU 4V
M/%<K!:\A#\PS3/XAJU57C9^S=76Q8 P7Y1)F;>O,S4HH21@=QXW0<RGB''G3
M0+8S']!NF/"2>AH=EKXUI^,L5$Y957CR@U!,FGQ8Y!W![BR/GQ1-NUU:;9R(
MF"95S0T<\K[XJ9,AXKEGW8P2SU Y\*'NS4L3Z@2@4[K0Y@)=J,IL-+0^J[H)
M2,8!E%T!7^=0I-[Q+"S,&\ [JD1VFQ:7$L6T]/- *LU1703;D.9E\5W.A<7
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M#*6..N[8I:M:Z+:2JCD&@(7PG0$'#::P5&P*R'#%M HII*GQK!-A' M- *<
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M%8?(VC!PYO@73&/OX/\#4$L#!!0    ( ,2+-EL(A13NY7T! '9-"0 3
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M'6:8ICL-9^W'OM%9ZQ]QL7E]%[OAEP>'GTZ071T!9X#C=O'7("62'K#^OW[
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MKU^:7SRHV+ASQT;Q+CZ0R%BP3WA[KGZ-W*/B7M')MPOVD^*$9I<2!WV5Q;;
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M>YB9,08C49%#WW*[:+'<5E<<7XA7;<$IQIY;I+,>)$!U\(A*C1Q[OHNI!,:
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MQVQ6T7IJ'F[S ]E[7#M,.>M+L-I>0W8@)9^:HP &7$<K_:"E=P0'*J1<QRI
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M66X"(EU5J6DNUQGDP-LIBQ<C%J'&&#1/IV3=A&%8Y?5=RM0:Q;Z0GU'85\E
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MK2VNAUAVF8BNJK=:5B1LX,$;YL:-S>[G:2#W(?5LQ7JR@O(8L5YXU-$T*5>
MO0\WS$[9LJ5=Q=^LUB)KT6:5MNIAI><?:C-)S?V\OEDZE#=T"]T)NCDU+#^-
MQ%%*?Y4:,&L.6T4*QWV..Y63_O5KZ63^9X7J 86BPCXA\(=O56SZ9X2K0P4X
M^M:70. <"]Z,)XQ)(.2X '80X.Y1A=-P70('TK,27\C"J&+E*.I2?R@O(>@E
M<W_L?N#Y#$Y+%("MG6R(2\G/E!R/-Y13W&+B]LL$?->D.+'0):@5 5QE5'&&
M7ECVO?B-E;NV0DM22^1GW2I.]UD!]04$9_D2'6]=6D)PPC/67JI"'GG\B4.C
ME]%W& ]*S"%"C]0,@CF(AK38)N(94;PTX5;G",[&F?F$F@S&&)QV1D6FLG44
MY80=H6+M$_;S"4&E:FK_\IH8%%"\':V XH9BJ#>*1;C!UN)7HQY0,&PG/8L4
M:,*;:.)+ZU3,]JQ'['4@.8NE (.TWD":>-)WW#[.?0U]6:#+8N;<!NJ%,FE)
MB)*FEWC@>3J?<G4%5J"HL(VO8$FBAD>9E-M;&_\R\>Q>@EIS(!<';!-YZ602
MLD"DO@14'7D!:=X*#-P2QZ[?BA >J(PF77.=5>N\ZV!,45(X7UF/F$8QP+*F
MLK'C390>AFLMN-4A*^ ZV/ER5I[HK""$#Y6@T9Z"EI&7B8&5\40;UE/;(T4]
M74 E*25U&!Y,J@N9SXF!2[-01E2)GMKZ-M//LYEX/->Q$7@<M 4%P(:1-S;R
MWL9M1#U-)9I,):KHIK4 /KJ;O*FB(_3"NN",DVGO9L,OSI&14L\2]@70#!SC
M" P6U-:L5XK59MFENC3EUZ:T3$K?GEZ837$DOUHN1_+^BR.YB8J.I6$<VBD)
M&!J;**0(EHJ(YCKL2Y*!X0SYSRM4\-B99RYVNBY2<:8X.;&W!/EU2_1F: Q,
MO+.]J$4_>CKUDM/ NO!8.;)Z3\QY@\BB?;A;+\.;JIQ<?Q(_9GR'P/$FVCH-
M:%QYQTPOFFH&KFNN(Y4AO(&!+ 2OQ.H*/]ISLIM\IQD:'CK@!NW929$[[M%D
MI27PRE!)U1B?@-MB6RL&)"(1#"^#.Z^3 6:,]4D#L3U#V<$W# WF"]W$L)5&
M65/<JYM*IZ] \?NO$;_B.\6&JK8M-L5)6WN,TQF3ON&LQ'@-S$U]^0S/6EZC
MS5A+8XX":$A1VNQ<$.HB2YM-Z-A=KAL<65@"=$8,T%ZR'C(T -:;8C*4#23X
M3>(IB<WT5D]<7&7><8(DT8FTW.EEF?<2$;*G@$=95&_Y"]@YD'O,".\"INVT
MNW.AMB=!ATLG.S9N!.3;MS@FHS;9,Z,QK1AP=%P/QG:^WFR;820(8CIH*PVM
M*6P+97I \U\4'N'D<(/^SE7*H"MQD;) 2M*W8([JWPFL,F;P>,HHAX]]$"RQ
MP8"/!10^]>^ D>1I;&!>8PT5SVGI BP?-X#C8Q<Y/M8]%/$OQHZGD>AN>33J
MBI/>&4(^-ACR HH5)3$EC00(R0J$U5'74=JC)%*TN;@@GZ%JV5DLL>P7P):)
MY'@!/#("+6_CZ_=4#2> /8]>B.NXL[6UL[QK=W(T#CG0R]*],(FUQ ].OG-<
MTVECN;Q+:)=FPM'S+F+ RMW=ES4KS5&: /O9<K6SBGLOJUB.ZW,_>O3"22O*
M/SHHJUKJ.""K(]>X2*RZXY>,L9/6V)OZVS#4FUKZ?"2QCXGP,>Q2P,9@C7Z8
MZ$J!I7'OQ^N6=^MMDZEQ]D1T:T&'<Q@ HEZ=XBZ>G)]>'#CX?\'>V]?[5L^(
MEU>QUPKQF*Y.&%?3D+"HVET54;_TG-ZB3SM=\1R#P/ZL^W;8"B\'<SU@R'6.
MJ?FPZ]BIE!5>S,-"\J"Z%1Q3PM\YN4>PZWE::LV;/W%(HU2,-UV [HWKIW,8
M$Z"OO"ZZBOKQD<7)L&ST$4NX.."TNH+HM9VH5+:I:-+2-YTZ "#.+5]$#CP]
M8?S>OKD?=:D56Z&B6(<E3:XGVSH<O:@'8C_5@RL$R1>(>K<]D(]PK[+K2/+\
M:"V*Y(:3I0@P-@PR.$T:EY\_@1FDG*D5A1XU.\]PVN0G] J]I$W"\E*.-D1:
M^H'0-F=X[&*=$JJ#7H0:J%&,U@[8.\O$I,& >^*G=3B_<84@>!'YR QB((4(
MJ3I/.X-O\HI<78/\ECN2*3R&5-;Y>RXM:6D3.WE44(6"3M1Q7L3.$GQN)X\9
MT96&5^K:1BKR$V[;$]PO1DCNP]E ZSA[^J,Q)<+S>KDB/*]>(CR>LWQ_Z^^:
M%/*ZHL:Q7)9%Z:,N^0E)HC@J!$$L%*K1]=;Z4VB@Q7I)458.Q/?:80NUM^<!
MC-Y/67$HSW"T,%E8&T)M($"J*8"FEE79HEN,[2>,AQ=IY17C$ZE&3K,W:4V6
MH$EE.!%HHSFC7CHP:B F6]<$'UFZS9%F96T-\/,9;UM=N5:I1GAWL@PUFZ.;
M.2/1Z_^(R*S21GW&\;E)YWZ+283QQ/:W\#"[DG_]V,]E]+W%NR(Y(3FV#+HJ
ML#LT;(1*!JB@]# SX9J4'H2S146'%* 8$PF V?1#DSF +L\A$$'*WD/<+@*9
MA$/"]V._(<Y()R=ESV:<$BFLKN@2.?2!IE1<)UB26':Q@:VNDBSIU_!.SF*
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M)&QNMKN$8\L\QJP@-^R8LH2K*_.<\GE66E*]LIE6U\^NTC7VJ$>XBXDH(N2
MK&;?*U2[IJ^ANW9$- _(&VR%IY M36@2V1JBG*5,ND&5?N&H+)/5Z48D!.J
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MH+36>56OKG-S"#&SY[^U(&LGMP]9LRQX9QEM<?CV6\?]-/I^I]MP$,#20GW
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MV*Y#PO].,N%O7Q?9"EDZB\.75KW=NXUEGS&OB8QA3'\Z W9$HF][JE(,G0!
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M^;]^YU,KYNCN74\X&_:6$B.KZ 7>NR!H+.X%&\RNC3>O@D9@\@70>L/%[>'
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MGVO #>4"U-9VB=--2<3!TG969);DRGO8R'M60,X#E24O(TYIVRV!WRW1N>[
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M_-[3DR>37-1R&\X;9]-UGA!O)_7_2/:9[D;>S<;+D=6?M&%=BOZ@*Z1)9?Q
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M,&0=+0Z,-55;9+3DI*_*2NB"9:S-7-<&:N)NI\,!>>+6\2Q<'S2>FH93N^$
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MS:P;N4#A*8$BT#S110T<9<"11]M_/.=Y%-*)IC<K5FH(H?EWZP3?H"2Z_&.
M&):'<F8Z8O4!;$J!MFZ\P^HJ5T.?V[H$YVWAB2G_Y"$S$;:]Y_D5O./^>? L
M^<#CBZ]Z?/09#C!8G9&AJJ-+/Q>?7P*XX@.L@$EXQR02^A ;>?=#-B*YL8FP
M/&IJ!WY:0['KZHD_*[NLA;,Z?4/AG*# 1B0W-!''1Y_)1@3I(SNS7NL I,&
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MJ)M72]_9YJ)R0SI<"_63UO]-JQZ>H^PVQ#M$F7M\*,?Y<X&).-D\'(X/(0E
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MGSNJ?2\.J]KW_&"K?8/,Z-8VJ ,<]L)J@[U!<_]<5*"%%!V.!2-6WN;K#MF
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M3Q1+/$4)4+HUHX4A GR^*T"J6<^_@@N:*:&,IZ_8#3S]R+.-TXHLA^(5(@V
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MVT6=2[.N1,4B@<)(J)3TP"AU4S<JE;4#M<7=-O %?I?Z[2GQ1<A1>62\Y,C
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MC,U-T0VI:A^;!2M6)CG$@=N2+C@)68E&TKP6"E)*HQEKN)DC\W2;8$*8W\#
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M@"?+II.G9U-GQR'/ZI)<UCLV3U#6647ZC9S04R5X+T$X/KKC(R1>=D(+T/X
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M&'\%?31XR"L3DV8:T:/.']509S8J,O(!]4>+_[:3\6T2ITGK5/K1/'3*C:9
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MV>+/>D/]/R33TG9K,V3J N-JJ,9S,"C3PF.Q5S 9T8W>^>;^Z+T6LV=3VU!
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M)DS<@C2RR\W&$VO<C1Z0N IN"'Q)V*H9@_J'DG/&D0!&)7R),NQ%G5-LS.D
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MGR=O3Y)EOD!F:;,B &+39>\!#0[E:19K=]XLV<M1;S8==6>%&8Y:"'[/KTX
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M4K)KJNHS!'_$\AK' 8$1KS@?WNBM:Y@83FK'BFSW,36V0O9.AHJQ54FY?KA
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MWYVY8L:F[ (5#7HM 4Q/#W'%>'T\;"C6.C-OU%6V6*Y*%8\Y&O\VPB_6KK8
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M2P$"% ,4    " #$BS9;'FB132P#  #Q"P  $0              @ $
M87-S="TR,#(U,#DR,BYX<V102P$"% ,4    " #$BS9;(/O6)/T*  !_A@
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=,C Q+FAT;5!+!08     !0 % $,!   TR0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>dp234662_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="asst-20250922.xsd" xlink:type="simple"/>
    <context id="AsOf2025-09-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001920406</identifier>
        </entity>
        <period>
            <startDate>2025-09-22</startDate>
            <endDate>2025-09-22</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-09-22" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-09-22" id="Fact000004">0001920406</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-09-22" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-09-22" id="Fact000010">2025-09-22</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-09-22" id="Fact000011">STRIVE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-09-22" id="Fact000012">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-09-22" id="Fact000013">001-41612</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-09-22" id="Fact000014">88-1293236</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-09-22" id="Fact000015">200 Crescent Ct</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-09-22" id="Fact000016">Suite 1400</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-09-22" id="Fact000017">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-09-22" id="Fact000018">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-09-22" id="Fact000019">75201</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-09-22" id="Fact000020">855</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-09-22" id="Fact000021">427-7360</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-09-22" id="Fact000022">true</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-09-22" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-09-22" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-09-22" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-09-22" id="Fact000026">Class A Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-09-22" id="Fact000027">ASST</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-09-22" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-09-22" id="Fact000029">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-09-22" id="Fact000030">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
